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Patients with dysphagia following acute stroke are at increased risk of developing 
aspiration pneumonia, which leads to increased morbidity and mortality. Silent 
aspiration is a leading cause of aspiration pneumonia, but is notoriously difficult to 
identify by standard clinical swallowing examination. Adjunctive tests, such as cough 
reflex testing, have been evaluated as a means of increasing sensitivity of clinical 
assessment. 
  Historically, diurnal variation in cough sensitivity has been considered a major 
confounding variable that is controlled for by testing at the same time each day. Study 
I investigated whether such variation exists when the tidal-breathing method – 
commonly used in clinical assessment – is used to measure cough reflex sensitivity. 
Fifty-three young, healthy participants underwent cough reflex threshold testing on 
two occasions: once in the morning (between 9am – 12pm) and once in the afternoon 
(between 2 – 5pm). Oral bacteria levels were controlled for by participants’ brushing 
their teeth immediately prior to testing. There was no evidence of diurnal variability 
in cough reflex sensitivity, with morning cough thresholds (! = 0.4 mol/L) not 
significantly different from afternoon cough thresholds (! = 0.4 mol/L), p > .05. 
Regardless of time of day, first cough thresholds (! = 0.3 mol/L) were lower than 
second cough thresholds (! = 0.5 mol/L), p < .01, raising the question of 
reproducibility of cough reflex testing; an issue which warrants further investigation.  
Previous reports evaluating the effectiveness of cough reflex in acute clinical 
settings have provided mixed results. This has prompted careful consideration of how 
cough reflex testing should be translated into clinical routine and the development of 
a standardised management pathway. In Study II, pneumonia-related outcomes were 
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measured from 284 patients with acute stroke who were managed according to a 
Dysphagia in Stroke Protocol (DiSP). The DiSP guided clinical decision-making 
regarding oral intake based on clinical assessment with cough reflex testing and 
videofluoroscopic swallowing study (VFSS). Outcomes were compared to an 
historical cohort of 148 patients who were managed with cough reflex testing and 
VFSS in the absence of a prescriptive protocol. The rate of aspiration pneumonia was 
significantly lower among protocol-managed patients (10 %) compared to control 
patients (28 %). The odds of developing aspiration pneumonia were 3.24 times higher 
if no protocol was used. Although no differences in mortality were observed between 
the DiSP and control groups, patients in the DiSP group were more likely to be 
referred for a VFSS, spent significantly fewer days in hospital (24 days versus 32 
days; p < .001) and were more likely to be on a normal diet at three months post-
stroke compared to control patients. These data support the use of cough reflex testing 
when incorporated into a dysphagia management protocol. 
Patients with acute stroke and dysphagia are also at increased risk for 
colonisation by potential respiratory pathogens, which, if aspirated, have been linked 
to the development of aspiration pneumonia. There is evidence to support a 
relationship between oral hygiene and reflexive cough sensitivity in the elderly, but 
this relationship is poorly understood. To characterise this relationship, 102 patients 
with acute stroke and dysphagia underwent saliva sampling and cough reflex 
threshold testing at three time points: on admission to hospital, at discharge from the 
acute stroke ward and at one month post-stroke. In addition, patients’ medical notes 
were reviewed for symptoms of aspiration pneumonia. Molecular testing was used to 
measure the prevalence of pathogenic bacteria in saliva samples. No relationships 
between cough reflex sensitivity, oral bacteria levels and aspiration pneumonia were 
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found; however, results were limited by low statistical power. A non-significant trend 
for bacteria levels to increase following admission to hospital was observed, which 
warrants further investigation.  
This programme of research has contributed to the field of speech-language 
therapy by providing the first report of the effectiveness of the DiSP in reducing the 
incidence of aspiration pneumonia among patients with acute post-stroke dysphagia, 
as well as identifying future research directions for studies of oral bacteria in this 
population. Finally, this research has contributed to the growing body of knowledge 
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Chapter 1. Introduction 
Dysphagia represents a significant healthcare issue as it is associated with increased 
morbidity, mortality and associated healthcare costs. In the acute post-stroke period, 
patients are at increased risk of complications related specifically to aspiration 
pneumonia (AP). Multiple risk factors for AP have been identified, including silent 
aspiration and the aspiration – and lack of clearance – of pathogenic oral bacteria into 
the lungs. This research programme focused on predicting and preventing AP in an 
acute stroke population based on these risk factors.  
 Part A provides a review of the literature including an overview of swallowing 
physiology, reflexive airway protection mechanisms and oral bacteria. The 
consequences of dysphagia are discussed with particular attention to the acute post-
stroke period as well as the strengths and limitations of current clinical assessment 
and management approaches. The role of the reflexive cough response in airway 
protection is described as well as the consequences of impairments to this reflex 
(dystussia). Current issues in cough reflex testing methodology are also discussed. 
Finally, the role of oral bacteria in the pathogenesis of AP is reviewed with emphasis 
on previous research findings and evidence supporting a link between oral bacteria 
and cough reflex sensitivity is presented.  
 In Part B, three studies are presented that are related to predicting and 
preventing AP among patients with acute stroke and dysphagia. In Study I, attention 
was given to cough reflex testing methodology. Specifically, the question ‘does 
diurnal variation exist in cough reflex testing?’ was asked. Study II investigated the 
effects of the Dysphagia in Stroke Protocol in an acute patient population. Study III 
examined the relationships between pathogenic oral bacteria, cough reflex sensitivity 
and AP among patients with acute post-stroke dysphagia.  
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 In Part C, the results of the research programme are discussed. Due to the 
translational nature of this research, results have direct implications for clinicians 
working in acute dysphagia management. The DiSP has already been translated into 
current clinical practice in a number of hospitals, but continued refinement of the 
protocol to incorporate other risk factors for pneumonia is recommended. The impact 
of methodological limitations on the results is discussed and directions for future 
research are identified, particularly with regard to further studies of oral bacteria in 
patients with acute stroke. This research programme has contributed to the 
advancement of speech-language therapy practice by addressing gaps in the 
knowledge base supporting the use of cough reflex testing in clinical care and has also 
opened the door to future collaborative research between the fields of microbiology, 








Chapter 2. Normal Swallowing  
2.1 Swallowing Physiology 
Swallowing is a complex biological process that facilitates the transport of 
food from the oral cavity through the oesophagus and into the stomach in a safe and 
timely manner. While in reality swallowing is a single dynamic event, in order to 
conceptualise this, it can help to describe swallowing in distinct functional phases.  
Daniels and Huckabee (2008) describe swallowing as a four-stage process. 
The first phase is the pre-oral phase, in which preparation for the incoming bolus 
takes place. At a mechanical level, this may include the initiation of airway protection 
mechanisms (e.g. vocal fold closure) and increased salivation. At a higher cortical 
level, this may involve the monitoring of bolus size and rate of ingestion, as well as 
associating the visual and olfactory aspects of the bolus with certain memories. The 
second phase is the oral phase, where bolus acceptance, manipulation, and mastication 
occur, facilitated by volitional tongue movement. Bolus transfer from the oral cavity 
into the pharynx marks the end of this phase, and the beginning of the third 
(pharyngeal) phase of swallowing. This phase is characterised by a rapid succession 
of events: hyolaryngeal excursion, velopharyngeal closure, base of tongue to posterior 
pharyngeal wall approximation, pharyngeal shortening, epiglottic deflection, 
laryngeal valving, and relaxation of the upper oesophageal sphincter. During this 
phase, breathing must also cease to facilitate airway protection, and then rapidly 
resume. Temporal coordination of these components is crucial for the safe and 
efficient transfer of the bolus through the pharynx (Daniels & Huckabee, 2008). The 
final phase is the oesophageal phase, during which peristaltic contractions from the 
striated muscles and sequential contractions from the smooth muscles of the 
 
 27 
oesophagus propel the bolus through the upper and lower oesophageal sphincters and 
into the stomach.  
This system is not without potential for complications due to the anatomy of 
the swallowing mechanism. Due to the close proximity of the oesophagus and trachea, 
the potential for airway compromise is significant. In a healthy system, this risk is 
minimised by intrinsic pulmonary protective mechanisms.  
2.1.1. Pulmonary protective mechanisms. 
Due to the importance of pulmonary protection for survival, multiple airway 
protective mechanisms exist. During swallowing, the hyoid bone and larynx move 
anterosuperiorly and there is concomitant deflection of the epiglottis and pharyngeal 
shortening. The true and false vocal folds adduct upon activation of the 
thyroarytenoid, cricothyroid, lateral cricoarytenoid and vocalis muscles, providing 
another layer of airway protection. Compression of the quadrangular membrane 
effectively seals the entrance to the larynx during swallowing. This anatomical 
configuration serves to prevent material from entering the laryngeal vestibule – 
known as penetration – and proceeding into the tracheal airway – known as aspiration.  
 Another mechanism of pulmonary protection is the cough response. There are 
different types of cough response, including the cough reflex and the expiratory (or 
laryngeal adductor) reflex. The cough reflex is defined as “forced expulsive 
manoeuvre against a closed glottis” (Morice et al., 2007, p. 1256) whereas the 
expiratory reflex is defined as “a forced expiratory effort (without preceding 
inspiration) with closure of the glottis, followed by opening of the glottis and an 
expulsive phase” (Widdicombe & Fontana, 2006, p. 10). Although both reflexes have 
distinct neurological afferents and are subject to different modulations and inhibitors 
(Widdicombe & Fontana, 2006), the terms are often used interchangeably. In reality, 
 
 28 
the expiratory reflex often occurs in conjunction with a series of coughs and the 
distinction between the two types of reflex may not be clinically relevant (Addington 
et al., 2003).  
2.2. Neural Control of Swallowing 
 Swallowing is mediated by a complex neural network involving cortical and 
subcortical regions of the brain that relay sensorimotor information to the brainstem. 
It is accepted that the basic motor plan for swallowing is produced by a central pattern 
generator in the medulla (Daniels & Huckabee, 2008). This central pattern generator 
is comprised of groups of nuclei, including the nucleus tractus solitarius (NTS) and 
nucleus ambiguus (NA).  
The bilateral NTS, located in the dorsal region of the medulla, are the primary 
sensory nuclei for cranial nerves VII, IX, and X, and thus receives afferent signals 
from the tongue, pharynx and larynx, including the superior laryngeal nerve (critical 
for initiating the reflexive cough response). Cranial nerve V, with bilateral sensory 
nuclei located in the pons, also provide afferent information to the NTS. Important 
sensory information from the mucosal receptor cells in the pharynx, muscle spindle 
receptors in the pharyngeal and oesophageal muscles and specific cortical regions, 
converge in the NTS to facilitate the programming of a motor output for swallowing 
(Daniels & Huckabee, 2008). This contributes to the precision of muscle contraction 
(e.g. timing, pressure) that is required to swallow a variety of different bolus sizes, 
textures, and temperatures (Daniels & Huckabee, 2008).  
The second key components of swallowing motor control are the bilateral NA, 
located in the ventral medulla. The NA are the primary motor nuclei for cranial nerves 
XI, X and XI and thus supply input to the soft palate, pharynx and larynx, among 
other structures. Importantly, the NA receives direct efferent input from the NTS. This 
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connection allows the specific motor plan for swallowing, generated in the NTS, to be 
received by the NA and transmitted to the pharynx, larynx and oesophagus. Of 
particular interest is the presence of direct connections from the superior laryngeal 
nerve, essential for the elicitation of the protective cough reflex, in both the NTS and 
NA. In the case of a reflexive cough, bypassing the NTS and generating this response 
directly in the NA may be a survival adaptation in response to an aspiration event.  
Animal studies using repetitive electrical brain stimulation have identified that 
supratentorial regions of the brain directly influence swallowing (e.g. Miller & 
Bowman, 1977; Sumi, 1969). By using neuroimaging techniques in human subjects, 
researchers have identified a number of cortical structures that are activated during 
swallowing, including the pre- and post-central gyri, superior temporal gyri, middle 
and inferior frontal gyri, supplementary motor area, parietal cortex, anterior cingulate 
cortex, insula, frontal operculum and caudal anterior cingulate cortex (Huckabee, 
Deecke, Cannito, & Gould, 2003; Martin, Goodyear, Gati, & Menon, 2001; Martin et 
al., 2004; Suntrup et al., 2013; Vasant et al., 2014). However, in neural activation 
studies it is difficult to distinguish between cortical areas that are responsible for 
swallowing-associated functions (e.g. jaw movement) and swallowing-exclusive brain 
regions (Malandraki, Sutton, Perlman, Karampinos, & Conway, 2009). Studies which 
use blood oxygen level measures are also unable to differentiate excitatory versus 
inhibitory activation (Leopold & Daniels, 2009). The implication of the research to 
date is that any brain lesion has the potential to modify or disrupt swallowing in some 
form. In other words, disordered swallowing is not purely a function of a brainstem or 




Swallowing is a complex physiological process that involves timely and precise 
coordination of over 50 paired muscles innervated by five cranial nerves. While 
heavily brainstem-modulated, it also relies on input from cortical and subcortical 
areas. Stroke is a permanent brain injury caused by a sudden interruption in blood 
flow to the brain and can, as a result, impair swallowing. 
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Chapter 3. Stroke-related Dysphagia  
3.1. Cerebrovascular Accident. 
Cerebrovascular accident (CVA), also known as stroke, is a permanent loss of 
brain tissue as a result of disrupted blood flow. The vast majority of strokes occur as a 
result of an ischaemic event, where a thrombus (blood clot) or embolus (arterial 
plaque) becomes lodged in a blood vessel, disrupting the flow of blood. Eighty 
percent of strokes are ischaemic in nature (Della-Morte et al., 2012). The remaining 
twenty percent are attributable to a haemorrhage caused either by a ruptured blood 
vessel or a cerebral arteriovenous malformation (Birenbaum, 2010). In New Zealand, 
stroke represents the third largest cause of death (Ministry of Health, 2009). The long-
term consequences of stroke depend upon the site and severity of the lesion and the 
speed and effectiveness of the treatment.  
Dysphagia, or disordered swallowing, is a common consequence of acute 
stroke arising from injury to the neural, sensory, and/or motor systems that underlie 
deglutition. Medical literature suggests that the incidence of dysphagia is particularly 
high in stroke patients. Between 25-81 % of patients experience dysphagia in the 
acute stages of stroke, with the wide variation in incidence due to poor agreement 
between sources regarding what constitutes the acute phase and differing definitions 
of dysphagia (Daniels & Foundas, 1999; Gottlieb, Kipnis, Sister, Vardi, & Brill, 
1996; Kidd, Lawson, Nesbitt, & MacMahon, 1993; Langdon, Lee, & Binns, 2007; 
Mann, Hankey, & Cameron, 1999; Marik & Kaplan, 2003; Martino et al., 2005; 
Meng, Wang, & Lien, 2000). For many patients, swallowing function eventually 
resolves, however, persisting dysphagia has been documented in 50 % of stroke 
patients after 6 months (Mann et al., 1999).  
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The consequences of post-stroke dysphagia are often debilitating and can 
hinder recovery, resulting in increased length of hospital stay and long-term care 
requirements (Odderson, Keaton, & McKenna, 1995). Addressing outcomes for 
stroke patients with dysphagia has become a key focus of acute stroke care 
worldwide. 
3.2. Pathophysiology  
Stroke-related dysphagia is highly variable in presentation between patients, 
depending, in part, on the type of stroke and lesion laterality. Patients with 
haemorrhagic stroke are more likely to experience dysphagia compared to patients 
with ischaemic stroke (Paciaroni et al., 2004). However, the vast majority of strokes 
are ischaemic (Wardlaw, Murray, Berge, & del Zoppo, 2009). Lesions of the right 
hemisphere tend to be associated with pharyngeal dysfunction (e.g. poor pharyngeal 
motility, increased risk of aspiration) whereas left hemisphere lesions tend to result in 
oral dysfunction (e.g. poor bolus manipulation and transport [Robbins, Levine, Maser, 
Rosenbek, & Kempster, 1993; Robbins & Levine, 1988]). Although Daniels & 
Foundas (1999) reported no inter-hemispheric differences in dysphagia presentation, 
their dysphagia rating scale relied heavily upon observed penetration/aspiration, 
which is not a necessary feature of dysphagia. It has also been suggested that there 
may be a “dominant swallowing hemisphere” (Hamdy et al., 1997; Singh & Hamdy, 
2006) which, if damaged, is more likely to result in dysphagia compared to a lesion in 
the non-dominant hemisphere (Hamdy et al., 1997). Others, however, have reported 
more significant dysphagia (i.e. aspiration) in patients with lesions to the non-
dominant hemisphere (Robbins & Levine, 1988).  
Specific site of lesion also plays a significant role in dysphagic presentation. 
Bilateral cranial nerve damage is more likely to result in dysphagia and aspiration 
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compared to unilateral lesions (Horner, Massey, & Brazer, 1990; Horner & Massey, 
1988). Anterior lesions (relative to the central sulcus) are more often associated with 
the presence of dysphagia and aspiration, compared to posterior cortical lesions 
(Daniels & Foundas, 1999; Robbins et al., 1993). Lesions of the precentral gyrus tend 
to affect the contralateral facial, lip, tongue, and pharyngeal muscles (Veis & 
Logemann, 1985). Large vessel lesions (e.g. middle cerebral artery) are more strongly 
associated with aspiration compared to smaller vessel lesions (e.g. deep white matter 
[Daniels & Huckabee, 2008]). Brainstem strokes, while not as common as cortical 
strokes, tend to impair swallowing function the most (Martino et al., 2005). Lesions in 
this area can alter oral sensation and impair coordination of pharyngeal swallowing 
(i.e. the precise sequence of events involving swallowing initiation, hyolaryngeal 
excursion, airway closure, and upper oesophageal opening [Martino, Terrault, 
Ezerzer, Mikulis, & Diamant, 2001]). Other sites that have been associated with 
dysphagia include the pre-motor and primary motor cortices, primary somatosensory 
cortex, insula and periventricular white matter (Alberts, Horner, Gray, & Brazer, 
1992; Daniels & Foundas, 1999; Daniels, Foundas, Iglesia, & Sullivan, 1996). 
Even if the stroke occurs in an area of the brain that is not directly associated 
with swallowing, dysphagia may still be present. This is due to normal, age-related 
changes in anatomy, sensation and cognition. Symptoms such as prolonged bolus 
transport time through the oropharynx, decreased upper oesophageal sphincter (UES) 
resting tone and opening and increased post-swallow residue have all been 
documented in healthy, ageing populations (McKee, Johnston, McBride, & Primrose, 
1998; Rademaker, Pauloski, Colangelo, & Logemann, 1998). Since the incidence of 
stroke increases with age (Devroey, Van Casteren, & Buntinx, 2003), these normal 
swallowing changes may exacerbate dysphagia caused by stroke (Martino et al., 
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2005). Conversely, an elderly post-stroke patient may have reduced capacity to 
compensate for age-related swallowing changes (Martino et al., 2005). 
Given the many factors that can influence swallowing, it is not surprising that 
stroke-related dysphagia is highly variable in presentation between patients. 
Difficulties may be present in the pre-oral, oral, pharyngeal and/or oesophageal 
phases of swallowing. An example of pre-oral phase dysphagia may be ‘impulsive’ 
swallowing behaviours – poor monitoring of bolus size, rapid rate of ingestion, etc 
(Daniels, 2006). Oral phase dysphagia may be characterised by poor orolingual 
control of the bolus, including poor containment and preparation of the bolus prior to 
swallowing (Robbins & Levine, 1988). Pharyngeal phase dysphagia may present as 
any or all of the following: delayed initiation of swallowing (Robbins & Levine, 
1988), reduced anterior movement of the hyoid bone during swallowing (Teasell, 
Foley, Fisher, & Finestone, 2002), reduced contact between the base of tongue and 
posterior pharyngeal wall during swallowing, poor pharyngeal motility (Horner & 
Massey, 1988). Finally, oesophageal phase dysphagia may be characterised by 
impaired opening of the upper oesophageal sphincter muscle during swallowing 
(Logemann & Kahrilas, 1990). Any or all of these symptoms may be present on a 
continuum ranging from mild impairment to profound impairment. 
3.3. Consequences of Dysphagia 
The consequences of dysphagia in the acute stages of stroke are potentially life 
threatening. For example, malnutrition and dehydration can hinder survival and 
recovery if left untreated (Dávalos et al., 1996). Dysphagia has been associated with 
poor patient outcomes, including poor nutritional state, poor recovery from stroke and 
increased level of dependence for care (Smithard et al., 1996). Guyomard et al. (2009) 
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reported odds ratios for increased length of hospitalisation and mortality of 3.9 and 
12.5 among stroke patients if dysphagia was present.  
Utilising alternative routes of nutrition can be a temporary solution to some of 
these problems. Examples include nasogastric tubes for nutrition, intravenous fluids 
for hydration and administering medications sublingually or rectally. These temporary 
measures are often replaced by oral intake as recovery progresses. However, the use 
of alternative routes of entry for administering medications is not always beneficial, 
as this can change drug metabolism and effectiveness (Dollery, Davies, & Conolly, 
1971) and is associated with poor quality of life (Dennis, Lewis, & Warlow, 2005). 
Another potentially life-threatening consequence of dysphagia is aspiration of 
food or fluid into the respiratory tract. Approximately 54 % of acute stroke patients 
experience aspiration of pharyngeal contents into the airway (Holas, DePippo, & 
Reding, 1994). Aspiration is a leading cause of pneumonia during acute 
hospitalisation and carries an odds ratio for death of 4.35 (Power et al., 2009). 
Importantly, even when oral feeding is completely replaced with nasogastric tube 
feeding, 31 - 44 % of patients still develop pneumonia (Dziewas, 2004; Mamun & 
Lim, 2005). Prevention of pneumonia is a key goal of acute stroke intervention. 
A systematic review iby Martino et al. in 2005 reported the worldwide 
incidence of pneumonia following stroke. Internationally, the rate of pneumonia in the 
general stroke population was between 2 % to 16 %. In patients with dysphagia 
following stroke this increased to a range of 16 % to 19 %, with the exception of one 
study at 33 %. An earlier study that was not included in the review by Martino et al. 
reported a 44 % incidence of aspiration pneumonia, however a strict exclusion 
criterion of admission to hospital within 24 hours of stroke onset may have excluded 
patients with less severe strokes, resulting in selection bias (Dziewas, 2004). 
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Pneumonia continues to represent a significant healthcare issue, prompting the need 
to examine post-stroke dysphagia management practices.  
Attempting to prevent the development – and recurrence – of pneumonia relies 
on an understanding of the aetiology. The aetiology of pneumonia is explored below 
with reference to specific risk factors.   
3.4. Pneumonia 
Pneumonia can be broadly divided into two categories: community-acquired 
and nosocomial (hospital-acquired). As the name suggests, community-acquired 
pneumonia (CAP) originates in the community.  The infection is acquired via social 
contact. By contrast, nosocomial pneumonia can be defined as an infection that 
develops within 48 hours of admission to an institution such as a hospital or rest 
home. There are several different subtypes of nosocomial pneumonia, with distinctive 
aetiologies and underlying bacterial causes (Table 1). Aspiration pneumonia is of 
particular interest, given its association with dysphagia.  
3.4.1. Aspiration pneumonia.  
As its name suggests, aspiration pneumonia results from the introduction (aspiration) 
of food, fluid, or secretions that are colonised with pathogenic bacteria, at or below 
the level of the vocal folds. It is a common consequence of dysphagia among patients 
with neurologic injury. It should be noted that aspiration pneumonia differs from 
aspiration pneumonitis, which is a chemical injury to the lungs (Marik, 2001). The 
focus of this thesis will be on aspiration pneumonia. 
3.4.2. Diagnosis of aspiration pneumonia. 
A widely accepted definition of AP is an infective pneumonia that occurs in patients 
with a predisposition for aspiration (Lim et al., 2009; Mandell et al., 2007) following 
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Healthcare-associated pneumonia Patients who have been hospitalized or 
who reside in a rest home; patients with 
underlying disease; patients who have 
received parenteral antimicrobial 
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respiratory tract (Marik, 2001). There is currently no gold standard test to diagnose 
AP. The British Society for Antimicrobial Chemotherapy (2008) and American 
Thoracic Society (2005) have provided guidelines for the diagnosis of hospital-
acquired pneumonia (Table 2), although the latter guidelines do not take into account 
the quality of the evidence-base. Within the field of dysphagia, Mann et al. (1999) 
provide the most thorough and often-cited criteria for pneumonia, although there is 
difficulty extending these criteria to non-hospital populations where measures such as 
arterial blood gas are not routinely conducted. Other commonly cited criteria for 
diagnosing pneumonia in patients with dysphagia are listed in Table 2.  
3.4.3. Aetiology of aspiration pneumonia.  
In a landmark study in 1998, Langmore and colleagues described the multifactorial 
and complex aetiology of aspiration pneumonia. They analysed specific risk factors in 
189 male patients recruited from acute wards, nursing homes and outpatient clinics 
over a four-year period. Patients from intensive care units were not recruited, and few 
patients were recruited from post-surgical units. Dysphagia was not an inclusionary or 
exclusionary criterion in this study.  
The contributions of several specific risk factors in the development of 
aspiration pneumonia were evaluated. Participants with non-aspiration pneumonia 
were excluded from analysis but it is unclear how these participants were identified. 
Risk factors included dysphagia (as evident on videofluoroscopy and/or endoscopy), 
functional status, medical status and oral/dental status. Several variables related to 
oral bacteria, including number of decayed teeth and number of medications (leading 
to side effects such as reduced salivary flow and subsequent increased bacteria 





Diagnostic Criteria for Hospital-acquired Pneumonia from International Guidelines and Selected Journals Relating to Patients with Dysphagia  
Reference Major criterion Additional criteria 
American Thoracic Society 
(2005) 
New infiltrates on chest x-ray Two of: purulent secretions, fever (>38 °C), leukopenia/leucocytosis. 
The British Society for 
Antimicrobial 
Chemotherapy (Masterton 
et al., 2008) 
New infiltrates on chest x-ray or 
purulent secretions 
Fever (>38.3 °C), increased oxygen requirements, white cell count >10 or 
<4. 
Langdon, Lee, & Binns 
(2009) 
 At least three of: fever (> 38 °C), abnormal respiratory examination 
(tachypnea > 22 breaths/minute, tachycardia, bronchial breathing, 
inspiratory crackles), productive cough with purulent sputum, abnormal 
chest x-ray, arterial hypoxaemia (PO2 < 70 mmHg), isolation of a relevant 
pathogen (positive result on Gram stain and culture). 
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Yeh et al. (2011) Rales in breath sounds/dullness in 
chest percussion, or evidence of new 
infiltrate, consolidation, cavitation or 
pleural effusion on chest x-ray 
At least one of: purulent sputum, positive sputum culture, positive blood 
culture  
Bax, McFarlane, Green, & 
Miles (2014) 
 At least three of: fever (> 38 °C), abnormal respiratory examination 
(tachypnea > 22 breaths/minute, tachycardia, bronchial breathing, 
inspiratory crackles), productive cough with purulent sputum, abnormal 
chest x-ray, arterial hypoxaemia (PO2 < 70 mmHg), isolation of a relevant 
pathogen (positive result on Gram stain and culture). 
Bravata et al. (2009)  Clinician diagnosis of pneumonia or fever, cough, shortness of breath, 
evidence of pneumonia on chest x-ray 
Dziewas (2004)  At least three of: fever (> 38 °C), abnormal respiratory examination 
(tachypnea > 22 breaths/minute, tachycardia, bronchial breathing, 
inspiratory crackles), productive cough with purulent sputum, abnormal 
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chest x-ray, arterial hypoxaemia (PO2 < 70 mmHg), isolation of a relevant 
pathogen (positive result on Gram stain and culture). 
Gandolfi et al. (2014)  At least three of: fever (>38 °C), abnormal chest x-ray, abnormal 
respiratory examination, productive cough with purulent sputum, 
combined antibiotic therapy 
Mamun & Lim (2005) New infiltrate on chest x-ray Chest symptoms (new/worsening cough, choking, shortness of breath, 
bronchospasm), and raised white blood cell count or fever  
Gordon, Hewer, & Wade 
(1987) 
Cough or fever Evidence of new infiltrates on chest x-ray. 
Masiero, Pierobon, 
Previato, & Gomiero (2008) 
 At least three of: fever (> 38 °C), abnormal respiratory examination 
(tachypnea > 22 breaths/minute, tachycardia, bronchial breathing, 
inspiratory crackles), productive cough with purulent sputum, abnormal 
chest x-ray, arterial hypoxaemia (PO2 < 70 mmHg), isolation of a relevant 
pathogen (positive result on Gram stain and culture). 
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Mann et al. (1999)  At least three of: fever (> 38 °C), abnormal respiratory examination 
(tachypnea > 22 breaths/minute, tachycardia, bronchial breathing, 
inspiratory crackles), productive cough with purulent sputum, abnormal 
chest x-ray, arterial hypoxaemia (PO2 < 70 mmHg), isolation of a relevant 
pathogen (positive result on Gram stain and culture). 
Miles, Zeng, McLauchlan, 
& Huckabee (2013a) 
 At least three of: fever (> 38 °C), abnormal respiratory examination 
(tachypnea > 22 breaths/minute, tachycardia, bronchial breathing, 
inspiratory crackles), productive cough with purulent sputum, abnormal 
chest x-ray, arterial hypoxaemia (PO2 < 70 mmHg), isolation of a relevant 
pathogen (positive result on Gram stain and culture). 
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The highest incidence of AP occurred in rest-home patients (44 %), followed by 
hospitalised patients (19 %) and patients living in their own home (9 %). Of those 
who developed AP, large proportions were post-stroke (27 %), had ‘other’ 
neurological disease (33 %) or had respiratory, heart or gastrointestinal disease (32 
%). A diagnosis of both respiratory and gastrointestinal disease carried nearly a 50 % 
incidence of AP. Not surprisingly, patients with no underlying medical problems did 
not develop AP. Activity levels also played a role in the development of AP. Among 
participants who developed AP, 16 % were bed-bound and 43 % had reduced activity 
levels. These proportions were significantly higher than the corresponding values for 
patients who did not develop AP. Results contribute to an overall picture of general 
independence and physical health as likely protective factors against AP. The 
mechanism for this may be related to increased levels of oral pathogens in the 
dependent elderly (Russell, Boylan, Kaslick, Scannapieco, & Katz, 1999; Sumi, 
Miura, Michiwaki, Nagaosa, & Nagaya, 2007; Sumi, Miura, Sunakawa, Michiwaki, 
& Sakagami, 2002).  
There was a significant difference between patients who developed AP and 
those who did not with regard to the presence of dysphagia. Of patients who 
developed AP, 81 % were diagnosed with dysphagia. Among participants with 
dysphagia, 58 % aspirated liquid, 27 % aspirated food and 50 % aspirated secretions. 
These proportions were significantly lower amongst patients who did not develop AP. 
The presence of dysphagia and aspiration were significantly related to AP 
development, primarily amongst acute care patients. Other aspects of dysphagia such 
as delayed initiation of pharyngeal swallowing, premature spillage and post-swallow 
pharyngeal residue were also significantly related to AP.  
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Despite these significant associations between presence of dysphagia and 
development of AP, dysphagia did not emerge as an independent predictor of AP in 
the multiple logistic regression model. The best independent predictors for aspiration 
pneumonia in orally-fed, dentate patients were dependence for feeding (OR = 11.8 
[OR = odds ratio]) and multiple co-morbidities (OR = 7.3). When edentulous patients 
were also considered, dependence for feeding remained the most significant risk 
factor for AP (OR = 20.0), alongside multiple medications (OR = 1.2) and current 
smoking (OR = 4.1). When tube-fed patients were also included, significant risk 
factors were dependence for oral care (OR = 2.8) and tube-feeding (OR = 1.0).  
Of particular interest was the finding that dysphagia alone was not sufficient 
to cause aspiration pneumonia. In a person who is medically stable, active and 
independent in activities of daily life (especially feeding) and who has a clean and 
healthy mouth, dysphagia and aspiration may not be problematic in terms of 
pneumonia risk (Langmore et al., 1998). This theory is supported by the fact that 45 
% of healthy adults aspirate during sleep (Huxley, Viroslav, Gray, & Pierce, 1978) yet 
do not go on to develop aspiration pneumonia.  
The heterogeneity of the participant cohort in the Langmore et al. (1998) study 
can be considered both a strength and a weakness. On one hand, the results can be 
considered to be broadly generalizable to several different patient populations, 
including those in acute care as well as the more stable, nursing home residents. On 
the other hand, the study cohort was not so heterogeneous that results can apply to all 
patient groups. By including few post-surgical patients, no female participants and no 
participants with past/present head and neck cancer, the opportunity to identify 
population-specific risk factors, if any existed, was lost. Although the inclusion of 
control participants adds a useful comparison, the large imbalance in size between the 
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‘study’ group (n = 160) and control group (n = 29) makes it difficult to draw 
meaningful comparisons. 
Since the study by Langmore et al. (1998), several other research groups have 
attempted to identify independent risk-factors for AP that are specific to the acute 
stroke population. Among the findings, severity of stroke/stroke-related impairment, 
increased age, history of hypertension, low serum albumin, dysarthria or aphasia, 
diabetes mellitus, cognitive impairment, male gender and dysphagia have all emerged 
as independent risk factors for AP (Aslanyan, Weir, Diener, Kaste, & Lees, 2004; 
Dziedzic et al., 2006; Hinchey et al., 2005; Kammersgaard et al., 2001; Sellars et al., 
2007). Studies to date, however, are limited by a lack of blinding during outcome 
measurement (Aslanyan et al., 2004; Dziedzic et al., 2006; Hassan et al., 2006), lack 
of heterogeneity among stroke sub-categories (i.e. infarction versus haemorrhage 
[Sellars et al., 2007]), lack of instrumental examination of swallowing (Sellars et al., 
2007), lack of differentiation between community- and hospital-acquired pneumonia 
(Hinchey et al., 2005; Sellars et al., 2007) and a lack of robust methods for collecting 
pneumonia-related outcome measures (Sellars et al., 2007). Perhaps the greatest 
limitation of these studies is the restricted number of covariates taken into 
consideration (Dziedzic et al., 2006). Until a study that addresses these limitations is 
completed, it is difficult to say whether dysphagia is a true independent risk factor for 
AP in acute stroke patients. Regardless, the literature is in agreement that it is an 
important factor in the pathogenesis of AP. 
Langmore et al. (1998) used broad criteria to define pneumonia: fever, 
elevated white blood cell count and evidence of a new change on chest radiograph. 
This may have contributed to the high, observed rate of pneumonia at 22 %. While 
diagnosis of pneumonia was made by a team of three physicians including a 
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pulmonologist, one could argue that the criteria used were broad and lacked 
specificity, as fever and increased white cells are symptomatic of many kinds of 
infection and chest infiltrates are not unique to pneumonia. Unfortunately, it is 
impossible to compare pneumonia rates between studies that have used alternative 
diagnostic criteria due to the wide variability in applied exclusion criteria and 
confounding patient variables.  
Langmore et al.’s (1998) findings represented an important shift in the way 
clinicians approach dysphagia management in the acute and sub-acute phases of 
recovery. In the past, emphasis has been placed on dysphagia as the most important 
risk factor for aspiration pneumonia. By this line of thinking, keeping patients nil by 
mouth (NBM) and utilising alternative routes of nutrition and hydration or, 
alternatively, cautious assisted feeding, would be the best way to prevent AP. 
However, the evidence presented by Langmore et al. challenged this school of 
thought. In fact, their results suggested quite the opposite – that tube-feeding and 
dependence for feeding were two of the most significant risk factors for AP and 
presence of dysphagia was not. Langmore et al. proposed a model for the 
development of pneumonia, suggesting that a feature from each of the following must 
be present in order for pneumonia to develop: a) the presence of pathogenic bacteria 
in the upper aerodigestive tract, b) aspiration of pathogenic bacteria into the lungs and 
c) an inability to clear the aspirate, leading to bacterial colonisation and subsequent 
lower respiratory tract infection. Controlling these three factors may be one way of 
preventing aspiration pneumonia from developing in high-risk populations. Yet 
despite these findings being published almost 20 years ago, the role of bacteria and 
airway protective mechanisms are two areas of stroke research that remain relatively 
under-explored. Understanding these factors may have direct implications for how 
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patients with acute stroke are assessed for risk of AP as well as the management of 
patients with stroke-related dysphagia in the acute setting.  
3.5. Summary 
Stroke is a highly prevalent condition and a leading cause of adult long-term 
disability. Dysphagia is a common consequence of acute stroke (Daniels & Foundas, 
1999; Gottlieb, Kipnis, Sister, Vardi, & Brill, 1996; Kidd, Lawson, Nesbitt, & 
MacMahon, 1993; Langdon, Lee, & Binns, 2007; Mann, Hankey, & Cameron, 1999; 
Marik & Kaplan, 2003; Martino et al., 2005; Meng, Wang, & Lien, 2000) that 
increases the risk of pneumonia and death (Power et al., 2009; Sellars et al., 2007). 
For many patients, swallowing function eventually resolves. However, persisting 
dysphagia has been documented in stroke patients after six months (Mann et al., 1999; 
Smithard et al., 1997). Because stroke-related dysphagia is highly variable in 
presentation between patients, a thorough understanding of the risk factors for 
pneumonia is needed to adequately assess and manage this patient population. 
Dysphagia, when accompanied by increased oral bacteria, aspiration and poor 
pulmonary clearance, may substantially increase the risk of pneumonia in patients 
with acute stroke. Particular attention should be given to understanding the 
relationships between these risk factors and how they could be modified to decrease 
the risk of aspiration pneumonia.
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Chapter 4. Assessments and Interventions to Reduce the 
Incidence of Aspiration Pneumonia in the Acute Stroke 
Population 
4.1. Silent Aspiration: A Clinical Conundrum 
Langmore et al. (1998) identified aspiration of pathogenic bacteria into the lungs as a 
precursor to aspiration pneumonia in patients with dysphagia. Videofluoroscopy (VF) 
is considered to be the gold standard in dysphagia assessment and identification of 
aspiration. However, due to costs associated with equipment, training and skilled staff 
as well as the radiation exposure involved in VF, it is not appropriate to screen every 
patient using this tool. For this reason, alternative screening assessments have been 
developed that can be performed at bedside with little disruption to the patient. Many 
of these assessments use coughing as a clinical indicator, where the presence of cough 
suggests aspiration. For example, the water swallow test (DePippo, Holas, & Reding, 
1992; Gordon, Hewer, & Wade, 1987; Smithard et al., 1998, etc) defines aspiration as 
the presence of coughing during or up to one minute after swallowing certain amounts 
of water. The presence of wet dysphonia may also be used as a clinically positive 
indicator of aspiration during this test. Unfortunately, in using such tools, 
identification of aspiration can often be missed in patients who present with silent 
aspiration, defined as aspiration in the absence of a reflexive cough. 
An historic study by Splaingard and colleagues (Splaingard, Hutchins, Sulton, 
& Chaudhuri, 1988) reported that 42 % of patients who aspirated did so silently. Of 
utmost concern is that 70 % of patients with severe aspiration (as observed on 
instrumental assessment) were not identified as “at risk” on clinical assessment. In 
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other words, patients who were most at risk were also the least likely to be identified 
on clinical assessment (Splaingard et al.). Subsequent large-scale studies have 
supported this finding with very similar results (Garon, Ormiston, & Sierzant, 2009; 
Smith, Logemann, Colangelo, Rademaker, & Pauloski, 1999). 
Clinicians are faced with a significant challenge: how to identify silent 
aspirators at bedside? In an attempt to meet this challenge, several research groups 
have investigated the use of cough reflex testing (CRT [Addington, Stephens, & 
Gilliland, 1999; Leow, Beckert, Anderson, & Huckabee, 2012; Miles et al., 2013a; 
Miles et al., 2013b; Moore & Huckabee, 2013; Wakasugi et al., 2008; Watando et al., 
2004]). 
4.2. The Reflexive Cough Response 
Intact airway protection mechanisms are essential to prevent the development of 
aspiration pneumonia. The swallowing and cough reflexes, when intact, serve to 
protect the airway from aspiration of potential pathogens, and the attenuation of these 
reflexes is a main contributor in the development of aspiration pneumonia (Yamaya, 
Yanai, Ohrui, Arai, & Sasaki, 2001). For example, it has been reported that patients 
with stroke who show both a latency of reflexive swallowing of greater than five 
seconds and decreased cough reflex sensitivity have a higher incidence of pneumonia 
(Nakajoh et al., 2000).  
 Cough reflex testing has been utilised in the field of respiratory medicine since 
the 1950s (Bickerman, Barach, & Drimmer, 1954). More recently, the application of 
CRT to clinical dysphagia assessment and management has received attention, as 
research has revealed significant relationships between pneumonia and reduced 
voluntary cough strength (Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; Smith 
Hammond et al., 2009), reduced laryngo-pharyngeal sensation and reflexive airway 
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closure (Aviv et al., 1997) and reduced reflexive cough sensitivity (Addington, 
Stephens, & Gilliland, 1999; Miles et al., 2013a; Nakajoh et al., 2000; Niimi et al., 
2003), in patients both with and without impaired neurology.  
The role of CRT in clinical practice is to identify patients at risk of silent 
aspiration. It is important to note that a patient who presents with an abnormal 
response to CRT (e.g. “weak” or “absent” cough) cannot be labelled a “silent 
aspirator” as CRT does not involve the ingestion of any food/fluid to be silently 
aspirated and silent aspiration can only be identified through observation of internal 
structures i.e. via videofluoroscopy or nasoendoscopy. Rather, in the event of 
aspiration, an abnormal response to CRT may increase a patient’s risk of silent 
aspiration. 
The test itself involves inhalation of a tussive agent delivered via a nebuliser. 
In clinical practise, the outcome is measured by a subjective judgement of cough 
presence +/- cough strength. The European Respiratory Society Council (ERS) have 
published a recommended protocol (Morice et al., 2007). However, several methods 
of CRT have been described in the literature; to date there is no universally accepted 
method for research or clinical purposes.   
4.2.1. Cough reflex testing in dysphagia management. 
The application of CRT in clinical dysphagia management is fairly recent. As 
previously mentioned, CRT is an appealing tool as it is inexpensive, quick and non-
invasive compared to traditional assessment tools such as videofluoroscopy and 
videoendoscopy (VE). For use in screening, however, CRT must have acceptable 
sensitivity and specificity for detecting silent aspiration.  
Wakasugi et al. (2008) investigated the usefulness of CRT as a screening tool 
for silent aspiration at bedside by validating results from CRT against results from an 
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instrumental assessment, either videofluoroscopic swallowing study (VFSS) or 
videoendoscopic evaluation of swallowing (VEES). Participants (n = 204) ranged in 
age from 18 to 100 years, with a mean age of 70 years. Participants were a 
heterogeneous group that included both inpatients and outpatients with suspected 
dysphagia. Each participant underwent CRT and instrumental assessment, performed 
on the same day or within one day of each other. The CRT involved patients inhaling 
nebulised citric acid (1.0 w/v %) orally for one minute while their cough response was 
monitored. Five or more coughs was considered a ‘pass’ (normal) and less than four 
coughs was considered a ‘fail’. The result of precisely four coughs was not directly 
stated. 
 For approximately half of the participants, CRT results were combined with 
findings from another bedside diagnostic test: the modified water swallowing test 
(MWST [Tohara, Saitoh, Mays, Kuhlemeier, & Palmer, 2003]). The MWST consisted 
of a 3 mL aliquot of water placed on the floor of mouth. Participants were instructed 
to swallow the bolus followed by two saliva swallows. This procedure was repeated 
three times. The test was scored depending on the participants’ swallowing response, 
ranging from no response, to post-swallow dyspnea, to coughing and/or wet vocal 
quality. Participants suspected of severe aspiration did not undergo the MWST. 
 The CRT alone had a positive predictive value (PPV) of 0.74 and a negative 
predictive value (NPV) of 0.95. Sensitivity and specificity of the CRT for detecting 
silent aspiration was .87 and .89, respectively. Combining the CRT with the MWST 
improved the accuracy of dysphagia diagnosis. Using this protocol, 89 % of the 
predicted normal group were also found to be normal on instrumental examination, 73 
% of the predicted aspiration with cough group actually aspirated and coughed, and 
88 % of the predicted silent aspiration group were actually silent aspirators. The 
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protocol did, however, fail to identify one silent aspirator, and five patients who only 
silently aspirated trace amounts of fluid. The authors interpreted these results as 
evidence for combining the CRT and MWST and incorporating these into dysphagia 
bedside screening protocols. 
 A difficulty that the authors of this study encountered was how to analyse 
results from participants who coughed on large amounts of aspirate but did not react 
to trace amounts during VFSS. Initially, these participants were analysed separately 
from the silent aspiration group and the PPV and NPV of the CRT was very high. 
However, even when this group was re-analysed as silent aspirators, the PPV and 
NPV was 0.77 and 0.84, respectively. Regardless of how trace aspiration is 
interpreted, these results suggest that the CRT can predict silent aspiration with high 
levels of accuracy.  
 Patients in the Wakasugi et al. (2008) study were assigned to receive either 
VFSS or VEES to evaluate their swallowing. However, specific details regarding how 
this decision was made as well as comparisons between the two groups in terms in 
terms of dysphagia severity, aspiration, patient characteristics and CRT/MWST 
results were not reported. This may be problematic for clinicians attempting to 
generalise these findings to their own practice. VEES may result in a higher incidence 
of perceived aspiration compared to VFSS (Butler, Stuart, & Kemp, 2009). Results 
from data obtained using VFSS and VEES should not be pooled without first 
controlling for this. Another limitation of the Wakasugi et al. study was the lack of 
justification for the citric acid dosage. The clinical validity of the dosage used by 
Wakasugi et al. is unknown.  
 Miles et al. (2013b) addressed this in a validity study that included doses of 
citric acid that were based on normative data (Monroe et al., 2014). Cough reflex 
 
 54 
thresholds from 181 hospitalised patients referred for instrumental swallowing 
assessment were measured. Patients were allocated to receive either a VFSS (n = 80) 
or a VEES (n = 101). The prevalence of silent aspiration was 21 % for patients who 
received VFSS and 57 % for patients who received VEES. Sensitivity and specificity 
differed between the different types of instrumental assessment and at different doses 
of citric acid. Among patients who aspirated, for VFSS studies, the optimal dose of 
citric acid that identified a silent aspirator was 0.6 mol/L (71 % sensitivity and 
specificity). Among patients who aspirated, for VEES, the optimal dose of citric acid 
that identified a silent aspirator was 0.4 mol/L (69 % sensitivity, 71 % specificity). 
For both tests, sensitivity/specificity improved when trace aspirators were removed 
from the analysis and decreased when the non-aspirators were included in the 
analysis. The fact that the optimal citric acid dose differed between VFSS/VEES 
studies likely reflects that patients in the VEES group were older and more acutely 
unwell than the VFSS group and is a limitation of the study.  
Sensitivity/specificity values of the CRT reported by Wakasugi et al. (2008) 
and Miles et al. (2013b) compare favourably to other reported single measures of 
aspiration risk, suggesting that it is appropriate for use in clinical populations. As both 
studies reported findings from heterogeneous patient cohorts it remains unknown 
whether there is an optimum dose of citric acid that differs between patient 
populations. 
 Sato et al. (2012) completed a validation study of CRT methods using a hand-
held mesh nebuliser and citric acid in 141 adults with suspected dysphagia. 
Participants were a heterogeneous cohort, with the majority having cerebrovascular 
disease. The primary outcome measure was the time taken between presentation of 
citric acid (1 mol/L) and the participants’ first cough. Citric acid was presented 
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through a mouthpiece for a maximum of one minute. Participants also underwent a 
VEES within two days of the CRT and outcomes relating to aspiration were recorded. 
Aspiration was observed in 53 participants with silent aspiration in 37. Presenting 
citric acid for 60 seconds provided the best diagnostic accuracy for detecting silent 
aspiration with a sensitivity of 81 % and specificity of 65 %. Among the participants 
who aspirated, 30 seconds provided the best diagnostic accuracy from distinguishing 
silent aspirators from overt aspirators. While these results provided evidence for CRT 
methods, the study could have been strengthened by selecting a citric acid dose that 
was based on normative or clinical data. The use of a mouthpiece may also be 
problematic in neurologically-impaired populations where concomitant lip 
weakness/difficulty following instructions may be present.  
 Imoto, Kojima, Osawa, Sunaga and Fujieda (2011) attempted to characterise a 
cough reflex threshold level that would accurately inform safety for oral intake in a 
group of 21 patients with neurogenic dysphagia and twelve healthy control 
participants. Although a detailed description of their CRT technique was not 
provided, threshold testing using fifteen-second trials of capsaicin (0.5 – 250 μM) was 
completed. The main outcome measures were cough reflex threshold (as measured 
using the C5 criterion) and dysphagia severity (as measured by diet recommendation 
following VEES or VFSS). Dysphagia severity was classified as normal (i.e. no 
dysphagia), mild (full oral intake), moderate (oral intake with supplemental 
nutrition/hydration) or severe (no oral intake). Dysphagia severity was shown to have 
a moderately strong correlation to cough threshold level. Participants with normal 
swallowing had a cough threshold of 0.98 – 7.8 μM capsaicin, mild dysphagia 
correlated to a cough threshold of 1.95 – 15.6 μM, moderate dysphagia correlated to a 
cough threshold of 15.6 – 62.5 μM and severe dysphagia correlated to a cough 
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threshold of 31.2 – 250 μM. Despite the differences between groups being statistically 
significant, there is limited clinical significance of these findings due to considerable 
overlap in the range of capsaicin thresholds. Measuring dysphagia severity by diet 
recommendation levels is fraught with bias that comes with clinician experience and 
individual practice patterns, familiarity with the patient and within-patients factors 
such as dentition and food/texture preferences. CRT assesses laryngeal sensory 
integrity only and as such, a more appropriate criterion reference would be to measure 
presence/response to aspiration as viewed under videoendoscopy or videfluoroscopy. 
 More recently, Wakasugi et al. (2014) investigated the usefulness of a small, 
hand-held nebuliser in a similar heterogeneous cohort of inpatients and outpatients 
with suspected dysphagia. The study design and methodology were essentially the 
same as the 2008 study (Wakasugi et al., 2008) with the exception that the MWST 
was not used for dysphagia screening. Similar high sensitivity (0.86) and specificity 
(0.71) of the CRT were calculated for identifying silent aspiration. Positive predictive 
value was lower at 0.78 and negative predictive value was 0.93. Results confirmed 
previous findings that citric acid CRT can be used as a screening for silent aspiration 
risk in heterogeneous populations with acceptable sensitivity and specificity (Miles et 
al., 2013b; Wakasugi et al., 2008). However, the later study by Wakasugi et al. (2014) 
had the same limitations as earlier work, namely a lack of detail and comparative data 
between participants who received VFSS versus VEES and the pooling of data taken 
using these different assessments.  
 These limitations were addressed in a recent validation study by Guillén-Solà 
et al. (2015). First-event, subacute patients with stroke (N = 134) and suspected 
dysphagia underwent both CRT and VFSS. The CRT method involved presenting a 
single dose of citric acid (1 mol/L) for one minute and counting the number of coughs 
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produced by the patient. A result of four or fewer coughs constituted a ‘fail’ result. 
The nebuliser was an ultrasonic nebuliser with a flow rate of 3 mL/min. Specific 
details regarding the method of presentation (e.g. face mask, mouthpiece) were not 
reported. Patients underwent VFSS immediately following CRT. VFSS outcomes 
were measured using the Penetration-Aspiration Scale (Rosenbek, Robbins, Roecker, 
Coyle, & Wood, 1996) by a researcher who was blinded to the patients’ CRT result. 
Silent aspiration was identified on VFSS in 26 participants (19 %). Of this group, 
only five participants had failed the CRT. Out of the total number of patients who 
failed the CRT (n = 36, 27 %), five participants (14 %) were identified as silent 
aspirators on VFSS, 12 participants (33 %) were identified as normal, 14 participants 
(39 %) were penetrators and five participants (14 %) were overt aspirators. Sensitivity 
of the CRT for identifying silent aspiration was 0.19, specificity was 0.74, positive 
predictive value was 0.5 and negative predictive value was 0.4. The authors 
concluded that the single-dose method of CRT using citric acid at a concentration of 1 
mol/L is not an appropriate screen for silent aspiration in subacute stroke patients.  
 There are several limitations of this study. Inclusion criteria for the study was 
suspected dysphagia based on the results of a volume-viscosity swallowing test 
(Clavé et al., 2008). This test relies on several subjective judgements (i.e. observed 
coughing, change in vocal quality) as well as objective measures (i.e. oxygen 
desaturation) to identify aspiration. However, given that there is little convincing 
evidence that a change in vocal quality is a reliable indicator of penetration/aspiration 
and that oxygen desaturation is not considered to be a valid marker of aspiration 
(Steele & Cichero, 2014), it is concerning that this was the main inclusion criteria for 
the study. It is likely that a selection bias that limited the number of patients with 
silent aspiration was a factor in this study, although the reported prevalence of 35 % is 
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similar to other published reports of 38-39 % in subacute dysphagic patients (Holas et 
al., 1994; Horner & Massey, 1988). Decreased cognition was an exclusion criterion 
for this study, which may also contribute to a selection bias and decrease the 
generalizability of results. Another explanation for the low sensitivity observed by 
Guillén-Solà et al. (2015) could be related to trace aspirators. Previous researchers 
have noted that people who present trace silent aspiration during VFSS are more 
likely to pass CRT compared to people who silently aspirate larger amounts 
(Wakasugi et al., 2008) and higher sensitivity of CRT is achieved when trace 
aspirators are removed from data analysis (Miles et al., 2013b; Wakasugi et al., 2008). 
It is not clear from the data reported by Guillén-Solà et al. (2015) whether sensitivity 
of the CRT may have been affected by a high proportion of trace silent aspiration.  
 Wakasugi et al. (2008), Miles et al. (2013b) and Wakasugi et al. (2014) 
demonstrated that CRT can identify patients who silently aspirate with reasonable 
sensitivity and specificity. In terms of cost, patient comfort, and time taken to 
administer, CRT presents as a clinically useful alternative to many other single 
measures in identifying those patients most likely to benefit from further instrumental 
swallowing evaluation. The next logical question is: how does using CRT translate to 
reduced end-point pneumonia rates in patients with dysphagia?  
 Addington, Stephens, and Gilliland (1999) compared 602 consecutive acute 
stroke patients from two different hospitals to examine whether the use of CRT would 
differentiate patients who developed pneumonia from those who did not. The CRT 
protocol involved the use of nebulised tartaric acid (20 % solution l-tartaric acid 
dissolved in 2 mL saline) that participants inhaled as a microaerosol through a 
mouthpiece at the bedside. Data were not included when there was leakage around the 
mouthpiece. The CRT concluded when either a) a cough response was elicited, or b) 
 
 59 
there was no response after three trials. An algorithm was provided to Speech-
Language Therapists (SLTs) to guide their interpretation of CRT results. Specifically, 
where participants demonstrated a strong cough and had adequate cognition 
(subjective judgement relating to the participant’s capacity to follow compensatory 
strategies), the SLT was advised to complete the bedside swallowing exam, including 
presentation of oral trials. Where participants did not have intact cognition, SLTs 
were advised to proceed with the bedside exam, but consider alternative feeding (i.e. 
nasogastric tube [NGT], percutaneous endoscopic gastrostomy [PEG]). Where 
participants presented with an absent or weak cough, the SLT was advised to 
recommend a restricted diet, NBM, or alternative feeding. The procedure for standard 
clinical swallowing evaluation was described, including evaluation of cranial nerves, 
cognition, volitional cough, a two-part water swallowing test, post-swallow vocal 
quality, and trials of foods and fluids of varying texture/consistency.  
 Participants were followed for the duration of their acute stay (average 9-10 
days) and outcomes related to pneumonia recorded. Within the CRT group, 1 % 
developed pneumonia versus 13 % of the no-CRT group (p < .001). The authors 
concluded that CRT was effective in identifying pneumonia risk in patients with acute 
stroke and could be used to prevent the development of pneumonia by informing 
decisions around feeding.  
 The results of this study are significant both clinically and statistically (high 
statistical power was reported). However, there were also several significant 
limitations in methodology. The major limitation was the absence of a true control 
group. Confounding variables such as differing oral care practices, patient meals, 
hygiene practices, medical management, etc, combine with significant effect to 
decrease the validity of results. Furthermore, the authors mention that an inadequate 
 
 60 
lip seal around the mouthpiece during CRT was not considered to be an “effective 
inhalation”, however it is unclear how many patients could not could not achieve an 
adequate lip seal and were excluded from data analysis. In a clinical population, it is 
expected that a substantial proportion of patients may present with a poor lip seal due 
to unilateral hemiplegia/hemiparesis, dystonia of the orbicularis oris muscle, poor 
attention to the task, etc. If high numbers of patients were excluded from this study 
the results lose generalizability and significance. This may also account for the low 
reported pneumonia rates. Finally, the authors did not report their reasons for 
selecting the dosage of tartaric acid that was used in the study and do not cite 
normative data, leaving the reader unclear about what constitutes a clinically 
abnormal response and subsequently, whether patients’ responses to CRT were 
normal/abnormal. However, the early work by Addington et al. (1999) has paved the 
way for subsequent studies, which has ultimately improved the body of knowledge 
and quality of evidence in this area.  
 One such study was completed by Miles et al. (2013a), who completed a 
Phase III randomised controlled trial that sought to further evaluate the use of CRT in 
standard clinical practice. Patients with acute stroke from four metropolitan hospitals 
(N = 311) were randomised to either a) a control group who received usual care in 
terms of swallowing assessment and management according to local clinical 
protocols, or b) an experimental group who underwent CRT in addition to usual care, 
with CRT results informing subsequent swallowing management. Results revealed 
that patients who underwent CRT had a higher frequency and speed of referral for 
instrumental assessment (VFSS or VEES), compared to patients in the control group. 
However, in contrast to Addington et al. (1999), the use of CRT did not significantly 
reduce pneumonia or mortality rates.  
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 The authors suggested that this result may have been in part attributable to a 
heavy reliance on clinician judgement and interpretation of CRT findings in the 
absence of a defined management protocol, such as was seen in the Addington et al. 
(1999) study. Qualitative analysis of clinician comments as well as anecdotal 
evidence suggested that routine clinical practice was often favoured over decisions 
that incorporated the novel CRT results, which may well have resulted in 
unfavourable patient outcomes. Indeed, this could be seen in the rate of referral for 
instrumental assessment amongst patients who ‘failed’ CRT (i.e. had an absent 
reflexive cough) – merely 46 %. In other words, 64 % of patients with absent 
reflexive cough were initially managed based on clinical impression alone.  
 The findings from Miles et al. (2013a) suggest that clinicians’ ability to 
identify aspiration risk does not necessarily result in the prevention of aspiration 
pneumonia in their patients. In order for this to occur, assessment findings must be 
reflected in management decisions.  
Several considerations need to be taken into account when applying CRT to 
clinical or research applications, including the different types of equipment, tussive 
agents, method of administration, instructions given to the subject, within-subject 
diurnal variation in cough response, placebo effects, the effects of tachyphylaxis and 
the effects of medications on reflexive cough. These are explored below.  
4.2.2. Equipment. 
Nebuliser flow rate has been found to impact cough response to citric acid by altering 
the deposition of aerolised particles (Barros, Zammattio, & Rees, 1990). For this 
reason, the ERS recommend the same nebuliser (or nebulisers with identical output) 
be used for all research involving CRT, preferably a compressed air-driven nebuliser 
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controlled by a dosimeter and inspiratory flow regulator valve that limits output to 0.5 
L/second (Morice et al., 2007).  
4.2.3. Administration of CRT. 
Two main methods of CRT administration are described in the literature: vital-
capacity breath inhalation (e.g. Addington, Stephens, & Goulding, 1999) and tidal-
breath inhalation (e.g. Miles et al., 2013a). The vital-capacity breath inhalation 
method requires the subject to exhale and then take a deep inspiration through a 
mouthpiece that delivers the tussive agent. The subject’s nose is pinched or blocked 
during the test and cough response is recorded. Flow rate is controlled via a 
dosimeter, which eliminates variation in intra-subject inspiratory effort. In contrast, 
the tidal-breathing method uses a facemask that covers the nose and mouth to deliver 
the tussive agent for a specific period of time at a specific flow rate. The subject’s 
nose may or may not be blocked, and cough response is recorded. Both methods have 
advantages and disadvantages. As noted by Miles et al. (2013a), the tidal breathing 
method may allow more opportunity for cortical modulation of the cough reflex 
compared to the vital-capacity method which may be more likely to elicit a true 
reflexive cough. On the other hand, the tidal breathing method does not require 
compliance to a specific set of instructions (Miles et al., 2013a) and as such may be 
more appropriate for use in patient populations where language, cognition or 
oromotor function are impaired, such as in acute neurological settings. Fifteen-second 
presentations of the tussive agent is considered sufficient when the outcome of 
interest is number of coughs (Dicpinigaitis, 2007).  
Aerosol deposition in the upper and lower respiratory tract has also been 
shown to vary depending on whether a person breathes through their nose, mouth, or 
through a mouth-tube (Wolfsdorf, Swift, & Avery, 1969). Nasal breathing and oral 
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breathing results in a greater proportion of particles deposited in the upper respiratory 
tract compared to breathing through a mouth-tube. In contrast, breathing through a 
mouth-tube deposits more particles in the lower respiratory tract compared to nasal or 
normal mouth breathing. As noted by Miles et al. (2013a), for application in 
dysphagia assessment, CRT incorporating nasal or mouth breathing may be preferable 
as the goal is to test integrity of laryngeal airway protection mechanisms rather than 
lower respiratory tract function.  
4.2.4. Tussive agents. 
The most commonly used tussive agents include tartaric acid (Addington, Stephens, 
& Gilliland, 1999), capsaicin (Dicpinigaitis, 2003a; Sams, Truncale, & Brooks, 2005), 
citric acid (Leow et al., 2012; Miles et al., 2013a; Miles et al., 2013b; Monroe, 
Huckabee, & Robb, 2010; Smith, Owen, Earis, & Woodcock, 2006; Wakasugi et al., 
2008) and distilled water (Fontana, Lavorini, & Pistolesi, 2002). Of these, citric acid 
may be preferable for use in dysphagia assessment, as it is known to stimulate both 
the chemo- and mechano-receptors of the larynx (Morice et al., 2007) in a manner 
that is reproducible across time (Wright, Jackson, Thompson, & Morice, 2007), less 
susceptible to the effects of tachyphylaxis (Morice et al.) and has no reported adverse 
reactions (Bickerman et al., 1954).  
To date, the only normative data available on response to citric acid cough 
reflex testing are from two observational studies reported in a single publication 
(Monroe, Manco, Bennett, & Huckabee, 2014). These data represent 160 healthy 
individuals with equal proportions of males, females, young (under 60 years) people 
and old (over 60 years) people. Cough reflex was tested in individuals by presenting 
nebulised citric acid via a face mask for up to 15 seconds. Both the natural cough 
reflex and suppressed cough reflex (i.e. participants were instructed to try to suppress 
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the cough) were measured, with two consecutive coughs on two out of three trials 
constituting a positive response. Data from these studies suggest that 5 % of healthy 
individuals may not produce a reliable cough response to citric acid when presented at 
concentrations of up to 1.2 mol/L and 22 % may be able to suppress the cough reflex 
beyond 1.2 mol/L. Among those in which a reflexive cough was triggered, 90 % of 
participants demonstrated a natural cough by 0.8 mol/L with 96 % of participants 
unable to suppress their cough reflex at 1.2 mol/L. The mean threshold for the natural 
cough reflex was 0.4 mol/L in both old and young participants. Female participants 
showed both significantly lower natural cough thresholds and suppressed cough 
thresholds compared to males. 
4.2.5. Outcome measurement in CRT 
Several methods of recording cough reflex outcome measures have been reported in 
the literature. In laboratory-based studies, objective measures such as recording cough 
airflow (e.g. Troche, Brandimore, Okun, Davenport, & Hegland, 2014), cough 
inspiratory volume and total expired volume (e.g. Hegland, Troche, & Davenport, 
2013), compression phase duration and cough volume acceleration (e.g. Wheeler 
Hegland, Troche, Brandimore, Davenport, & Okun, 2014) have been described. Most 
clinical studies, however, simply rely on counting the number of coughs (Addington, 
Stephens, & Gilliland, 1999; Guillén-Solà et al., 2015; Miles et al., 2013a; Miles et 
al., 2013b; Wakasugi et al., 2008, 2014). The ERS Task Force recommend using 
either the C2 or C5 method (i.e. two or five consecutive coughs following presentation 
of the tussive [Morice et al., 2007]). As the response to the tussive agent is usually 
immediate, a fifteen-second measurement period is sufficient (Dicpinigaitis, 2007). 
As discussed above, this method has been shown to satisfactorily identify patients at 
risk of silent aspiration. 
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4.2.6. Safety of CRT equipment. 
Typical nebulisers used in CRT generate small particles of 1 – 3 µm diameter that, 
when inhaled, can reach the terminal bronchioles and alveoli of the lungs. Since the 
1960s, inhalation therapy equipment has been linked to cases of nosocomial 
pneumonia (Reinarz, Pierce, Mays, & Sanford, 1965). Pathogenic bacteria colonise 
the equipment and are subsequently inhaled into the lungs, leading to infection. There 
are important distinctions between the use of nebulisers for inhalation therapy as 
opposed to CRT. First, when CRT is applied per the protocol described by Miles et al. 
(2013a), the total time of inhalation is around 45 seconds, with frequent pauses 
throughout. This is less than the time it takes for bacteria to reproduce. By 
comparison, nebulisation therapy typically lasts several hours. Second, given that the 
equipment used in CRT is single-use only, the risk of contamination is likely to be 
lower than that used of inhalation therapy equipment, which is cleaned and re-used 
(Ombler & Huckabee, 2015). Using the same CRT equipment described in the 
literature (e.g. Miles et al., 2013a), Ombler and Huckabee (2015) reported no 
significant bacterial growth in the mask, reservoir cup or tubing when comparing pre- 
and post-nebulisation with citric acid. However, it should be noted that these results 
reflect a laboratory environment and a single, careful administrator of CRT, as 
opposed to a hospital setting with intra-individual variation in CRT practises. 
Falconer et al. (2014) investigated the stability of citric acid solution (0.8 M) stored at 
4 °C and the sterility of two-week old citric acid from a hospital ward as well as citric 
acid that was inoculated with C. albicans, E. coli and S. aureus. Stability was 
maintained over 28 days. In the innoculated citric acid, E. coli and S. aureus were 
killed but C. albicans remained viable. There was no evidence of contamination of the 
ward-based citric acid. The authors recommend the use of aseptically prepared citric 
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acid in single-use aliquots to reduce the risk of accidental contamination. However, in 
the real-world condition of ward-based citric acid, no contamination was detected, 
suggesting that careful repeated opening of citric acid may be acceptable. It should be 
noted that only three organisms were tested for in only one concentration of citric 
acid. Further research is needed to clarify best practice around the storage and use of 
citric acid for CRT.  
4.2.7. The impact of diurnal variation in CRT. 
Another consideration in the administration of CRT is within-subject diurnal variation 
in cough reflex sensitivity. This was first described in the mid 1980s (Pounsford & 
Saunders, 1985). Cough sensitivity was measured in ten healthy participants (age 
range = 19 – 40 years) by presenting nebulised citric acid at varying concentrations 
(i.e. cough reflex threshold testing; CRTT) in the morning (between 9am – 12pm) and 
the afternoon (between 2pm – 5pm). The vital-capacity method was used. The lowest 
concentration of citric acid that elicited a reflexive cough was considered to be that 
participant’s cough threshold. Testing was carried out over four days (two morning 
sessions and two afternoon sessions) and an average of the morning values and 
afternoon values was used in analysis. Two out of ten participants had no response to 
citric acid; their data were excluded from analysis. The remaining participants had 
significantly higher cough reflex thresholds in the afternoon, compared to the 
morning. An analysis of variance revealed no significant change in the mean cough 
reflex threshold over the four days. The authors concluded that diurnal variation in 
cough response to citric acid represents a significant potential confounding variable, 
which should be controlled for by testing at the same time of day. It remains unknown 
whether the same diurnal variation in cough reflex sensitivity is present or observable 
in dysphagic patient populations (e.g. acute stroke), whether such changes are 
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clinically significant or whether the effect is present when different CRT methods are 
employed. In research applications, controlling time of day may be more feasible. 
Indeed, when steps are taken to control time of day, cough reflex thresholds have 
been shown to remain constant within participants across time (Rees & Clark, 1983). 
4.2.8. Placebo effects in CRT. 
There is evidence for a placebo effect in evoked cough reflex testing. Rostrami-
Hodjegan, Abdul-Manap, Wright, Tucker and Morice (2001) gave healthy subjects a 
placebo antitussive syrup followed by repeated presentations of 1 M citric acid via a 
face mask. Participants demonstrated an immediate suppression of the number of 
coughs, compared to baseline measures. This increase in cough suppression continued 
in a non-linear fashion to peak at 4 hours post-placebo administration, with females 
adapting their cough response significantly quicker than males (p < .05). Similar 
findings have been reported using capsaicin-induced cough testing (Hutchings & 
Eccles, 1994; Leech, Mazzone, & Farrell, 2012).  
Findings such as those reported by Rostami-Hodjegan et al. (2001), Hutchings 
and Eccles (1994), and Leech et al. (2012) suggest that the cortex may play a 
significant role in the modulation of cough. Mazzone, Cole, Ando, Egan, and Farrell 
(2011) tested this theory using functional brain imaging in healthy participants who 
performed different tasks relating to cough: 1) inhalation of nebulised saline (control 
condition), 2) voluntary cough, 3) evoked cough in response to inhaled capsaicin, 4) 
suppressed cough in response to inhaled capsaicin. Results showed that, despite 
sharing many areas of cortical activation, voluntary cough, evoked cough and 
suppressed cough were each associated with unique areas of the cortex. For example, 
evoked cough was associated with activation of the posterior insula, posterior 
cingulate cortex, primary motor and somatosensory cortices, premotor cortex, and 
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medulla that was distinct from voluntary or suppressed cough, while activation of the 
lower brainstem was conspicuously absent in voluntary cough. Suppressed cough was 
associated with unique activation in the pre-supplementary motor area and caudate. 
The authors concluded that capsaicin-evoked cough is not purely a brainstem-
mediated response to airway irritation, rather it involves active cortical involvement 
(an ‘urge to cough’) and is able to be regulated by higher level inhibitory functions. 
Studies of cortical activation such as this are, however, constrained by the fact that 
some of the observed cortical activation may relate to cognitive-language processing 
associated with the task.  
With evidence such as Mazzone et al.’s (2011) in favour of complex cortical 
interactions during both reflexive and voluntary cough tasks, it has been proposed that 
a suppressed cough condition may give a more accurate picture of laryngeal 
sensitivity, as cortical inhibition can no longer override the brainstem response to 
cough (Hegland, Bolser, & Davenport, 2012; Monroe et al., 2010). This has 
implications for the instructions that are given to subjects undergoing cough reflex 
testing. Studies of evoked cough in both healthy subjects (Hutchings & Eccles, 1994; 
Leow et al., 2012) and subjects with Parkinson’s Disease (Leow et al.) have 
demonstrated that subjects are able to inhibit or produce cough to a very large extent 
depending on the instruction they are given (i.e. “cough if you need to” vs. “try not to 
cough”). The ERS guidelines on the assessment of cough (2007) caution researchers 
to expect a significant placebo effect in research involving cough reflex testing and to 
design research studies accordingly. To rule out voluntary suppression of the cough 
and to increase participant blindness during threshold testing, the use of placebo 
presentations is recommended (Dicpinigaitis, 2007; Morice, 1996; Morice et al., 
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2007). Instructing participants to suppress the cough may also be useful when 
assessing integrity of the reflexive airway protection mechanisms. 
4.2.9. Effects of tachyphylaxis in CRT. 
Short-term tachyphylaxis, or blunting of the reflexive cough response, has been 
documented where multiple doses of citric acid or capsaicin have been presented over 
short (e.g. one minute) periods of time (Morice, Higgins, & Yeo, 1992). This has 
implications for randomised, repeated presentation study designs, as it is likely that 
decreased sensitivity to lower citric acid concentrations would occur as a result of 
short-term tachyphylaxis (Morice, 1996). In order to avoid this, presenting citric acid 
in increasing increments with 30-second intervals is recommended, with placebo 
saline interspersed throughout (Morice et al., 2007; Morice, Kastelik, & Thompson, 
2001). In addition, to avoid the significant adaptation effect that occurs between 
presentation one and presentation two (Morice et al., 1992), it is recommended for 
research that all participants are familiar with cough testing before measures are 
recorded, e.g. present a placebo saline dose prior to citric acid presentations.  
4.2.10. Reproducibility in CRT. 
Because the number of coughs that a person produces in response to evoked cough 
reflex testing varies between trials, it is recommended that a number of trials are 
performed in order to obtain a more accurate measure of cough frequency (Morice, 
1996). The same is likely to be true for measuring reflexive cough thresholds. Table 3 
summarises some of evidence for within-subject variability in cough reflex 
thresholds. A large number of studies have found cough reflex thresholds to be highly 
correlated within subjects, with variations rarely more than one dose, or one 
“doubling dose” above or below initial thresholds. However, such a statement does 
not take into account that the difference in concentration of tussive agent between 
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Table 3.  
Evidence of Within-subject Variability in Cough Reflex Testing 
Fujimura, Sakamoto, Kamio, & Matsuda (1992) 
Study population Healthy adults (N = 38) 
Nebuliser type Bennett Twin nebuliser 
Inhalation method Tidal breathing, 15 seconds 
Tussive agent Tartaric acid 1.56 – 800 mg/mL 
Outcome measure C5 response 
Reproducibility testing Test repeated within three days in a subgroup of nine participants 
Reproducibility of outcome measure Reproducible – no correlation between the difference and size of thresholds. 
Comments Difference in thresholds was within two doubling concentrations. 
O’Connell, Thomas, Studham, Pride, & Fuller (1996) 
Study population Healthy adults (N = 103) 
Nebuliser type Dosimeter-controlled nebuliser 
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Inhalation method Vital-capacity method, one-second inhalation 
Tussive agent Capsaicin 0.5-500 μM 
Outcome measure Number of coughs in one minute 
Reproducibility testing A control group (n = 26) were measured at 6-18 months after baseline test 
Reproducibility of outcome measure Reproducible – 95 % of thresholds were reproducible within one incremental dose 
Pounsford & Saunders (1985) 
Study population Healthy adults (n = 8) 
Nebuliser type Wright’s nebuliser, 10 L/minute 
Inhalation method Vital capacity method, five second inhalation 
Tussive agent Citric acid 0.025 – 0.9 M 
Outcome measure Presence of cough 
Reproducibility testing Tested over two morning sessions and two afternoon sessions 




Comments No more than two doses difference between morning and afternoon. A non-significant trend for cough 
reflex thresholds to decrease over time.   
Barber et al. (2005) 
Study population Healthy adults (N = 25) 
Nebuliser type Hand-held glass DeVilbiss 40 nebuliser Air-driven nebuliser controlled by a Mefar MB3 breath-
activated  dosimeter 
Inhalation method Vital-capacity method, two-second inhalation Vital-capacity method, one-second inhalation 
Tussive agent Citric acid 0.01 – 3 M Citric acid 0.01 – 3 M 
Outcome measure Number of coughs in 10 seconds Number of coughs in 10 seconds 
Reproducibility testing Test repeated at the same time of day on 
consecutive days in 11 participants 
Cough thresholds compared to alternative nebuliser 
Reproducibility of outcome measure Reproducible – r = 0.96. 91 % of thresholds were 
reproducible within one incremental dose 
Reproducible – outcomes measured by the different 
nebulisers correlated highly, r = 0.95 
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Comments Measurements obtained using two different nebulisers correlate highly, but differ by 2-3 threshold levels 
Di Franco et al. (2001) 
Study population Healthy adults (n = 16) 
Nebuliser type DeVilbiss 646 jet nebuliser 
Inhalation method Vital-capacity method, one-second inhalation 
Tussive agent Citric acid 0.5 – 10-4 M Capsaicin 10-4 – 10-8 M 
Outcome measure Number of coughs in one minute Number of coughs in one minute 
Reproducibility testing Test repeated after one week in a subgroup of 
eleven participants 
Test repeated after one week in a subgroup of nine 
participants 
Reproducibility of outcome measure Reproducible – ICC = 0.75 Less reproducible – ICC = 0.55 
Dicpinigaitis (2003b) 
Study population Healthy adults (N = 80) 
Nebuliser type Compressed air-driven nebuliser (DeVilbiss 646), dosimeter-controlled, 1 mL/minute 
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Inhalation method Vital-capacity, one-second inhalation 
Tussive agent Capsaicin 0.98 - 1000 μM 
Outcome measure C2 and C5 response in 15 seconds 
Reproducibility testing Forty participants measured two weeks after initial testing. Forty participants measured 6-62 months after 
initial testing 
Reproducibility of outcome measure Reproducible – 75-85 % of short-term thresholds and 83 % of long-term thresholds were reproducible 
within one doubling dose 
Comments Short-term reproducibility was superior to long-term reproducibility 
Rees & Clark (1983) 
Study population Healthy young males (N = 8) 
Nebuliser type Hudson nebuliser 
Inhalation method Vital capacity method, one- second submaximal inhalation 
Tussive agent Citric acid 1 – 50 % 
Outcome measure Single cough 
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Reproducibility testing Tested three times at the same time of day. Tests at least one week apart 
Reproducibility of outcome measure Reproducible – cough thresholds never varied by more than one dose level 
Bickerman et al. (1954) 
Study population Healthy adults (n = 21) and adults with asthma (n = 17) 
Nebuliser type Vaponefrin nebuliser, flow rate 6 L/minute 
Inhalation method Five successive inhalations of tussive agent 
Tussive agent Citric acid 5 – 10 % 
Outcome measure Number of coughs during in five minutes 
Reproducibility testing Tested at weekly or monthly intervals over 2 – 9 months. The number of tests varied between participants 
Reproducibility of outcome measure Undetermined 
Comments Descriptive statistics reported only. Participants’ responses were “fairly consistent” (p. 162) 
Midgren, Hansson, Karlsson, Simonsson, & Persson (1992) 
Study population Healthy adults (N = 26) 
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Nebuliser type Bird asmastick, flow rate 0.5 mL/minute 
Inhalation method Tidal breathing method, tussive presented for one minute 
Tussive agent Capsaicin 2, 10, 50 μM   
Outcome measure Number of coughs during presentation of tussive 
Reproducibility testing Re-tested at 20 minutes and 1-14 days 
following initial test (n  = 12) 
Re-tested three months following initial test (n = 9) 
Reproducibility of outcome measure Reproducible for 10 and 50 μM (p > .05) but 
not for 2 μM (p < .05) 
Reproducible for 2 and 10 μM (p > .05). 50 μM not 
tested 
Nejla, Fujimura, & Kamio, 2000 
Study population Healthy adults (n = 22) and patients with respiratory illness (n = 4) 
Nebuliser type Dosimeter-controlled jet nebuliser (DeVilbiss 
601) 
Bennett Twin jet nebuliser, 5 L/minute 
Inhalation method Single inhalation Tidal breathing for fifteen seconds 
Tussive agent Capsaicin 0.49 – 4000 μM Capsaicin 0.49 – 4000 μM 
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Outcome measure C5 during one minute period following 
presentation of tussive 
C5 during presentation of tussive 
Reproducibility testing Test repeated one – three weeks following initial test 
Reproducibility of outcome measure Reproducible – r = 0.76 Reproducible – r = 0.84 
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doses can often be large. Importantly, it is unknown whether such differences are 
clinically significant. For example, the difference between a cough reflex threshold of 
0.4 mol/L and 0.6 mol/L citric acid is enough to accurately distinguish a silent 
aspirator from non-silent aspirator in a hospital setting (Miles et al., 2013b). It is 
difficult to draw firm conclusions from the literature as few studies have controlled 
for the potentially confounding variable of time of day on cough response. There are 
also large within- and across-study variations in the amount of time between repeated 
measures as well as tussive agent, nebuliser and tussive dose. Information regarding 
the instructions given to participants is rarely reported and there is a lack of 
consistency in the method of outcome measurement. In 2007, Morice et al. called for 
the amount of information about CRT reproducibility to be increased. To date, this 
has yet to be adequately addressed.  
4.2.11. Drug effects on reflexive cough. 
Several medications have been documented to either suppress or enhance reflexive 
cough sensitivity. Opioids have been shown to suppress the reflexive cough response 
in animal models (Kamei, 1996) and to reduce suppressed cough reflex sensitivity in 
healthy human participants (Kelly, Shaw, Brett, Greenwood, & Huckabee, 2016). 
Angiotensin-converting enzyme (ACE) inhibiting drugs are commonly used to treat 
hypertension and have also been shown to increase cough reflex sensitivity in animal 
models (Ebihara, Sekizawa, Ohrui, Nakazawa, & Sasaki, 1996; Sekizawa et al., 
1996). Antihistamines may also reduce cough reflex sensitivity in patients with 
chronic cough, but do not affect the cough reflex sensitivity of healthy people 
(Tanaka, Hirata, Kurihara, Yoshikawa, & Takeda, 1996). From a clinical perspective, 
the various interactions between medication and cough reflex sensitivity may be less 
relevant as the outcome of interest is simply the patient’s risk of silent aspiration.  
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4.2.12. Medical conditions and their relationship to the cough reflex. 
Several conditions have been documented to result in increased cough reflex 
sensitivity, including gastroesophageal reflux disease (Phua, McGarvey, Ngu, & Ing, 
2010), asthma, (Koskela, Purokivi, Kontra, Taivainen, & Tukiainen, 2008), allergic 
rhinitis (Pecova, Vrlik, & Tartar, 2005), atopic dermatitis (Pecova, Frlickova, Pec, & 
Tatar, 2003) and chronic obstructive pulmonary disease (COPD [Doherty, Mister, 
Pearson, & Calverley, 2000]). While smoking reduces cough reflex sensitivity 
(Dicpinigaitis, 2003a), smoking cessation leads to improved reflexive cough 
sensitivity after only two weeks (Dicpinigaitis et al., 2006). It is unknown whether 
this enhanced cough reflex sensitivity may be present earlier than two weeks post-
smoking cessation. A recent study demonstrated that a reflexive cough sensitivity is 
significantly inhibited after only a single electronic cigarette (e-cigarette) session 
(Dicpinigaitis, Chang, Dicpinigaitis, & Negassa, 2016). In this study, the effects of 
the e-cigarette were transient (i.e. lasting less than 24 hours) and only observed in e-
cigarettes containing nicotine.   
Decreased cough reflexive sensitivity has been documented in patients with 
pneumonia in two small studies. Niimi et al. (2003) measured cough reflex sensitivity 
to inhaled capsaicin in seven patients with recurrent pneumonia and no underlying 
medical condition and compared this to healthy age- and gender-matched controls. 
Cough reflex thresholds were significantly higher in the recurrent pneumonia group 
compared to controls. Nakazawa, Sekizawa, Ujiie, Sasaki and Takishima (1993) 
measured cough reflex sensitivity to inhaled citric acid in ten patients with dementia, 
ten patients with aspiration pneumonia and ten healthy controls. Participants were 
closely age-matched. While the control participants had an average cough reflex 
threshold of 2.6 mg/mL, cough thresholds were higher in participants with dementia 
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and aspiration pneumonia, at 37 mg/mL and 180 mg/mL, respectively. Seven out of 
ten participants with aspiration pneumonia did not cough at the highest level of citric 
acid, 360 mg/mL. Unfortunately no further statistical analyses or instrumental 
swallowing assessments were undertaken so it is not clear how statistically or 
clinically relevant these differences were. The authors also did not provide further 
details about how aspiration pneumonia was diagnosed or how recent the diagnosis 
was, which makes it difficult to generalise these findings further.  
The studies presented by Niimi et al. (2003) and Nakazawa et al. (1993) raise 
an interesting question: does decreased cough reflex sensitivity lead to pneumonia or 
does pneumonia decrease cough reflex sensitivity? Further investigations involving 
larger sample sizes are required to definitely answer this question. However, other 
explanations must also be considered, such as the relationship between oral hygiene 
and reflexive cough sensitivity in patients with recurrent pneumonia.  
In patients with acute neurological injury such as stroke, the transient or 
permanent loss of reflexive cough sensitivity has been related to a condition referred 
to as ‘brainstem shock’ (Addington, Stephens, Widdicombe, & Rekab, 2005). This 
condition is defined as a global neurological event affecting one or more vital 
functions, including the reticular activating system, respiration and the cough reflex. 
Patients in brainstem shock may have reduced consciousness, reduced respiratory 
drive and/or reduced cough reflex sensitivity, irrespective of stroke location. 
Addington et al. propose that recovery from brainstem shock may be an important 
predictor of patient outcomes.  
Others have proposed that certain neurological injuries may actually heighten 
cough reflex sensitivity. Smith and Wiles (1998) proposed a model whereby 
corticobulbar pyramidal tract lesions may lead to hypersensitivity of the cough reflex. 
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This theory was based on their study of 28 heterogeneous patients on a neurological 
ward. They reported that patients with dysphagia (as identified by a water-swallowing 
test) had similar or increased cough reflex sensitivity to inhaled capsaicin as 
compared with non-dysphagic patients. This study was significantly limited by the 
lack of a homogeneous patient cohort, lack of instrumental assessment for dysphagia, 
small sample size and lack of normative data for capsaicin-induced cough thresholds 
and the extent to which results can be generalised to typical patients with acute stroke 
is uncertain. It remains unknown whether patients with acute stroke can be 
categorised as either hypo- or hyper-reflexive in terms of cough sensitivity by their 
specific site of lesion. Further investigation into patterns of recovery of the cough 
reflex in stroke is also warranted.     
While CRT provides clinicians with insight into patients’ risk of silent 
aspiration, in order to ensure positive outcomes for patients, CRT results must be 
incorporated appropriately into clinical management decisions. One way to achieve 
this may be the use of standardised management protocols.   
4.3. Standardised Patient Management 
In their review of healthcare quality, Every et al. (2000) explain the difference 
between clinical guidelines, clinical protocols, and clinical pathways. Clinical 
guidelines are recommendations developed to assist clinicians and patients in 
choosing the appropriate course of action in response to a specific condition or 
scenario. Guidelines incorporate expert consensus and current scientific knowledge 
relating to the prevention, diagnosis, treatment, and management of particular 
diseases (Hasnain-Wynia, 2006). Clinical pathways, while based on clinical 
guidelines, are management plans that describe patient goals as well as the timing and 
sequence of events required to achieve these goals with maximum efficiency. Such 
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pathways are useful tools that can highlight inefficiencies in health services 
irrespective of whether there is evidence for implementing changes to those services. 
There are certain benefits of clinical pathways, for example, as a means of reducing 
variation in patient care, improving quality of care, and maximising resource usage.  
Similarly, clinical protocols are intended to reduce variation in patient care. However, 
unlike clinical pathways, clinical protocols place more value on guideline compliance 
than identifying opportunities to streamline treatment. They are treatment plans or 
specific steps to be taken in patient care, and the patient’s response is continuously 
monitored. Protocols can be conceptualised as a practical, step-by-step guide to 
implementing clinical guidelines (Hasnain-Wynia).  
Although it may seem intuitive that flexibility in decision-making regarding an 
individual patient’s presentation may be beneficial to that patient’s care, the opposite 
may in fact be true: patients who are managed with standardised protocols have better 
outcomes compared to patients receiving non-standardised care. An example of this 
can be found in the field of acute traumatic brain injury (TBI), a population whose 
treatment has traditionally been highly variable between facilities and clinicians. 
Fakhry, Trask, Waller and Watts (2004) devised a standardised protocol for all patient 
with severe TBI that incorporated staff education and the timing of medications and 
specific interventions. After 6 years, compliance with the protocol was 85 %. 
Compared to pre-protocol figures, patients managed with the new protocol spent 
significantly less time in the intensive care unit and total length of hospital stay was 
reduced by five days. In addition, the overall mortality rate dropped by 4 % and 
patient outcomes (as measured by the Glasgow Outcome Scale) significantly 
improved to the point where the over half of patients experienced either “good 
recovery” or only “moderate disability”. As compliance with the protocol improved, 
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patient mortality and length of stay outcomes also improved. The authors concluded 
that eliminating variance in treatment using a standard care protocol was effective at 
improving patient outcomes and reducing the associated cost of care.  
Although compelling, the findings from this study are not immune to the 
significant effects of bias, due to the prospective-retrospective nature of this study. 
The possibility that random variation, or other uncontrolled factors, played a part in 
the results did not go unrecognised by the authors. Although a positive trend towards 
increased survival was observed, the causes of death in both the historical and 
present-day cohorts were not reported, leaving the reader to question the reason for 
increased survival rates. Could it be possible that improvements in survival were due 
to factors unrelated to TBI? Without additional details, it is impossible to tell. 
Similarly, it is difficult to draw strong conclusions from the authors’ report of reduced 
length of hospital stay. Such an outcome is sensitive to changes in policy, inter-
facility transfer agreements, numbers of beds, funding, etc, and as such the results 
should be interpreted with caution.  
Similar reports of success following the implementation of standardised patient 
management protocols have been reported in more recent studies among patients with 
a range of morbidities from septic shock (Micek et al., 2006), fractured neck of femur 
(Friedman, Mendelson, Kates, & McCann, 2008) and oesophageal cancer (Low et al., 
2007). Despite this, the literature surrounding standardised management in patients 
with dysphagia is surprisingly scarce; research regarding dysphagia post-stroke is 
even more rare.  
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4.3.1. Dysphagia assessment and management protocols in acute stroke 
care 
During the acute phase, patients with stroke have a very high risk of dysphagia, 
pneumonia, and mortality from aspiration pneumonia (Addington, Stephens, & 
Gilliland, 1999; Holas et al., 1994; Martino et al., 2005) and standardisation of patient 
care following stroke is strongly supported as a means of improving patient outcomes 
(Altman, 2011). 
International published guidelines from both the American Stroke Association 
(Jauch et al., 2013) and the Stroke Foundation of New Zealand (Stroke Foundation of 
New Zealand & New Zealand Guidelines Group, 2010) state that all acute stroke 
patients should remain NBM until they have undergone swallowing screening and be 
referred for SLT dysphagia assessment if indicated. Yet despite these few very clear 
recommendations, details regarding dysphagia assessment and consequent 
management are distinctly lacking.  
Historically, research in this field has focussed on the use of dysphagia screening 
protocols (e.g. Hinchey et al., 2005; Perry & McLaren, 2003) and standardisation of 
dysphagia assessment tools (e.g. Mann & Hankey, 2001; Middleton et al., 2011), 
while protocols for the initiation of oral feeding and prescription of diet consistency 
are lacking. In fact, only six studies have been identified which have attempted to 
evaluate the effects of a dysphagia assessment and management protocol in acute 
stroke care. One of these, conducted by Addington et al. (1999), has already been 
discussed above.  
One of the first published reports of a dysphagia-specific stroke management 
protocol was by Odderson et al. (Odderson et al., 1995), who studied 124 patients 
with acute non-haemorrhagic stroke who were managed according to a dysphagia 
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assessment and management protocol. The assessment arm of the protocol consisted 
of dysphagia screening conducted by a SLT or nurse. Screening items included the 
patient’s level of alertness, a subjective judgement of voice and volitional cough 
strength, the ability to swallow water and ice chips ‘briskly’, subjective evidence of 
laryngeal elevation during swallowing and no overt signs of post-swallow aspiration. 
Patients who passed screening proceeded to an oral diet of puree consistency with thin 
and thick fluids; if this was tolerated the patient could advance to other textures. 
Patients who failed screening remained on a restricted diet and were referred for 
instrumental swallowing assessment. All patients were reviewed daily by a SLT. A 
total of 39 % of patients failed swallowing screening and were considered to be 
dysphagic. In the year-long study period, no patients developed AP. Three patients 
died, however the cause of death was not reported. Unfortunately, no comparisons 
were drawn between patients managed per the dysphagia protocol and a control group 
of patients not managed per a protocol. The authors reported that the use of this 
protocol was successful and cost-effective, although this is difficult for the reader to 
judge in the absence of a control group. The rationale and implementation of this 
protocol is problematic for several reasons. First, the authors’ justification for using 
ice chips/water in the swallowing screen was that aspiration occurs only on liquid 
boluses. This is inaccurate. Second, the presence of a strong volitional cough was 
included in the screen to identify patients at risk of aspiration. It is now known that 
volitional coughing activates different neural networks from reflexive coughing 
(Mazzone et al., 2011) and results in a different expiratory pattern (Addington, 
Stephens, Phelipa, Widdicombe, & Ockey, 2008). For these reasons, Addington et al. 
(2008) have stated that it is inappropriate to attempt to assess reflexive airway 
protection status using voluntary cough measures. Third, the screening items do not 
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account for silent aspiration. Fourth, even patients who failed screening were 
provided with oral intake, although the compensatory strategy of diet modification 
was put in place. Given these limitations, it is surprising that no patients developed 
AP during the year-long study period. Perhaps other aspects of stroke management, 
e.g. aggressive antibiotic use, could account for this finding.     
Leder, Suiter, Warner, Acton, and Siegel (2012), investigated the effects of a 
dysphagia assessment and management protocol in a heterogenous group of patients 
(including stroke) with suspected dysphagia who were referred for a SLT assessment 
of swallowing. Participants (N = 1000) were recruited from a tertiary care, teaching 
hospital. Participants had a range of aetiologies including head and neck surgery, 
dementia, Parkinson’s disease and stroke. Details of pre-existing medical conditions 
were not reported. The protocol dictated that all patients underwent a 90 mL water 
swallow challenge (uninterrupted drinking from a cup or using a straw). An inability 
to drink the entire amount uninterrupted or coughing during or immediately following 
the test were considered a ‘fail’ response; these patients were excluded from the rest 
of the study. If a patient passed the water swallow challenge, the SLT completed an 
oromotor examination and a basic cognitive bedside evaluation. Diet 
recommendations were based on these results: if the patient was edentulous, they 
received a puree diet and regular fluids, all other patients received either a puree, soft 
or regular diet with regular fluids. Patients received a follow-up visit from the SLT 
within 12-24 hours and nursing staff discontinued oral intake if overt signs of 
aspiration were noted. Outcomes were measured via chart review after 1 day. 
Outcomes of interest were: diet level, percent of meal eaten and volume of liquid 
ingested during a meal. Ninety-three patients were excluded from analysis after their 
medical condition worsened post-swallowing assessment. No further details about 
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these patients were reported so it cannot be ruled out that worsening pulmonary 
function may have been present. Results revealed that all patients were drinking 
regular fluids “successfully and safely” at 12-24 hours post-swallowing assessment, 
although the criteria for determining this was not reported. Patients ate between 10-
100 % of their first meal, however, more specific data for this outcome was not 
reported, nor was the proportion of the different diet consistency levels. The authors 
concluded that the swallowing assessment and management protocol assisted SLTs to 
recommend specific oral diets successfully, negating the need for instrumental 
assessment of dysphagia among patients who pass the 90 mL water swallowing 
challenge.  
While the authors should be commended for tackling an important, under-
researched aspect of dysphagia assessment and management, the methodology 
employed in this study unfortunately limits the usefulness of results. For example, 
patient outcomes were only evaluated at one point in time, 12-24 hours after 
swallowing assessment. By neglecting to measure patient outcomes beyond this time 
period, the opportunity to investigate important long-term outcomes was lost. 
Hospital-acquired pneumonia is defined as pneumonia which develops at least 48 
hours following admission (American Thoracic Society, 2005) and is easily measured 
by employing the same chart review technique that was used in this study. In addition, 
the validity of the outcome measures is questionable. ‘Total amount ingested’ and 
‘diet recommendation’ are only two potential outcomes of dysphagia assessment, 
while other important outcomes such as penetration/aspiration, pneumonia, nutritional 
status, quality of life, and mortality were overlooked. Based on their limited outcome 
measures, the authors have over-generalised their results to conclude that 100 % of 
patients were able to swallow “successfully and safely” post-assessment. One could 
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argue whether the patients (n = not reported) who only ingested 10 % of their first 
meal were indeed swallowing “successfully” and an absence of long-term health 
outcome measurement (e.g. aspiration pneumonia) and instrumental assessment limits 
the extent to which comments can be made about swallowing “safety”. 
Also of concern is the apparent lack of consideration of silent aspiration. The 
main author has also published a study that reports silent aspiration as ‘volume 
dependent’ i.e. individuals who silently aspirate small bolus volumes (i.e. 1-10 cc) 
tend to show overt signs of aspiration on larger bolus volumes [i.e. 90 mL] (Leder, 
Suiter, & Green, 2011). In fact, what the 2011 study showed was that over 50 % of 
small-volume, liquid silent aspirators did not cough while completing the 90 mL 
water-swallow test. On this basis, the authors’ conclusion that the issue of silent 
aspiration is mitigated when using the 90 cc water-swallow test is questionable. 
Although the study population was both large and heterogenous, the greatest 
proportion (36 %) of patients had presented to hospital with ‘medical’ aetiologies. It 
is unclear whether such heterogeneity increases generalizability to patients outside of 
this study or whether it disguises any effects specific to sub-populations, such as acute 
stroke. The authors identified that this protocol is not appropriate for use with 
tracheostomised patients due to the high risk of silent aspiration in this group and 
likelihood of high false negative results.  
This study assessed a protocol for dysphagia assessment and management in the 
acute setting. Further development of such a tool must include a plan for 
rehabilitation and review if SLTs are to continue to offer a holistic approach to patient 
care. Burek et al. (2008) conducted a three-year study documenting outcomes relating 
to pneumonia in patients with stroke following the implementation of a strict acute 
clinical management protocol. The protocol included nurse dysphagia screening 
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within two hours of admission to hospital, standardising dysphagia assessment and 
intervention provided by SLTs and optimising VFSS imaging protocols. Details of 
SLT dysphagia assessment and interventions were not reported. It was mentioned that 
when SLT services were not available (i.e. after hours), the Standardized Swallowing 
Assessment (Perry, 2001) was performed, although details of who performed this 
were not provided. An additional focus of this study was on education of the MDT. 
For example, nurses were provided training in oral hygiene and assisting patients with 
eating. This training occurred in the first year of the study only. 
A significant overall reduction in pneumonia rates was documented from 11.1 
% to 5.4 % over three years following implementation of the clinical management 
pathway. The proportion of patients with dysphagia changed minimally from year to 
year, as did the distribution of dysphagia severity levels. Interestingly, among patients 
who were considered severely dysphagic, the rate of pneumonia decreased 
dramatically from 37 % to 21 % in the first year of the protocol. However, in the 
second year, the pneumonia rate rose to 47 %. The authors speculated that the reason 
for this may be that those patients were simply too severely impaired to benefit from 
the protocol, which may be better suited to patients with mild to moderate dysphagia. 
On the other hand, it should be noted that patients who were identified as dysphagic 
during initial screening were not made NBM until a VFSS was performed three to 
four days later. It is possible that recommending NBM earlier may have resulted in 
fewer incidences of pneumonia.  
It may also be argued that this protocol failed to address the issue of silent 
aspiration by including the Standardized Swallowing Assessment (Perry, 2001), 
which is based almost entirely on observations of water-swallowing and has 
questionable validity, sensitivity and specificity. Horner and Massey (1988) found a 
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silent aspiration rate of 38 % in patients who were, on average, 2.8 months post-
stroke. This rate may be much higher in acute stroke patients, and as such, a 
swallowing assessment that relies on the patient having an observable cough response 
may be expected to yield very high false negative rates. Despite the above limitations, 
Burek and colleagues (2009) did provide promising evidence in support of 
standardising acute dysphagia management. Regrettably, by omitting the details of 
SLT intervention, the extent to which the study can be replicated, or the intervention 
can be applied in real-world settings, is severely limited.  
Gandolfi et al. (2014) retrospectively evaluated a multidisciplinary 
management protocol in patients with post-stroke dysphagia (n = 39) compared to a 
control group receiving usual care (n = 45) over a four-year period. A neurologist 
assessed potential participants for clinical signs of dysphagia using a water-
swallowing test and those with no evidence of dysphagia were excluded. Pre-existing 
dysphagia was also an exclusion criterion for this study. All participants underwent a 
clinical assessment of swallowing including cranial nerve examination and water-
swallowing tasks as well as either a VEES or VFSS. Following instrumental 
evaluation, participants received five hours of swallowing rehabilitation per week 
until discharge. Swallowing rehabilitation involved ‘sensorial stimulation’, facial and 
mouth exercises, breathing exercises, implementing compensatory strategies and oral 
trials. No further details of these rehabilitation strategies were reported and no 
specific exercise or stimulation protocols were cited. Outcome measures included 
mortality, occurrence of pneumonia, need for respiratory support and need for 
nutritional support at discharge. Pneumonia was defined as the occurrence of three or 
more of the following symptoms: fever >38 °C), abnormal chest x-ray, productive 
cough and purulent sputum, abnormal respiratory examination and need for 
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antibiotics. There were no differences in demographic variables between the group 
who received the protocol and the control group. Patients who were managed using 
the protocol had a significantly lower risk of needing respiratory support during 
hospitalisation compared to the control group, however there were no differences in 
the rates mortality or tube-feeding at discharge. While patients managed under the 
protocol had a significantly lower risk of pneumonia compared to control patients, 
there were no differences in the frequency of pneumonia between the two groups. 
Given these results, it is surprising that the authors drew firm conclusions that the use 
of a protocol can significantly reduce aspiration pneumonia and in-patient mortality.  
Methodological limitations make it difficult to ascertain the true value of the 
protocol described by Gandolfi et al. (2014). Specifically, by screening potential 
participants for dysphagia on the basis of a clinical evaluation and water-swallowing 
test creates a selection bias against patients with silent aspiration. Although this bias 
would have been present for both the treatment and control groups, it limits the 
generalizability of findings to patients with overt aspiration only. The rehabilitation 
aspect of the protocol is also significantly flawed. Although the actual numbers of 
participants who received VEES versus VFSS was not reported, providing dysphagia 
rehabilitation based on a VEES is inappropriate as this method does not provide 
information about the oral phase of swallowing and does not allow detailed analysis 
of pharyngeal kinematics. Limited information about the rehabilitation provided to 
participants in either study group was reported with no direct referencing of evidence-
based techniques. It is unknown how many hours of rehabilitation the control group 
received and it is likely that this represents a confounding variable. It is also 
problematic that pneumonia outcomes were only analysed amongst surviving 
participants. Although the authors reported that no participants in the protocol group 
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died from pneumonia, including participants from the control group who died from 
pneumonia would have been informative and potentially altered the results. Finally, it 
seems that future studies of this nature must include a larger sample population as the 
authors noted they had low statistical power (1 - β not reported). 
Ickenstein et al. (2010) evaluated a dysphagia protocol in patients with acute 
stroke (N = 114). Every patient received a nurse-administered dysphagia screening on 
day one of admission. The screening involved observations about the patient’s 
secretion management, alertness, vocal quality and tongue movement. If there were 
no concerns, the patient proceeded to a water-swallowing challenge with one 
teaspoon of water. According to criteria published by Perry (2001), if there was no 
evidence of swallowing, if anterior leakage, coughing or a change in respiratory rate 
or vocal quality were present the test was terminated, or if the nurse suspected that 
dysphagia was present. The patient then proceeded to the 90 mL water-swallowing 
test (Suiter & Leder, 2008). As per the test criteria, if coughing or a change in vocal 
quality was observed or if the test was unable to be completed then screening was 
terminated. Depending on the results of screening, the patient proceeded to a 
‘swallowing-adjusted diet’, which ranged from normal to NBM. Decisions about 
adjusting diet consistencies were made in conjunction with the SLT or doctor. 
Patients deemed an aspiration risk were recommended NBM and patients with mild to 
moderate difficulties were recommended an altered texture diet. In conjunction with 
this screening, patients received a clinical swallowing evaluation from a SLT within 
72 hours of admission to hospital and a VEES within five days. Specific details of 
these examinations were not reported. Patients then received rehabilitation from the 
multidisciplinary team, although specific details were not reported. Outcomes were 
measured by comparing results to retrospective data from preceding years and to 
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other hospitals in the area. The main outcomes were mortality and pneumonia, 
although the authors do not mention how pneumonia was diagnosed. Outcomes 
relating to mortality were analysed descriptively. Following the implementation of the 
protocol, mortality rates reduced from 7.4 % to 4.2 %. Pneumonia rates reduced from 
8 % to 2.8 %, significantly lower than the 9 % reported from surrounding hospitals. 
As no patient demographic or clinical variables were reported, the extent to which 
results can be generalised outside of this study is limited. It is also unclear whether 
any of these variables were taken into account during statistical analysis (i.e. logistic 
regression), which could be considered essential when drawing comparisons between 
prospectively- and retrospectively-collected data. It seems as though the authors’ aim 
in conducting this study was to reduce the time between a patient’s admission to 
hospital and initiation of dysphagia management by incorporating nurse-led 
dysphagia screening. Patients with no overt signs of dysphagia could commence a 
normal oral diet without delay while those with signs of dysphagia could be placed on 
a ‘safer’ oral diet or alternative route of nutrition until a formal swallowing evaluation 
was completed. Whether it is appropriate for patients who are considered mildly to 
moderately dysphagic to be given an oral diet prior to an instrumental evaluation of 
swallowing is debateable. It also seems unlikely that this particular screening method 
– which relies on patients displaying overt signs of dysphagia – is sensitive enough to 
detect patients with silent aspiration.   
4.4. Summary 
The cough reflex is a dynamic physiologic response (Dicpinigaitis, 2007). Under 
certain conditions a person may show a different pattern of cough reflex sensitivity. 
For example, people with dementia (Nakazawa et al., 1993) or chronic chest 
infections (Niimi et al., 2003), smokers (Dicpinigaitis, 2003a) or those on opioids 
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(Kelly et al., 2016) may have reduced cough reflex sensitivity, while people on ACE 
inhibitor drugs, who have chronic coughs or have recently stopped smoking tend to 
have heightened cough reflex sensitivity. Time of day and familiarity with the CRT 
may also play a role. Although an individual’s cough reflex is subject to multiple 
influences, there appears to be a clinically relevant threshold for cough sensitivity, 
which, if not triggered, may result in silent aspiration (Miles et al., 2013b). 
While various dysphagia screening and assessment protocols have been 
assessed for their ability to identify patients at risk of aspiration, a common limitation 
is the lack of consideration of silent aspiration. The ability to identify patients at risk 
of silent aspiration on a clinical evaluation would greatly enhance the clinician’s 
ability to make appropriate recommendations and would presumably improve patient 
outcomes. CRT may be an ideal way of assessing silent aspiration risk and has been 
validated against instrumental assessment with acceptable sensitivity and specificity 
(Miles et al., 2013b). Despite this, the use of CRT in a standardised dysphagia 
assessment and management protocol has received little attention in the dysphagia 
literature. Studies to date have been plagued by methodological limitations and the 
range of CRT methods used makes comparisons difficult. Further research into this 
aspect of acute stroke care is required. 
Citric acid may be an ideal choice of tussive agent as it stimulates not only the 
chemoreceptors of the larynx but also the mechanoreceptors and it is a well-
established and safe technique with established normative data. In an acute stroke 
population, the tidal breathing method may avoid some of the difficulties that come 
with using a mouth-tube. The trade-off may be increased within-subject variability in 
the dose received due to variation in respiratory rates. 
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The presence of oral bacteria is also strongly aligned with adverse pulmonary 
consequences. Protocols that reduce oral bacterial loading and colonisation of 
pathogenic microorganisms reduce the risk of pneumonia (Simmons-Trau et al., 2004; 
Bousbia et al., 2012; Yoneyama et al., 2002; Yoshino et al., 2001; Watando et al., 
2002). This reduction in pneumonia can easily be attributed to a reduction in oral 
pathogens. However, Watando et al. (2002) identified another direct effect of oral 
hygiene: improved cough reflex sensitivity. This suggests that intensive oral care can 
increase airway protective mechanisms. However, it remains unknown whether 
improved cough reflex sensitivity is due to decreased oral bacterial load, increased 
mechanical stimulation of the oral cavity or a combination of both. Clarification 
through further investigation is required if we are to provide appropriate interventions 
for patients at risk of AP. Furthermore, despite a known increase in oral carriage of 
yeasts in acute stroke, there are no specific studies documenting the relationship 
between oral bacteria, cough sensitivity and pneumonia in the acute stroke population. 
Given that this population is at substantial risk of both aspiration and consequent 




Chapter 5. The Role of Bacteria in Aspiration Pneumonia  
The presence of potential respiratory pathogens in the oral cavity is recognised as a 
significant factor in the pathogenesis of pneumonia (Langmore et al., 1998; 
Scannapieco, 2006). The oral cavity is in constant contact with environmental 
pathogens when breathing, eating contaminated food and being exposed to 
contaminated hands or equipment. There are many surfaces present in the oral cavity 
on which potential respiratory pathogens may colonise. Subsequent aspiration of these 
pathogens increases the risk of developing a chest infection (Langmore et al., 1998; 
Scannapieco, 2006). Understanding the role of oral bacteria in AP may assist in 
predicting and preventing this disease.  
5.1. Oral Microflora  
In most people, there is a dynamic equilibrium between the oral microbial community 
and the innate defence systems of the body. Bacterial flora is the most common oral 
flora, with over 500 different strains present in the oral cavity, but fungi, protozoa, 
and occasionally, viruses, may also be present (Nagoba & Nagoba, 2007). Although 
oral bacteria can assist in the digestive process, their main role seems to be in the 
prevention of disease. The presence of a resident microbe community, or “core 
microbiome” (Zaura, Keijser, Huse, & Crielaard, 2009, p. 2), may serve to reduce the 
risk of colonisation by pathogenic microbes via the process of natural selection 
(Marsh, 2000).  
5.1.1. Identification and classification of bacteria. 
By convention, bacteria are referred to in terms of composition of the cell wall 
(Gram-classification) and oxygen requirements. The Gram test involves staining the 
cell wall with a crystal violet dye. Bacteria with a thick, single-cell layer wall will 
retain a purple colour and are classified as Gram-positive. Bacteria with a cell wall 
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more than one cell thick will not retain the purple stain and are classified as Gram-
negative. Aerobic bacteria are oxygen-dependent, anaerobic bacteria cannot survive in 
the presence of oxygen and facultative, or aerotolerant, anaerobic bacteria can live 
with or without oxygen. Aerobic bacteria are rare among the indigenous oral flora 
(Socransky et al., 1963) with the vast majority being facultative anaerobic. The role of 
Gram-negative, Gram-positive, aerobic and anaerobic bacteria in AP is debated in the 
literature and is discussed in depth in a later section.  
In healthy mouths, innocuous bacteria act as a barrier against colonisation by 
respiratory pathogens (Jenkinson & Lamont, 2005). Poor oral health may select 
against these bacteria, altering the balance from mainly Gram-positive bacteria to 
mainly Gram-negative bacteria (Sbordone & Bortolaia, 2003). Gram-negative, 
anaerobic bacteria are often pathogenic, can easily colonise oral surfaces, reproduce 
in large numbers and spread throughout the oral cavity via saliva (Pace & 
McCullough, 2010). The presence of oral pathogens has been suggested as a 
necessary precursor to aspiration pneumonia (Langmore et al., 1998). Therefore, 
testing the saliva for the presence of such pathogens may be one way of determining 
pneumonia risk.   
5.1.2. Flora of the normal oral cavity.  
Before exploring the oral microbial profiles associated with disease, it is pertinent to 
understand the oral microbial composition of a normal mouth. The oral microbiome 
can be considered an umbrella term that encompasses each of the distinct sites in the 
mouth (tongue, cheeks, hard and soft palate, tonsils, dental biofilms). Saliva, which 
washes over each of these sites, contains approximately 100 million bacterial cells per 
millilitre (Curtis, Zenobia, & Darveau, 2011). 
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The oral microbiome has been the subject of thorough investigation through 
established links between oral bacteria and disease in humans. As such, it is the most 
completely-characterised microbiota in humans (Curtis et al., 2011). By extracting 
and culturing tissue samples, early investigations have successfully identified 
differences in the types and quantities of microbes from different areas of the oral 
cavity, reflecting the different environments provided by the teeth, tongue, gingival 
crevices and saliva (e.g. Gibbons, Socransky, de Araujo, & van Houte, 1964;  
Gibbons, Socransky, Sawyer, Kapsimalis, & Macdonald, 1963; Gordon & Gibbons, 
1966; Gordon & Jong, 1968; Richardson & Jones, 1958; Socransky & Manganiello, 
1971). However, it has since been recognised that culture-based methods give an 
incomplete picture of the composition of the oral microbiome as a large proportion of 
oral bacteria cannot be cultured in laboratory conditions. Advances in culture-
independent analysis techniques have led to the discovery of vast numbers of bacterial 
species that have yet to be cultured. In 2004, it was estimated that approximately half 
of all oral bacteria have not been cultured (Wade, 2004). 
Using molecular-based analysis, Dewhirst et al. (2010) developed the Human 
Oral Microbiome Database (www.homd.org), a list of every species of bacteria found 
in the mouth. Eleven bacterial species are reliably present in the oral cavity: 
Actinobacteria, Chloroflexi, Bacteroidetes, Firmicutes, Tenericutes, Spirochaetes, 
Fusobacteria, Synergistetes, Proteobacteria and two unnamed phyla. Within each 
species are hundreds of individual species, representing the diversity of the human 
oral microbiome.  
 The term ‘commensal’ refers to a relationship in which one organism benefits 
and the other remains unaffected. Of interest, several respiratory commensal 
pathogens, while not considered to be part of the normal oral microbiome, can be 
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found in a percentage of healthy (i.e. asymptomatic) adults. For example, E. coli and 
Klebsiella spp. have been identified in the mouths of healthy volunteers (Mobbs, Van 
Saene, Sunderland, & Davies, 1999).  
The oral carriage of commensal pathogens appears to be strongly linked to 
subsequent infection in ‘at-risk’ groups, such as hospitalised patients. This is 
discussed in further detail in the following section. In otherwise healthy adults, the 
reason that infection does not develop appears to be an intact ability to promptly clear 
these bacteria from the mouth, thus preventing colonisation.    
5.1.3. Host factors that influence the oral microbiota. 
Both pathogenic and innocuous bacteria can be found inside a healthy oral cavity, 
existing in a symbiotic relationship (Shiffer Nield-Gehrig & Willmann, 2007). 
Changes to the intrinsic host environment, such as those caused by acute or chronic 
illness, or change to oral hygiene routines, may disturb this equilibrium. There are 
many factors that may predispose individuals to oropharyngeal or tracheobronchial 
colonisation by pathogenic bacteria. Those most pertinent to stroke patients are 
discussed in detail below.  
5.1.3.1. Age. 
The composition of the oral microbiota is very heavily influenced by age. In the 
elderly, these differences are a result of various factors such as lowered immunity, 
illness, poor nutrition, the use of dental prostheses, salivary hypofunction, a 
diminished ability to perform oral hygiene routines independently and a lack of access 
to regular dental services (Carter et al., 2004; Wilson, 2005). Such changes lead to 
increased prevalence in the oropharynx of Gram-negative bacteria (e.g. Klebsiella 
spp., E. coli and Enterobacter spp.) but increased colonization of Staphylococci – a 
Gram-positive species – have also been reported (Wilson, 2005). Of note, elderly 
 
 100 
individuals are also susceptible to diminished mucociliary function and loss of lung 
elasticity, which may lead to increased microbial colonisation of the respiratory tract 
as microbes that are normally expelled are able to remain (Skerrett, Niederman, & 
Fein, 1989; Wilson, 2005). 
From as early as 1974, the link between oral bacteria and aspiration 
pneumonia among the elderly was established (Bartlett, Gorbach, & Finegold, 1974; 
Cesar, Gonzalez, & Calia, 1975; Lorber & Swenson, 1974). By the late 1990s, it had 
become clear that mortality and morbidity from pneumonia was high among 
dependent elderly (Scannapieco & Mylotte, 1996). However, the role of dentures and 
natural teeth as sites of pathogenic bacterial colonisation remained unknown. As the 
prevalence of denture use increases with age (Pietrokovski, Azuelos, Tau, & 
Mostavoy, 1995), an understanding of the relationship between dentition and oral 
bacteria was required in order to identify those at increased risk of AP. 
Percival, Challacombe and Marsh (1991) were among the first to document 
age-related changes in oral bacteria. They investigated the presence and prevalence of 
select bacteria among healthy people aged 20-39 years (n = 30), 40-59 years (n = 23), 
60-79 years (n = 16) and over 80 years (n = 10). Participants in this study were 
dentate (i.e. had at least seven teeth), did not use dental prostheses and were in good 
health (e.g. no oral disease or need for antibiotics). Saliva and plaque samples were 
collected and analysed for several target bacteria using both aerobic and anaerobic 
culture methods. Results revealed significant differences between the different age 
groups with regards to the prevalence of target bacteria. These included an increase in 
the prevalence of lactobacilli, staphylococci and Actinomyces viscous in saliva in 
people aged over 60 years compared to those aged 20-39 years. The prevalence of 
bacteria was especially high in people over 70 years. These results suggest that age-
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related changes in the oral microbiota occur among healthy people. However, as only 
bacteria of “dental significance” were selected for analysis, the true extent of these 
age-related changes remains unknown. Generalisation of these results to the wider 
elderly population is limited, as the effects of denture-wearing and general health 
were not explored in this study. These factors are discussed in turn below.  
5.1.3.2. Dentition. 
There are several ‘degrees of dentition’, ranging from edentulous to fully dentate to 
dentate with the use of dental prostheses. The complete loss (or removal) of teeth may 
select against particular bacteria that colonise hard dental surfaces (Abdul-Kareem, 
2012). For example, the Neisseria species can be found in newly-edentulous subjects 
but disappears after denture use, while E. coli and K. pneumoniae tend to be absent 
from edentulous mouths but can be found after one month of denture use (Abdul-
Kareem, 2012). Binkley, Haugh, Kitchens, Wallace and Sessler (2009) reported that 
edentulous adults were more likely to be colonised with S. pneumoniae or Methicillin-
resistant Staphylococcus aureus (MRSA) than dentate adults. However, these results 
were based on buccal mucosa samples from edentulous subjects and dental plaque 
samples from dentate subjects, which could account for the differences. 
 With the constant improvements and innovations in dental care, more people 
may be retaining their own teeth into old age. These same people may not necessarily 
be able to maintain adequate oral hygiene and thus may have increased numbers of 
diseased teeth (Pace & McCullough, 2010). Increased risk for infection may be a 
consequence of this. 
Several studies have documented an increased prevalence of respiratory illness 
among dentate and edentulous elderly. Sumi et al. (2007) examined the dental plaque 
in a group of dependent elderly (N = 138, age range = 74 years). Although 
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information regarding comorbidities was not reported, all participants had evidence of 
poor oral hygiene, had not received antimicrobial drugs in the preceding eight weeks, 
had no history of diabetes and all were dependent on caregivers for oral hygiene. 
Sumi et al. reported that the presence of respiratory pathogens was 65 %. This number 
may in fact be an underestimation, as the sampling method described by Sumi et al. 
excluded anaerobic bacteria as well as bacteria that were unable to be cultured. The 
prevalence of respiratory pathogens reported by Sumi et al. is 1.5 times higher than a 
previous report from the same research group of pathogenic bacteria from dentures 
(Sumi et al., 2002). One reason for this difference may be that dentures can be 
removed and cleaned more thoroughly than fixed teeth.  
In a study comparing dentate and edentulous participants, Mojon, Budtz-
Jørgensen, Michel and Limeback (1997) reported that 40 % of dentate subjects had at 
least one incidence of respiratory illness compared to 27 % of edentulous subjects. In 
this study, participants also had a high overall rate of respiratory illness at 33 %. This 
rate may in fact have been under-reported, as the diagnosis of respiratory infection 
was made solely on the basis of clinical symptoms, which has low sensitivity and 
tends to result in false negative results (Woodhead, 2007). Yoneyama et al. (2002) 
reported that fewer edentate participants who received intensive oral hygiene 
developed pneumonia compared to dentate participants, although proportionately, the 
numbers were actually identical in both groups at 9 %. Among a no-oral-hygiene 
group, slightly fewer edentate participants developed pneumonia compared to dentate 
participants: 20 % and 21 %, respectively (Yoneyama et al., 2002). The studies by 
Mojon et al. and Yoneyama et al. suggest a link between dentition, oral health and 
respiratory health. This may be due to the fact that more hard surfaces are available 
for bacteria to colonise. However, in the absence of specific regression analyses, it is 
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not possible to determine whether dentition was a true independent predictor of 
pneumonia.  
In 2006, Tachibana et al. (2006) used molecular analysis to document the 
prevalence of six oral pathogenic bacteria (Porphyromonas gingivalis, Tannerella 
forsythia, Fusobacterium nucleatum, Actinobacillus actinomycetemcomitans, 
Treponema denticola and Streptococcus mutans) in 85 year olds (N = 204). Few 
details about the participants were reported, however the mean number of teeth was 
provided (x̄ = 7). By using the Mann-Whitney U-test, the authors established 
significant differences between the number of teeth and the number of bacteria 
present. Those with greater than eight teeth (approximately) had higher levels of four 
out of six of the pathogenic bacteria compared to those with fewer than eight teeth. 
The use of molecular analysis techniques adds weight to this finding as this technique 
does not rely upon the cultivation of live bacteria. Unfortunately, in the absence of a 
regression analysis, the strength of the relationship between dentition and bacterial 
numbers could not be established.  
Terpenning et al. (2001) prospectively evaluated medical and dental factors 
associated with AP among elderly veterans (N = 358). Among dentate patients, the 
number of decayed teeth significantly predicted the development of AP, with an odds 
ratio of 1.2. These findings confirm the earlier work by Langmore et al. (1998), 
however both the Terpenning et al. and Langmore et al. studies included only male 
participants, grossly limiting the generalizability of results. Unfortunately, although 
bacterial testing of dental plaque and saliva was undertaken, no comparisons were 




Denture-use has also been found to alter the oral microflora. Sumi, Miura, 
Sunakawa, Michiwaki and Sakagami (2002) documented the prevalence of potential 
respiratory pathogens from the denture plaque of dependent elderly (N = 50, age 
range = 60-89 years). Participants were dependent on caregivers for oral hygiene, had 
no evidence of active oral disease or diabetes and had not received antimicrobial 
therapy in the preceding 8 weeks. Dry dentures were swabbed, and the swabs were 
analysed for microbes via culture method. Aerobic bacteria were found to be present 
in 100 % of samples and potential respiratory pathogens were present in 46 %. The 
authors concluded that denture plaque is a specific site of colonisation of potential 
respiratory pathogens and control of this plaque is an essential step in the prevention 
of AP among dependent, denture-wearing elderly. However, in the absence of a 
control group of denture-wearing, independent elderly, it is impossible to say whether 
the results were a function of denture-use or dependence for oral care. 
It is difficult to determine the true impact of dentition and denture-use on the 
oral microflora. This is partly because it is difficult to design a research study that 
controls for the many confounding variables. Some sources report that dentate adults 
appear to be at greater risk of respiratory infection (Mojon et al., 1997; Yoneyama et 
al., 2002), with number of teeth predictive of pneumonia (Langmore et al., 1998; 
Terpenning et al., 2001). However, other sources do not agree (Binkley et al., 2009; 
Russell et al., 1999). It is true that respiratory pathogens have been isolated from the 
mouths of edentulous (Binkley et al., 2009), denture-wearing (Sumi et al., 2002) and 
dentate subjects (Sumi et al., 2007), suggesting that the most important factor in the 




The combined results from Sumi et al. (2002) and Sumi et al. (2007) 
complement Langmore et al.’s (1998) finding that dependence for oral care is a risk 
factor for pulmonary infection. These studies succeeded in identifying dependent, 
dentate elderly as a population who are at a significant risk for oral colonisation of 
respiratory pathogens (more so than their dentate counterparts). However, further 
examination of patient comorbidities/additional risk factors for bacterial colonisation 
is required in order to better identify patients at risk for AP.  
5.1.3.3. Diabetes mellitus. 
The presence of certain comorbidities also plays a role in determining the 
characteristics of an individual’s microflora. Although many different morbidities 
predispose individuals to infection, diabetes mellitus is worthy of mention because of 
its high prevalence among the elderly (15 % in the over 75 years age group [Ministry 
of Health, 2015]) and specific links to periodontal infection in adults (Berkey & 
Scannapieco, 2013; Salvi, Lawrence, Offenbacher, & Beck, 1997). The likely 
mechanism for this is through changes to the individual’s immunological defence 
functions, leading to reduced resistance to opportunistic, pathogenic bacteria (Mealey 
& Rose, 2008; Skerrett et al., 1989). This can have significant implications for 
respiratory health. Using strict criteria for the diagnosis of aspiration pneumonia, 
Terpenning et al. (2001) found that the presence of diabetes mellitus predicted 
aspiration pneumonia with an odds ratio of 3.5 among elderly, dentate subjects and 
with an odds ratio of 1.7 for both edentulous and dentate subjects.  
5.1.3.4. Dependence level. 
Another factor that contributes significantly to an individual’s oral microbiota is their 
level of dependence. The prevalence of potential respiratory pathogens within elderly 
rest-home residents is reported to be 46-65 % (Sumi et al., 2007, 2002), with rest 
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home residents exhibiting significantly poorer oral hygiene and significantly more 
oral pathogens compared to control subjects (Russell et al., 1999). Given that these 
reports do not include analyses of anaerobic bacteria, the true prevalence of potential 
respiratory pathogens in this population may be even greater.  
It is well documented that elderly people living in rest homes are more likely to 
have poor oral health (Awano et al., 2008; Ortega et al., 2014; Pietrokovski et al., 
1995; Russell et al., 1999; Sumi et al., 2007). Neither Sumi et al. (Sumi et al., 2007, 
2002) nor Russell et al. (1999) completed logistic analyses to determine the effect of 
institutionalisation on oral bacteria and it is likely that other risk factors such as 
chronic illness, multiple medications, dysphagia, caregiver training and resources play 
a major role in determining the oral microflora of rest home residents. It is also worth 
noting that the actual amount of oral bacteria may be vastly underestimated in the 
literature, as studies typically only involve subjects who are well enough to participate 
in examinations.  
Changes to the oral microbiota do not only occur in residents of long-term care 
facilities. Observational studies of elderly hospitalised patients (Preston, Gosney, 
Noon, & Martin, 1999), patients with acute stroke (Zhu, McMillan, McGrath, Li, & 
Samaranayake, 2008) and patients admitted to a critical care unit (Sachdev et al., 
2013) have all reported a high prevalence of Gram-negative bacteria. It is difficult for 
studies of this nature to include control participants. However, in the absence of 
controls it is difficult to determine the true influence of hospitalisation on the oral 
microflora.  
Several studies have been completed which have included control patients, with 
similar findings. For example, Gram-negative bacteria are reported to be present in 
34-42 % of oral swab/rinse samples of patients with acute stroke (Gosney, Millns, 
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Martin, & Field, 1997; Millns, Gosney, Jack, Martin, & Wright, 2003) – significantly 
less than healthy, elderly controls. Interestingly, long-term patients on rehabilitation 
wards (Millns et al., 2003) and psychiatric wards (Johanson, Pierce, & Sanford, 1969) 
also show very few of these bacteria suggesting the presence of Gram-negative 
bacteria cannot be entirely accounted for by hospitalisation and that acute illness and 
age likely play a role. Recovering the ability to independently manage oral hygiene 
routines may also explain this pattern of bacterial colonisation.  
Among people who are physically well, there are no differences in the amount of 
Gram-negative bacteria despite differences in exposure to the hospital environment, 
from no-exposure (community-dwellers) to intermittent exposure (medical staff) to 
continuous exposure (patients on a psychiatric ward) (Johanson et al., 1969). This 
finding suggests that it is not the hospital environment that contributes to changes in 
oral microflora.  
Studies using repeated-measures designs have provided more information about 
the effect of hospitalisation on oral bacteria. Zhu et al. (2008) quantified the changes 
in oral bacteria in elderly patients with acute stroke during their admission to hospital, 
at discharge from hospital and at six months. Oral carriage of Gram-negative bacteria 
peaked immediately following admission to hospital and progressively declined over 
six months. This was not associated with other variables such as age, stroke severity, 
use of dentures, difficulty tooth-brushing, etc. Sachdev et al. (2013) reported a similar 
result in patients admitted to a critical care unit. A significant increase in microbe 
counts from baseline to week one was documented, with bacteria associated with 
hospital-acquired pneumonia present in 26 % of patients. Combined results of these 
studies suggest that patients may be the most vulnerable to increased oral/pathogenic 
bacteria in the early stages of hospitalisation. Indeed, the risk may be under-estimated 
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by these studies, as sampling methods were limited to Gram-negative/anaerobic 
bacteria. Acutely-ill patients are more likely to have impaired pulmonary clearance 
(Johanson et al., 1969) and depend on others to provide oral hygiene. Importantly, 
these are all recognised as independent risk factors for pneumonia among elderly 
(Harkness, Bentley, & Roghmann, 1990; Langmore et al., 1998; Quagliarello et al., 
2005; Terpenning et al., 2001). It has been recognised that improving the oral hygiene 
of dependent elderly is essential for the prevention of pneumonia in this population 
(Sumi et al., 2007).  
5.1.3.5. Oral hygiene. 
When tooth-brushing and oral hygiene routines are ceased, dental plaque will 
proliferate, taking only three or four days to reach maximum growth (Wilson, 2005). 
The microbial composition of the dental surfaces will continue to change and the 
proportion of Gram-negative species will increase (Wilson, 2005). This is due to the 
ability of bacteria to respond rapidly to changes in their environment by replicating 
quickly (Shiffer Nield-Gehrig & Willmann, 2007). Conditions that favour pathogenic 
bacteria may result in large numbers of pathogenic bacteria in the oral cavity within a 
relatively small timeframe. 
It is also possible for bacteria to alter the host environment. Scannapieco and 
Mylotte (1996) proposed a model of respiratory pathogen colonisation in the oral 
cavity where pathogenic bacteria may adhere to and colonise the dental plaque in 
patients with poor oral hygiene. Poor oral hygiene is known to increase dental plaque 
load. The colonised bacteria produce increased amounts of hydrolytic enzymes in the 
saliva, which in turn modifies the proteins present on the mucosal surface, exposing 
these surfaces and promoting further colonisation.  
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A causal link has been established between poor oral hygiene and increased 
numbers of potential respiratory pathogens in oropharyngeal secretions (Loesche & 
Lopatin, 1998; Mojon & Bourbeau, 2003; Mojon et al., 1997; Scannapieco, 1999). 
Such pathogens possess several virulence features which make them more likely to 
lead to infection than other oral bacteria (Russell et al., 1999; Scannapieco, 1999).   
Elderly people have been identified as particularly susceptible to changes in 
the oral microflora due to poor oral hygiene. A study of rest home residents reported 
that only one quarter of residents cleaned their own teeth (Carter et al., 2004). The 
other three-quarters relied on others for oral hygiene. This number may in fact be an 
underestimation, as only residents who were able to consent and considered well 
enough to be involved in this study were recruited. 
 The long-term effects of poor oral hygiene on the respiratory system have also 
been documented. Awano et al. (2008) first documented the relationship between 
periodontal disease and pneumonia-related mortality among the elderly in a large 
cohort of rest-home residents (N = 697). At the start of this four-year longitudinal 
study, oral examinations took place as well as demographic surveys and the sampling 
of the lingual surface for anaerobic bacteria and fungi. At the end of the study period, 
the death certificates of participants who had died were reviewed for the cause of 
death. Results revealed that having more than ten diseased teeth was an independent 
predictor of pneumonia-related mortality. There was a non-significant trend towards 
increased oral anaerobic bacteria (as measured using gas chromatography) and 
prevalence of Candida in participants who died from pneumonia. Using more direct 
measures of oral bacteria, such as polymerase chain reaction (PCR) analysis, may be 
required to understand this relationship more clearly.  
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As previously mentioned, Binkley, Haugh, Kitchens, Wallace and Sessler 
(2009) used molecular analysis to determine the relationship between oral hygiene, 
the prevalence of target bacteria and respiratory status in middle-aged adults (N = 63) 
dependent for oral hygiene. Monthly assessments included oral examinations, oral 
sampling and medical record reviews over a six-month period. PCR analysis was used 
to determine the presence of S. pneumoniae, MRSA, Prevotella melaninogenica and 
Candida albicans. Baseline analysis revealed a high prevalence (55 %) of potential 
respiratory pathogens and “fair” oral hygiene. There were twelve incidents of 
pneumonia over the study period (19 % of participants). Participants who had any of 
the target microbes in their baseline samples were more likely to experience 
respiratory infection and those with poor oral hygiene were more likely to develop 
pneumonia. The limited number of assays completed means that the type/prevalence 
of pathogenic oral bacteria may have been underestimated and unfortunately, as no 
formal measurements of the oral hygiene provided to participants were undertaken, it 
is difficult to make firm statements about the relationship between oral hygiene, 
bacteria and pneumonia.  
Patients with stroke are at an increased risk of poor oral hygiene due to a 
sudden change in their ability to perform daily oral care routines such as a new 
hemiparesis, confusion or ataxia. Despite this, there are few published reports of how 
the oral microbiota changes in the days and weeks following an acute stroke. Given 
that morbidity and mortality from pneumonia is also particularly high in this 
population (Scannapieco & Mylotte, 1996), there is a critical need for research that 
clarifies the relationship between stroke, oral bacteria and pneumonia. However, it is 
important to note that poor oral hygiene and elevated oral pathogenic bacteria in 
isolation is not sufficient to cause aspiration pneumonia (Langmore et al., 1998; 
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Loesche & Lopatin, 1998). Respiratory pathogens must also be aspirated in such 
quantities or virulence that they overwhelm the respiratory system’s mechanical and 
immunological defence systems, leading to respiratory infection (Marik, 2001). 
Therefore, future research should also focus on airway protection and how this may 
influence the risk of developing infection.  
5.1.3.6. Stroke. 
Changes to mastication, salivation, swallowing, the ability to self-feed and the ability 
perform oral hygiene routines are all common consequences of stroke which may 
have the potential to disturb the microbial equilibrium of the oral cavity and lead to 
colonisation by potential respiratory pathogens. For example, although stroke is 
associated with AP (Yamaya et al., 2001), few studies had examined the relationship 
between oral bacteria and AP in this population until recently. 
In a prospective longitudinal study of 56 elderly Chinese patients with stroke, 
oral microbiological sampling revealed that oral yeast carriage was closely related to 
level of stroke-related functional disability (Zhu et al., 2008). Microbial sampling 
took place at three points in time: during acute hospitalisation, at discharge from 
hospital and at six months post-discharge. The average age of patients was 66 years, 
with approximately 75 % wearing dentures. The oral carriage of yeasts was found to 
be significantly increased during the acute stroke phase (p < .05), whereas coliform 
carriage was not. By six months, carriage of both yeasts and coliforms had 
significantly reduced compared to acute levels, indeed 92 % of patients who had 
evidence of oral coliforms at admission tested negative at subsequent sampling points. 
Seven coliform species were identified; interestingly, none were present across all 
three sampling periods. Candida albicans and K. pneumoniae were the most prevalent 
yeast and bacteria, respectively. Of particular interest, both microbes are known to be 
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associated with aspiration pneumonia, either directly (K. pneumoniae) or indirectly as 
a reflection of reduced host immunocompetence (C. albicans [Pace & McCullough, 
2010; Zhu et al., 2008]). High oral yeast carriage was directly associated with stroke-
related difficulty with oral care (i.e. tooth/denture brushing).   
However, findings were tempered by several methodological constraints. First, 
the lack of a control group from which to draw comparisons regarding usual 
microflora environments and oral hygiene regimes contributes to weak overall 
validity. The authors attempted to make comparisons by citing results from other 
studies; however, given the difference in study populations (e.g. Western versus 
Asian) and methodologies, these were of limited use. Second, while evidence-based 
techniques were applied to oral microbiological sampling and identification, the 
authors failed to take precautions in their methodology when they administered an 
oral rinse to obtain bacteria samples. Specifically, there was an increased risk of 
participants (all of whom had diagnosed dysphagia) aspirating the rinsing liquid. The 
unfortunate implication is that this limits the extent to which this study can be 
replicated. Future studies using this technique should consider safer methods of 
outcome measurement. Such studies in this line of research could also include other 
stroke subtypes, e.g. brainstem, to increase generalizability of results, as well as 
indications of stroke severity, which may reveal those patients who are most at-risk 
for increased oral bacterial colonisation. Finally, the methods used in this study to 
culture the oral bacteria for identification were singularly suited to Gram-negative 
bacteria. The rationale for this was not stated, however the unfortunate implication is 
that the potential presence of Gram-positive bacteria and the implications of this have 
been overlooked.    
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Nevertheless, this study provided a very clear link between patients in the 
acute stages of stroke and the colonisation of pathogenic oral bacteria. This 
population is at increased risk for aspiration of oral intake and subsequent pneumonia. 
Steps to prevent the colonisation of pathogenic bacteria in the oral cavity may be one 
way to prevent AP in post-stroke patients.  
5.1.4. Bacteria associated with acute stroke. 
In the acute stages of stroke, patients may be severely unwell with reduced 
consciousness, reduced movement down one side of the body (hemiplegia/ 
hemiparesis), reduced salivary flow or reduced control of secretions and poor 
swallowing. These conditions may all contribute to alter the composition of oral 
bacteria, either by altering the environment of the oral cavity or by preventing usual 
oral hygiene routines from being carried out. For this reason, there may be specific 
bacteria/patterns of colonisation that are unique to patients with acute stroke. 
Millns et al. (2003) obtained samples from the mouths of three groups of 
hospitalised patients: 1) patients with a first-time acute stroke, 2) patients from a 
stroke rehabilitation ward, 3) patients from a general (non-stroke) ward. A control 
group of healthy, elderly volunteers was also included. Samples from participants in 
groups 1 and 3 were collected using mouth swabs every three days for a total of 
eighteen days, whilst samples from participants in group 2 and control participants 
were collected using mouth-rinse samples every three days for the same period of 
time. Samples containing oral bacteria were cultured under aerobic conditions and 
analysed for the presence of any aerobic gram-negative bacteria colonies. The 
criterion for bacterial carriage was the presence of ten or more colonies on two or 
more consecutive samples. This was then compared to participants’ clinical outcomes 
(i.e. mortality) and results of a bedside swallowing evaluation (completed for all 
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patient groups but not for control participants) by means of a correlation analysis. 
Carriage of Gram-negative aerobes was documented in 34 % of participants with 
acute stroke, 4 % of participants on the stroke rehabilitation ward, 8 % of acutely ill 
hospitalised patients and in none of the control participants. The predominating 
species were Escherichia spp., Klebsiella spp., Enterobacter spp., Morganella spp. 
and Proteus spp. Of note, 24 % of participants with acute stroke and carriage of 
Gram-negative aerobes also had dysphagia. This number rose to 36 % when only the 
deceased acute stroke patients were considered. These results suggest that patients 
with acute stroke and dysphagia are at increased risk for the carriage of pathogenic 
oral bacteria and that the presence of these bacteria is a poor prognostic indicator. It 
appears that neither acute illness nor hospitalisation alone can account for these 
findings, suggesting that the presence of stoke and dysphagia may be factors in the 
carriage of oral pathogens. Age may also play a role, contrary to the authors’ 
interpretation. The median age of the healthy controls (71 years) differed by at least 
13 years from the two groups with the highest rates of carriage (84 and 89 years). The 
authors also considered the relative lack of denture-wearing in the acute stroke group 
to be an argument against the theory that denture-wearing increases pathogenic 
bacterial carriage. The fact that the acute stroke group had one of the lowest rates of 
denture use may in fact suggest that the ability to remove and adequately clean 
dentures is a protective factor against pathogenic bacterial carriage. 
 The results of this study were limited by several confounding variables, 
including poor age-matching of participants and the use of two different bacterial 
sampling techniques. The authors stated that mouth swabs were used for patients who 
were considered at risk of aspiration, as the mouth-rinse technique may have 
increased this risk. However, it is unclear why oral swabs were not used for all 
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participants, as the use of two different sampling techniques introduces a confounding 
variable. Indeed, the two groups who were sampled using oral swabs tested the 
highest for pathogenic bacteria. Finally, by only testing samples for Gram-negative 
aerobes that could grow under lab conditions, validity and sensitivity are diminished.  
The results presented by Millns et al. (2003) suggested that acute stroke 
patients behave differently from other people and other hospitalised patients. 
However, the microbiological characteristics of patients with stroke who develop 
aspiration pneumonia remained unknown. Several research groups since have 
contributed to the literature on this topic. A summary of these findings, with particular 
attention to investigations of non-ventilated, hospital-acquired pneumonia, is 
presented in Table 4.  
5.1.4.1. Characteristics of bacterial pathogens associated with post-stroke 
aspiration pneumonia. 
As previously mentioned, the presence of oral pathogens is necessary, but not 
sufficient, for respiratory disease to develop (Langmore et al., 1998; Pace & 
McCullough, 2010; Socransky & Haffajee, 1992). Socransky and Haffajee described 
seven criteria that must be met in order for a pathogenic microbe to cause disease: 1) 
the pathogen must be virulent (i.e. infectious) and clonal (i.e. a single cell is able to 
produce many cells), 2) it must possess the genetic factors to initiate disease, 3) it 
must be present in numbers that exceed the host’s threshold, 4) it must be in the right 
environment, 5) the environment must select for the expression of the pathogen’s 
virulent properties 6) other bacteria must foster/not inhibit the pathogen, and 7) the 
host must be immunocompromised.  
Sources differ as to which bacteria fit the above criteria and can therefore be 
considered as precursors to aspiration pneumonia. Traditionally, it was thought that 
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Table 4.  
Summary of Literature Characterising the Oral Microbiota of Patients with Aspiration Pneumonia. 




Identified bacteria  Comments 



















Zhu et al. 
(2008) 
Hospitalised 
patients with stroke 
Not reported Oral samples measured 
via culture methods 












Samples obtained within 
four hours of admission 
to hospital using 
protected 
bronchoalveolar lavage, 
cultured under aerobic 













Ewan et al. 
(2015) 
Elderly patients 





Oral swabs analysed 





Some patients received 
antibiotics and/or 











Samples obtained via 
protected specimen brush 
sampling and 
bronchoalveolar lavage, 
cultured under aerobic 









48 % of patients  received 
antibiotics prior to sampling 
Sachdev et 
al. (2013) 
Patients admitted to 
an intensive care 
unit 
Not reported Dental plaque samples 
cultured under aerobic 






Study aim was to document 
presence/changes in 
pathogens associated with 
pneumonia. Pneumonia 






Patients admitted to 




Samples obtained via 
bronchoalveolar lavage 












Wei et al. 
(2013) 
Patients admitted to 




Samples obtained via 
bronchoalveolar lavage 
and analysed using 
















Saliva, mucosa and 
plaque samples analysed 
















Samples obtained via 
transtracheal aspiration 
or thoracentesis and 
cultured under anaerobic 
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Hassan et al. 
(2006) 














Excluded patients who 
developed fever prior to 
diagnosis of pneumonia. 
Tracheal cultures only 
performed in patients who 















anaerobic Gram-negative bacteria were responsible for causing aspiration pneumonia 
among elderly people, as was reported in three landmark studies from the 1970s 
(Bartlett et al., 1974; Cesar et al., 1975; Lorber & Swenson, 1974). Sources have 
continued to report this (e.g. Awano et al., 2008; Pace & McCullough, 2010; 
Scannapieco, 2006), despite the fact that early studies were grossly limited by the 
technology available at the time and plagued by other methodological constraints. For 
example, in each of the early studies the microbiological samples used for analysis 
were acquired late in the course of the pneumonia, by which time other complications 
had developed. Furthermore, many of the participants were reported as having chronic 
alcoholism, a condition that is not necessarily reflected in the typical patient with 
acute aspiration pneumonia and there was often no differentiation between 
community-acquired and hospital-acquired pneumonia. Finally, because bacteria 
often require specific transport and culture conditions, it is unlikely that precise data 
regarding bacterial colonisation were obtained. 
More recent data, including that cited in Table 4, suggest that the aetiology of 
aspiration pneumonia may actually be polymicrobial, involving both Gram-negative 
and Gram-positive bacteria. Despite considerable work in this area, it is difficult to 
synthesize findings due to differing criteria for aspiration pneumonia, differences in 
bacterial sampling and analysis methods and lack of distinction between hospital-
acquired pneumonia, aspiration pneumonia and aspiration pneumonitis. Studies are 
also limited by retrospective designs (e.g. Hassan et al., 2006; Kollef et al., 2005), 
inclusion/exclusion biases (Hassan et al., 2006) and narrow bacteriology (Wei et al., 
2013; Zhu et al., 2008). This makes it difficult to determine the precise bacterial 
aetiology of aspiration pneumonia. 
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It is generally accepted that molecular-based bacterial analysis methods, such 
as those described by Bousbia et al. (2012) and Ewan, Sails, Walls, Rushton and 
Newton (2015) are likely to give a more accurate picture of the microbiological 
environment. Bousbia et al. (2012) attempted to characterise the microbiota of 
patients who were admitted with or developed pneumonia in intensive care units 
compared to controls without pneumonia. The prevalence of several bacteria that are 
directly or indirectly related to ventilator-associated pneumonia (VAP; n = 106), 
community-acquired pneumonia (CAP; n = 32), non-ventilator ICU pneumonia 
(NVP; n = 22) and AP (n = 25) was examined over a three-year period. Control data 
were obtained via bacterial clone libraries and included ‘immunocompromised’ 
controls (n = 25). Bacterial samples from ICU patients were extracted via 
bronchoalveolar lavage, and analysed using an extensive variety of traditional and 
moderen laboratory techniques, including the amplification and quantification of 
DNA from specific pathogens as well as culture-based testing. Patients with AP had 
the highest prevalance of S. mitis and S. pneumoniae compared to patients with VAP, 
CAP, NVP, and controls. S. mitis with origins in oral flora and dental plaque was 
detected in 12 % of patients with AP, compared to 6 % of patients with CAP, 12 % of 
patients with VAP, 9 % of patients with NVP and 4 % of controls. S. pneumoniae 
with origins from nasopharyngeal mucosa was detected in 24 % of the AP cohort, 
versus 6 % of patients with CAP, 6 % of patients with VAP, 5 % of patients with 
NVP and 0 % of controls. By associating S. mitis and S. pneumoniae – two Gram-
positive, facultative bacteria – with AP, Bousbia et al.’s (2012) findings contrast with 
the traditional view that AP is caused almost exclusively by Gram-negative bacteria 
(Awano et al., 2008; Pace & McCullough, 2010; Scannapieco, 2006). In fact, Bousbia 
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et al. (2012) reported that Gram-negative bacteria were only detected in very low 
levels in the AP group.  
One possibility for these contrasting findings could be related to methodology, 
specifically sampling and diagnostic techniques. Previous work has focussed on 
standardised routine culture tests (e.g. blood culture) and culture of lower respiratory 
tract specimens. However, these diagnostic tests have been described as having 
“suboptimal diagnostic sensitivity” for diagnosing pneumonia (Murdoch et al., 2009). 
For example, blood cultures are positive in <10 % of patients with pneumonia 
(Murdoch et al.). Bousbia et al. (2012) accounted for this by combining standard 
bacterial testing with molecular testing techniques (i.e. qPCR). Some advantages of 
molecular testing include the ability to detect potentially all respiratory pathogens 
even when present in very low levels and reduced liklihood of results being affected 
by antibiotic administration compared to culture-based methods (Murdoch et al.). 
Indeed, by including molecular testing, Bousbia et al. identified 73 bacterial species 
that had not previously been reported in the literature. Arguably, their extensive 
arsenal of diagnostic tests increased the accuracy of their results, lending support to 
the hypothesis that S. mitis and S. pneumoniae may be the main culprits in AP.  
More recently, Ewan et al. (2015) investigated the carriage of pathogenic oral 
bacteria at several time points in elderly hospitalised patients (N = 90). In this study, 
molecular-based bacterial analysis (i.e. qPCR) was used to detect and quantify seven 
potential respiratory pathogens in tongue and throat swabs obtained at five time points 
over a two-week period. Importantly, the participants were all considered to be 
healthy other than having a lower limb fracture. The seven target bacteria were S. 
aureus, MRSA, E. coli, P. aeruginosa, S. pneumoniae, H. influenza and 
Acinetobacter spp. Patients were followed for a period of 90 days and the incidence of 
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HAP was recorded. Results revealed that ten of the study participants developed HAP 
defined by the somewhat subjective criterion of ‘clinician-initiated antibiotics’. If the 
more rigorous criteria for lower respiratory tract infection (LRTI) described by the 
American Thoracic Society/British Society for Antimicrobial Chemotherapy 
guidelines were considered, seven out of 90 participants developed HAP/LRTI. Four 
bacterial species were significantly associated with the development of HAP: E. coli, 
S. aureus, MRSA and P. aeruginosa. If two or more of these bacteria were present, 
the odds of developing HAP increased by 9.4. In 90 % of participants, colonising (i.e. 
present on two or more occasions) bacteria were present within 72 hours of admission 
to hospital. The association between HAP and carriage of E. coli/S. aureus/MRSA/P. 
aeruginosa at day five or fourteen of admission was statistically significant.  
The study by Ewan et al. (2015) was limited by incomplete participant 
recruitment and data collection resulting in low statistical power, as well as an 
inclusion bias towards “well” patients, making generalisation to other groups of 
patients, such as patients with acute stroke, difficult. However, it is one of the only 
studies to date to systematically explore the association between pathogenic oral 
bacteria and HAP over several time points using robust bacterial analysis techniques 
and in doing so has highlighted several key pathogens that may be worth targeting in 
future research.  
To date, the particular species implicated in the development of AP in patients 
with acute stroke and dysphagia remains undocumented. The relationship between 
pathogenic bacteria and AP over time in this population also remains unknown. Based 
on the existing literature, six bacteria in particular may play a role in the pathogenesis 
of AP in the acute stroke population: S. mitis, S. pneumoniae, S. aureus, K. 
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pnuemoniae, E. coli and P. aeruginosa. Further investigation into this area is 
warranted. 
5.1.5. The relationship between oral care and aspiration pneumonia. 
In a large-scale, randomised controlled trial (RCT), Yoneyama and colleagues (2002) 
demonstrated that implementing regular tooth brushing by nursing staff three times 
per day combined with professional dental cleaning once per week amongst elderly 
rest home residents (N = 417) reduced the rate of pneumonia by 8 %, as well as 
significantly reducing the number of febrile days and death from pneumonia. 
Participants in this study had a range of aetiologies, including stroke. These findings 
suggest that not only does improving oral health decrease the risk of contracting 
pneumonia, but that oral care was more effective at preventing death from pneumonia 
than was medical intervention (e.g. antibiotics).  
Interestingly, there appear to be secondary benefits of improving oral hygiene. 
Yoshino, Ebihara, Ebihara, Fuji, and Sasaki (2001) documented decreased 
swallowing latency in a group of rest home patients with cerebrovascular disease (n = 
20) who underwent a daily, thorough oral care regime provided by their caregivers for 
30 days. The same effect was not observed among control patients (n = 20) who 
performed their own oral care. The authors hypothesised that increased stimulation of 
the sensory nerves in the oral cavity triggered the release of increased amounts of 
neuropeptides, which subsequently affected swallowing. Indeed, when tested, 
participants in the oral care group had larger amounts of serum substance P, a 
neurotransmitter known to play a role in swallowing elicitation, than participants who 
performed their own oral care.  
The same research group went on to investigate the effect of intensive oral 
care on cough sensitivity among rest home patients (Watando et al., 2004). Patients 
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were predominantly elderly, with a range of aetiologies including stroke, dementia, 
mild cognitive impairment, and diabetes mellitus. Some patients required assistance 
with eating, while others were independent, but all patients received nutrition orally. 
Patients were randomly assigned to one of two groups: a treatment group who 
received intensive oral care (n = 30) or a control group who performed their own 
(occasional) oral cares (n = 30). The treatment group received mechanical tooth 
brushing from nursing staff following every meal, in addition to professional dental 
cleaning from either a dentist or dental hygienist once per week. After three days, ten 
days, and 30 days, cough reflex sensitivity was measured by a citric acid cough reflex 
test (CRT). While both groups were comparable for cough reflex sensitivity at 
baseline, results identified a significant increase in cough reflex sensitivity among the 
treatment group at 30 days, regardless of whether patients were edentulous or not. No 
such change was observed in the control group. The authors concluded that intensive 
oral care was effective at reducing aspiration pneumonia in elderly rest home patients 
via increased cough reflex sensitivity.   
All three of these randomized controlled trials provide a high quality of 
evidence due to their meticulous control of confounding variables and avoidance of 
bias. A combination of prospective design, group randomisation, and presence of 
control group gives weight to the idea that, in each study, intensive oral care 
accounted for the observed treatment effects. On the other hand, a lack of reported 
blinding during outcome measurement decreases validity.  
A point of difference in the Watando et al. (2004) study is that participants in 
their treatment group not only received oral cares three times per day from their 
caregivers, but also received professional dental care once per week from either a 
dentist or professional oral hygienist. Thus it remains uncertain whether the observed 
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treatment effects were as a result of the daily oral cares, weekly professional cleaning, 
or a combination of both. 
In elderly rest home populations, intensive oral hygiene may reduce 
pneumonia rates may by improving the swallowing reflex (Yoshino et al., 2001) and 
increasing cough reflex sensitivity (Watando et al., 2004). Future studies exploring 
the effects of daily oral care versus weekly professional cleaning on health outcomes 
may be crucial in determining recommendations for future care in this population.  
5.2. Summary 
In most people, the oral microflora exist in a state of equilibrium. A variety of 
individual factors such as dentition, diet, self-care, medications and drug-use all 
contribute to an individual’s oral bacterial profile. The human oral microbiome has 
been extensively studied and recent advances in technology have allowed sampling to 
take place at the molecular level, allowing a more complete picture of both the 
healthy and diseased oral microbiome to emerge. 
Over several decades of research, the link between increased oral bacteria/oral 
colonisation by pathogenic bacteria and respiratory illness has become clear. What is 
less clear is the degree to which individual risk factors play a role in the pathogenesis 
of oral – and subsequent respiratory – disease, specifically, aspiration pneumonia. 
Increased age (Percival et al., 1991; Tachibana et al., 2006), increased level of 
independence (Mojon et al., 1997; Russell et al., 1999; Sumi et al., 2007, 2002; 
Yoneyama et al., 2002), diabetes mellitus (Terpenning et al., 2001), poor oral hygiene 
(Loesche & Lopatin, 1998; Mojon & Bourbeau, 2003; Mojon et al., 1997; 
Scannapieco, 1999) and acute hospitalisation (Sachdev et al., 2013; Zhu et al., 2008) 
have all been implicated as risk factors for respiratory infection. Because many of 
these variables are related, it may be impossible to determine the exact contribution of 
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each to an individual’s risk of aspiration pneumonia. What is striking is that many of 
these risk factors are also present in patients with acute stroke. Despite this, there are 
few published reports of how the oral microbiota changes in the days and weeks 
following an acute stroke. Given that morbidity and mortality from pneumonia is also 
particularly high in this population (Scannapieco & Mylotte, 1996) this represents a 
critical gap in the evidence base surrounding pneumonia prevention. The relationship 
between stroke, oral bacteria and pneumonia requires urgent clarification. 
To date, the particular species implicated in the development of AP in patients 
with acute stroke and dysphagia also remains undocumented. Based on the existing 
literature, six bacteria in particular may play a role in the pathogenesis of AP in the 
acute stroke population: S. mitis, S. pneumoniae, S. aureus, K. pnuemoniae, E. coli 
and P. aeruginosa. Further investigation into this area is warranted. 
The presence of oral bacteria is also strongly aligned with adverse pulmonary 
consequences. Protocols that reduce oral bacterial loading and colonisation of 
pathogenic microorganisms reduce the risk of pneumonia (Simmons-Trau et al., 2004; 
Bousbia et al., 2012; Yoneyama et al., 2002; Yoshino et al., 2001; Watando et al., 
2002). This reduction in pneumonia can easily be attributed to a reduction in oral 
pathogens. However, Watando et al. (2002) identified another direct effect of oral 
hygiene: improved cough reflex sensitivity. This suggests that intensive oral care can 
increase airway protective mechanisms. However, it remains unknown whether 
improved cough reflex sensitivity is due to decreased oral bacterial load, increased 
mechanical stimulation of the oral cavity or a combination of both. Clarification 
through further investigation is required if we are to provide appropriate interventions 
for patients at risk of AP. Furthermore, despite a known increase in oral carriage of 
yeasts in acute stroke, there are no specific studies documenting the relationship 
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between oral bacteria, cough sensitivity and pneumonia in the acute stroke population. 
Given that this population is at substantial risk of both aspiration and consequent 




Chapter 6. Methods of Characterizing the Oral Microbiota 
6.1. Methods of Obtaining Oral Bacterial Samples 
There are several widely-used methods for obtaining oral bacterial samples. One 
commonly-used method in clinical research is protected specimen brush sampling, 
whereby a small brush is inserted into the lungs via a bronchoscope to collect a 
sample, then retracted into a plastic tube to avoid contamination from the throat and 
oral cavity. This method, combined with quantitative analysis, is considered to be the 
gold standard in diagnosing nosocomial pneumonia (Mertens et al., 1998). Another 
widely-reported technique is bronchoalveolar lavage. In this technique, a 
bronchoscope is passed through the nose or mouth, into the lungs. A small amount of 
liquid is squirted into the lungs and then re-collected for analysis. The disadvantages 
of both of these methods are that they require a specialist with expertise in the 
technique and they are highly invasive. Sputum sampling is a routinely-used 
technique to diagnose nosocomial pneumonia and invasive respiratory testing is rare 
unless the patient is mechanically-ventilated. The disadvantage of sputum sampling is 
that samples contain a mixture of bacteria from the upper and lower respiratory tracts 
as well as the oral cavity. Many patients also find it difficult to produce a sputum 
sample.   
 Saliva sampling is another option when attempting to measure oral bacteria.  
Secreted saliva contains few, if any, bacteria, however it gains up to 109 microbes per 
millimetre as it washes over the tongue, mucous membranes, gingival and periodontal 
tissues (Gibbons & van Houte, 1975). The concentrations of bacteria found in saliva 
fluctuate throughout the day, with the highest concentrations present during 
mastication, and upon waking (Gibbons & van Houte). Salivary testing is considered 
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to be a practical and reliable means of measuring exposure to risk factors for many 
systemic illnesses (Lawrence, 2002). Considering that AP is caused directly by 
aspirated oral bacteria, it seems logical that a patient with AP would have the same 
organisms present in the oral cavity as they would at the site of infection (i.e. the 
lungs). Bacterial markers in the saliva may even be present before the infection 
presents. Salivary testing typically involves the use of a cotton bud or similar device 
inserted into the mouth for a short period of time before removing the device and 
analysing the collected saliva. This may be an ideal alternative to other more invasive 
methods of bacterial sampling. 
6.2. Methods of Analysing Oral Bacteria 
6.2.1. Chemotaxonomic methods. 
Chemotaxonomic methods classify bacteria based on chemical features such as the 
cell wall composition, lipids and proteins. This method may be particularly useful for 
the identification and classification of new bacterial species. There are several 
methods of chemotaxonomy, mainly involving variations of spectroscopy, 
chromatography and gel electrophoresis.  
6.2.2. Phenotypic methods. 
Analysis of bacteria in health research has traditionally relied on analysis of samples 
cultured under laboratory conditions. Bacteria are identified under microscopy based 
on their physical characteristics (morphology) and physiology. Culture-based 
techniques, however, present several limitations. Importantly, not all bacteria can be 
grown in laboratory conditions. Sample yields may be low, due to stress on the 
bacteria, fastidiousness and failure to thrive or slow growth (MacNeil, Kauri, & 
Robertson, 1995). Highly-related bacteria species with very similar phenotypes are 
not distinguishable. Successful growth often relies on timely delivery of samples to 
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the laboratory to ensure the detection of viable bacteria. Even when optimal growing 
conditions are met, growth under laboratory conditions may not accurately represent 
in vivo growth. Culture-based testing is biased towards bacteria which are easily 
and/or rapidly grown or samples that contain high concentrations of bacteria 
(MacNeil et al., 1995). Finally, greater than 99 % of bacteria found in any 
environment are not cultivable using standard culture techniques (Hugenholtz, 2002). 
Such limitations have led to the development of more sophisticated analysis 
techniques, namely, molecular testing.  
6.2.3. Molecular methods. 
The development of nucleic acid techniques in the 1980s revolutionised the field of 
microbiology as previously unculturable organisms could be analysed with relative 
efficiency and little cost. The polymerase chain reaction (PCR) is one of the most 
widely used technologies in molecular biochemistry (Fakruddin, Chowdhury, & 
Hossain, 2012) and will be the focus of this section.  
6.2.3.1. Polymerase chain reaction (PCR). 
PCR, also known as end-point PCR, can be used to amplify a specific piece of the 
DNA strand, known as the DNA target, in order to generate millions of copies of a 
particular DNA sequence. As the PCR progresses, the new DNA is itself used as a 
template for replication, resulting in exponential amplification of the target. This 
feature means that PCR has far higher sensitivity compared to traditional culture 
methods, whilst retaining high specificity (Tang, Procop, & Persing, 1997). Other 
benefits include improved efficiency of testing and the ability to identify dead or 
dormant microbes. The PCR is a well-established method and a summary of the 
reaction follows.  
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6.2.3.1.1. PCR procedures. 
A thermal cycler alternately heats and cools the PCR sample according to a defined 
series of temperature steps. PCR typically consists of 20-40 repeated temperature 
changes (cycles). The entire process generally takes about one hour and can be 
summarized into six steps (Table 5).  
6.2.3.1.2. Advantages and disadvantages of PCR 
The main advantage of PCR over other methods of bacterial analysis is that bacteria 
which are unable to be cultured can be detected at the molecular level, reducing the 
risk of false-negatives. Comparisons of culture methods and molecular methods such 
as PCR suggest higher bacterial detection rates using PCR (Johansson, Kalin, 
Tiveljung!Lindell, Giske, & Hedlund, 2010; Saukkoriipi, Leskela, Herva, & 
Leinonen, 2004; Templeton et al., 2005) even when antibiotics have been taken 
(Strålin, To, Kaltoft, & Olce, 2006).  
 One of the disadvantages of PCR is that the DNA targets must be specified a 
priori. This is problematic because the user may not be aware of all of the organisms 
present in a sample, inadvertently excluding organisms of interest. When designing 
the primers, extreme care must be taken to use accurate sequence data. DNA 
sequences are publically available through databases such as GenBank, however these 
data must be manually validated to ensure accurate and viable PCR products. The end 
product will represent all amplified DNA from the sample, not just the target DNA, 
therefore, DNA sequencing of the product must be undertaken post hoc to be sure that 
the product is indeed the target DNA and not a similarly-sized DNA product.    
Because the prevalence of oral bacteria is so high (100 million bacterial cells 
per 1 mL of saliva [Curtis et al., 2011]), it is essential that molecular analysis is highly 




The PCR process. 
Stage Process Result 
1. Denaturation The reaction mixture is heated to 94-98 °C for 20-
30 seconds.  
 
DNA melting/disruption of the hydrogen bonds between 
complementary bases, leading to physical separation of the 
DNA double helix into single-stranded DNA molecules. 
2. Annealing  The reaction mixture is cooled to 50-65 °C for 20-
40 seconds. 
Polymerase binds the primers to the DNA template and a new 
double-stranded DNA molecule begins to form. 
3. Extension/elongation The DNA polymerase synthesizes a new DNA 
strand that is complementary to the DNA template 
by adding dNTPs. Stages 1-3 are repeated 40 times. 
 
The amount of DNA target doubles i.e. the DNA target is 
amplified exponentially.  
4. Final elongation The reaction mixture is held at 70-74 °C for 5-15 
minutes. 




5. Final hold The reaction mixture is cooled to 4-15 °C. Storage of the product until analysis. 
6. Analysis Size analysis is performed using gel electrophoresis 
and sequencing 




analyses that are suitable for analysing oral bacteria however, for research purposes, 
qPCR may be the most appropriate as it is widely available in laboratories, cost- 
effective and provides reliable, quantifiable, highly sensitive and rapid information 
about target DNA within a sample.  
6.2.3.2. Quantitative PCR (qPCR) 
qPCR, also known as real time PCR, combines PCR amplification and detection into 
a single process. qPCR follows the principles of PCR; it differs in that the amplified 
DNA is detected in ‘real time’ as the PCR progresses, negating the need for post-PCR 
size analysis. qPCR is preferable to other PCR formats for several reasons. Unlike 
size analysis, which distinguishes the weight of molecules with limited specificity, 
qPCR characterises molecules by their sequence and therefore is a more reliable and 
useful tool (Saunders, 2009). Similarly, unlike other PCR formats that rely on post-
amplification manipulation and analysis, qPCR provides a quantitative outcome 
measure of the concentration of the target sequence in the sample in rapid time. Other 
advantages include the ability to constantly monitor the reaction, low contamination 
risk due to sealed reaction tubes, increased sensitivity and reproducibility, and 
software-driven operation (Logan & Edwards, 2009).   
During qPCR, fluorescent dyes are used to label and detect PCR products 
during thermal cycling. qPCR instrumentation measures the accumulation of 
fluorescent signal during each cycle. The cycle in which fluorescence is detected is 
called the quantitation cycle (Cq). The Cq is the basic result of qPCR. Low Cq values 
correspond to high initial copies of the target. Each target molecule is copied once 
during each thermal cycle and data are recorded throughout.  
There are two main strategies to fluorescently label the qPCR products: 1) 
target-specific DNA probes made up of oligonucleotides that produce a signal only 
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when the target DNA sequence is amplified (probe hybridisation; e.g. TaqMan® 
fluorogenic probes), 2) non-specific fluorescent dyes that bind to double-stranded 
DNA and emit fluorescence when bound (e.g. SYBR® Green I dye).  
6.2.3.2.1. Detection of bacteria by probe hybridisation versus non-specific 
fluorescent dye. 
 Both methods of qPCR have advantages and disadvantages. The main advantages of 
probe hybridisation methods such as TaqMan® are high sensitivity and specificity, as 
fluorescence will only be generated when there is a specific reaction between the 
probe and target. This method is generally less susceptible to providing false-positive 
results (Saunders, 2009). TaqMan® is considered to be more sensitive than other 
methods for detecting low numbers (fewer than 10 copies) of target DNA (Bookout & 
Mangelsdorf, 2003). However, this may be irrelevant, as most qPCR instruments have 
limited sensitivity below 10 copies of target DNA. The other main advantage of 
TaqMan® is that up to two different sequences can be amplified and detected in one 
reaction tube (duplex). However, if more than two sequences are of interest, the 
synthesis of several different probes is required, and TaqMan® chemistry is costly to 
run.  
The other method of qPCR is SYBR® dye chemistry. This method does not 
require probes, significantly reducing analysis costs. In general, the SYBR® dye and 
TaqMan® methods are considered to have comparable sensitivity (Schmittgen & 
Livak, 2008). However, because SYBR® dye binds to all DNA strands, it will bind to 
the target strands as well as any non-target strands. This increases the likelihood of 
generating false positive results. This can be managed by carefully designing primers 
that will not amplify non-target DNA strands and by performing melt curve analysis 




Despite the known links between oral bacteria and pneumonia, to date, there are no 
studies describing the relationship between oral bacteria and AP in patients with acute 
stroke. Considering that this population are likely to experience an acute, detrimental 
change to their oral hygiene routines during hospitalisation, this issue requires urgent 
attention. If changes in oral bacteria could be characterised during the acute stroke 
phase, this information could be used to inform oral hygiene protocols and potentially 
reduce the risk of AP.  
 A link between oral bacteria and cough reflex sensitivity in elderly rest-home 
residents has also been suggested (Watando et al., 2004). The mechanism behind this 
relationship remains unknown, but could be of great benefit to patients with acute 
stroke who are at risk of decreased cough reflex sensitivity and aspiration.  
 Salivary testing may be an ideal alternative to other invasive methods of 
bacterial sampling as it is fast, comfortable, relatively non-invasive and does not 
require expertise to perform. When attempting to measure bacteria associated with 
AP, testing of oral bacteria is relevant as the oral cavity is the presumed source of 
respiratory pathogens.  
 With recent advances in technology, molecular methods of bacteriology are 
often favoured over more traditional, culture-based methods as they provide enhanced 
sensitivity and overcome the issue of culturing live organisms. Within molecular-
based biochemistry, both probe hybridisation and non-specific fluorescent dye 
methods have advantages and disadvantages. For exploratory science, non-specific 
fluorescent dye methods may be preferred as their relatively cost-effectiveness allows 
a greater number of targets to be analysed. 
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6.4. Summary of Evidence  
Dysphagia, when accompanied by pathogenic oral bacteria, aspiration and poor 
pulmonary clearance, may substantially increase the risk of pneumonia in patients 
with acute stroke. Despite a documented increase in the oral carriage of pathogenic 
bacteria in this population compared to other patient cohorts (Millns et al., 2003), no 
studies have documented changes in oral bacteria in the days and weeks following an 
acute stroke. Given that morbidity and mortality from pneumonia is also particularly 
high during this period (Scannapieco & Mylotte, 1996), this represents a critical gap 
in the evidence base surrounding pneumonia prevention. Based on the existing 
literature, six bacteria in particular may play a role in the pathogenesis of AP in the 
acute stroke population: S. mitis, S. pneumoniae, S. aureus, K. pnuemoniae, E. coli 
and P. aeruginosa. The relationship between these bacteria, stroke, and pneumonia 
requires urgent clarification. 
A link between oral bacteria and cough reflex sensitivity in the elderly has 
also been suggested (Watando et al., 2004), although the mechanism for this remains 
unknown. If the relationship between cough sensitivity and oral bacteria were 
clarified, this could inform interventions specifically targeting those at risk of 
pneumonia due to decreased cough reflex sensitivity. 
Impairment of the cough reflex is a potential side-effect of stroke which can 
lead to silent aspiration. CRT is a sensitive and specific screen of silent aspiration 
(Imoto et al., 2011; Miles, McFarlane, Allen, & Huckabee, 2013; Sato et al., 2012; 
Wakasugi et al., 2008, 2014). However, a recent study investigating the usefulness of 
CRT in a clinical population found no effect on pneumonia or mortality rates (Miles 
et al., 2013a). There is evidence to support the use of standardised management 
protocols in dysphagia management (Addington, Stephens, & Gilliland, 1999; 
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Gandolfi et al., 2014; Ickenstein et al., 2010; Leder et al., 2012; Odderson et al., 
1995), leading to the question of whether the incorporation of CRT into a clinical 
protocol may be effective in reducing AP.  
CRT is increasingly utilised in research and clinical practice, with wide 
variations in methodology. Time of testing is considered to be a major confounding 
variable in CRT that is controlled for by testing at the same time of day. However, 
this may not be feasible in acute clinical settings. A pattern of diurnal variation in 
cough reflex sensitivity has only been described using the vital-capacity method 
(Pounsford & Saunders, 1985) and it remains unclear whether the same effect is 
present when the commonly used tidal breathing method of CRT is used, or when oral 
bacteria are controlled for. Clarification of this issue is needed to inform clinical and 




Chapter 7. Objectives and Hypotheses 
7.1. Study I: Diurnal Variation in Cough Reflex Testing  
7.1.2. Research question. 
Cough reflex testing is increasingly utilised in dysphagia research and clinical 
practice as a means of assessing reflexive cough sensitivity and silent aspiration risk. 
In 1985, Pounsford and Saunders described a strong pattern of diurnal variation in 
cough responsiveness to citric acid presented via a vital-capacity/mouthpiece method 
among healthy participants. Specifically, cough reflex thresholds were significantly 
lower when tested in the morning versus the afternoon. Since this study, several 
research groups have identified strong links between oral bacteria and pulmonary 
health (Bousbia et al., 2012; Simmons-Trau, Cenek, Counterman, Hockenbury, & 
Litwiller, 2004; Watando et al., 2004; Yoneyama et al., 2002; Yoshino et al., 2001). 
Watando et al. reported improved cough reflex sensitivity levels following intensive 
oral hygiene, suggesting a link between oral bacteria and the cough reflex. However, 
Pounsford and Saunders did not control oral bacteria levels. It is possible that oral 
bacteria represent a confounding variable. It is unknown whether diurnal variation in 
cough sensitivity exists when alternative cough reflex testing methods are used – such 
as the tidal-breathing method that is commonly used in clinical assessment – and oral 
bacteria are controlled. 
7.1.3. Hypotheses. 
1)! There will be no significant difference in participants’ cough reflex 
thresholds when measured in the morning compared to the afternoon. 
7.1.4. Rationale. 
To date, only a single study has described a pattern of diurnal variation in cough 
reflex sensitivity.  If this pattern truly exists, it would represent a major confounding 
 
 143 
variable in research and clinical practise. Further investigation into this aspect of 
cough reflex testing is warranted. 
7.1.5. Significance. 
Future research design as well as current clinical practice will benefit from answering 
the question, ‘is time of testing a confounding variable in cough reflex testing using 
the tidal breathing/facemask method?’. Results from this study will also contribute to 
the body of evidence regarding the repeatability of the CRT.  
7.1.6. Proposed study. 
The aim of this study is to characterise patterns of cough reflex sensitivity in healthy 
adults throughout the day using cough testing methods currently used in clinical 
practice. Fifty-three participants (19 – 37 years) will undergo cough reflex testing on 
two occasions: once in the morning (between 9am – midday) and once in the 
afternoon (between 2 – 5pm). The order of testing will be counter-balanced. Within 
each assessment, participants will inhale successively higher citric acid concentrations 
via a facemask, with saline solution randomly interspersed to control for a placebo 
response. The lowest concentration that elicits a reflexive cough response will be 
recorded. Oral bacteria levels will be controlled for by participants’ brushing their 
teeth immediately prior to testing.  
 
7.2. Study II: Evaluation of a Dysphagia in Stroke Protocol in Patients with 
Acute Stroke 
7.2.1. Research question. 
There is evidence to suggest that the use of structured dysphagia assessment and 
management protocols may be effective in improving outcomes in patients with 
dysphagia. Historically, little emphasis has been placed on the identification and 
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management of silent aspiration in such protocols. The incorporation of CRT into a 
dysphagia protocol may guide clinicians towards optimum feeding management 
decisions as well as identify patients at risk of silent aspiration who may benefit from 
further instrumental assessment of swallowing.   
7.2.2. Hypotheses. 
1)! Patients who are managed under the Dysphagia in Stroke Protocol (DiSP) 
will have a significantly reduced rate of pneumonia over three months, 
compared to an historical cohort. 
2)! Patients who are managed under the DiSP will have a significantly reduced 
length of hospital stay, compared to an historical cohort.  
3)! Route of nutrition/hydration intake at discharge will differentiate patients 
who are managed under the DiSP from an historical cohort, with 
significantly more patients in the latter group requiring an alternative route 
of intake. 
4)! Diet restriction at discharge (e.g. thin vs. thick fluids; modified diet texture) 
will differentiate patients who are managed under the DiSP from an 
historical cohort, with significantly more patients in the latter group 
requiring some form of diet restriction.  
5)! Patients who are managed under the DiSP will show a significantly reduced 
rate of re-admission for chest infection compared to an historical cohort 
within the first three months post-recruitment.  
7.2.3. Rationale. 
Post-stroke pneumonia represents a significant health issue and is strongly associated 
with poor patient outcomes including mortality. In addition, the costs associated with 
treatment increase dramatically when pneumonia accompanies stroke. Although 
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pneumonia is multi-factorial, silent aspiration (aspiration in the absence of an 
observable cough response) has been implicated in the pathogenesis of pneumonia. 
Cough reflex testing provides information about a patient’s reflexive cough response 
and silent aspiration risk. However, in the absence of a defined management protocol, 
the addition of the CRT into clinical routine does not improve patient outcomes 
(Miles et al., 2013a) suggesting that adherence to a protocol may be as important as 
the CRT itself. Standardising patient management has been shown to improve overall 
patient outcomes in many fields of medicine. The use of CRT combined with a 
standardised assessment and management protocol may be more effective in 
improving outcomes in a dysphagic stroke population compared to the use of CRT 
alone. 
7.2.4. Significance. 
Incorporating cough reflex testing into a standardised patient management protocol 
will improve clinicians’ abilities to make appropriate feeding management decisions. 
By identifying patients at high risk of silent aspiration early in the course of 
admission, completing instrumental swallowing assessments and following a protocol 
that bases feeding management on assessment findings, patients who are at risk of 
aspiration pneumonia can be managed appropriately, adverse outcomes can be 
avoided and hospitalisation costs can be lowered.  
7.2.5. Proposed study. 
The aim of this study is to evaluate the effect of a dysphagia assessment and 
management protocol that incorporated cough reflex testing in patients with acute 
stroke. The cough reflex test will be performed using the facemask method more 
suited to patients with neurological impairment and citric acid doses that are based on 
normative and validated data. Two hundred and eighty four patients will be recruited 
 
 146 
to the study and will be managed according to the DiSP. Clinically-relevant outcomes 
will be measured at three months post-stroke and compared with 148 historical 
patients whose management included cough reflex testing but no protocol. The 
primary outcome of interest is aspiration pneumonia.  
 
7.3. Study III: The Relationship between Oral Bacteria, Cough Reflex Sensitivity 
and Aspiration Pneumonia in Patients with Acute Stroke 
7.3.1. Research question. 
Patients with acute stroke and dysphagia are at increased risk for colonisation by 
potential respiratory pathogens such as S. mitis, S. pnuemoniae, S. aureus, E. coli, P. 
aeruginosa and K. pneumoniae. This may be because of hemiplegia/hemiparesis and a 
sudden change to oral hygiene routines, dependence on others for oral hygiene, 
reduced consciousness, reduced salivary flow as well as other non-stroke-specific 
factors such as increased age, poor dental health and other co-morbidities. These 
patients are also at increased risk of pneumonia due to the aspiration of 
food/fluid/secretions that may be contaminated with pathogenic bacteria and reduced 
reflexive cough sensitivity. Despite this, no studies to date have documented changes 
in oral bacteria in the acute stages of stroke in patients with dysphagia. Do these 
changes exist and are they related to pneumonia in this population? Improving oral 
hygiene has been shown to improve reflexive cough sensitivity in elderly rest-home 
residents, but whether this is due to reduced oral bacteria or another mechanism is 
unclear. This can be clarified by answering the question: is there a relationship 




1)! There will be a strong, positive correlation between prevalence of S. mitis, 
S. pnuemoniae, S. aureus, E. coli, P. aeruginosa and K. pneumoniae 
isolated from patients’ saliva samples and patients’ cough reflex threshold 
levels.  
2)! Prevalence of S. mitis, S. pnuemoniae, S. aureus, E. coli, P. aeruginosa and 
K. pneumoniae isolated from saliva samples and patients’ cough reflex 
threshold levels will be independent predictors of aspiration pneumonia.  
3)! Numbers of S. mitis, S. pnuemoniae, S. aureus, E. coli, P. aeruginosa and 
K. pneumoniae isolated from saliva samples will increase in proportion to 
the number of days a patient is hospitalised.   
4)! Numbers of S. mitis, S. pnuemoniae, S. aureus, E. coli, P. aeruginosa and 
K. pneumoniae isolated from saliva samples will be lowest at 30 days post-
stroke.  
7.3.3. Rationale. 
To date, the relationship between oral bacteria, cough reflex sensitivity and aspiration 
pneumonia in patients with acute stroke and dysphagia is undocumented. Clarification 
of this relationship is needed before large-scale studies addressing oral care and 
recovery of cough reflex sensitivity in this population can be undertaken.  
7.3.4. Significance. 
Findings from this study will contribute towards a greater understanding of the role of 
oral bacteria in aspiration pneumonia. By focussing on a patient population who are at 
increased risk of silent aspiration and subsequent pneumonia, results of this study will 
represent the first step towards inform the optimal allocation of healthcare resources, 
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addressing oral care during the acute recovery phase of stroke and potentially 
decreasing the rates of aspiration pneumonia. 
7.3.5. Proposed study. 
The aim of this study is to describe the relationships between pathogenic oral bacteria, 
cough reflex sensitivity and aspiration pneumonia over three time points in patients 
with acute stroke and dysphagia. One hundred and two patients will be enrolled in the 
study. Each will provide saliva samples and undergo cough reflex threshold testing at 
three time points: on admission to hospital, at discharge from the acute stroke ward 
and at one month post-stroke. In addition, patients’ medical notes will be reviewed for 
symptoms of aspiration pneumonia. Molecular testing will be used to identify the 
presence and prevalence of six target bacteria known to cause aspiration pneumonia in 
the saliva samples. The outcomes of interest are cough reflex sensitivity, 
presence/prevalence of target bacteria and diagnosed aspiration pneumonia.
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Part B: Experimental Studies
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Chapter 8. Diurnal Variation in Cough Reflex Testing  
8.1. Research Aim 
Diurnal variation in cough reflex testing is considered to be major confounding 
variable due to significant differences in cough reflex thresholds measured in the 
morning compared to the afternoon (Pounsford & Saunders, 1985). The evidence for 
this comes from a single historical study that used a vital-capacity/mouthpiece method 
and did not control for the possible confounding effect of increased oral bacteria 
throughout the day. The aim of this study was to investigate diurnal variation in cough 
reflex testing using CRT methods commonly used in clinical assessment and 
controlling for oral bacteria. Participants underwent repeated cough reflex sensitivity 
testing in the morning and the afternoon and results were compared. Oral bacteria 
were controlled for by participants brushing their teeth prior to each CRT.  
8.2. Materials and Methods 
8.2.1. Study design.  
Local ethical approval was received for this prospective experimental study 
(University of Canterbury Human Ethics Committee reference HEC 2014/36). 
Informed written consent was given prior to commencement of data collection. 
Participants provided data in two assessment sessions: one in the morning 
(between 9am – midday) and one in the afternoon (between 2 – 5pm). The order of 
testing was randomised and occurred on either the same day (i.e. morning, afternoon) 
or consecutive days (i.e. afternoon, morning). There was a minimum of three hours 
between sessions, with a mean of ten hours. In order to control for the potential 
confounding effect of oral bacteria on cough reflex thresholds (Watando et al., 2004), 
participants were instructed to brush their teeth using a toothbrush and water for two 
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minutes at the start of each session. 
8.2.2. Participants. 
Intially, 28 young, healthy participants were studied. An additional 25 participants 
were recruited in an attempt to increase statistical power so that the final dataset 
consisted of 53 participants (27 males, 26 females, age range = 19 – 37 years).  
Participants had no history of respiratory disease (e.g. severe asthma, chronic 
obstructive pulmonary disease), gastroesophageal reflux, neurological disorder (e.g. 
stroke, brain tumour, traumatic brain injury), chest infection within the past eight 
weeks or tobacco smoking in the past six months. Participants had not been 
previously exposed to CRT and none reported having a current dental infection or 
currently taking antibiotics, painkillers, cough syrup or ACE inhibitor drugs.  
8.2.3. Cough reflex threshold testing. 
Citric acid diluted in 0.9 % sodium chloride was prepared at twelve doses starting 
from 0.1 mol/L (1.92 %) and increasing in 0.1 mol/L increments up to 1.2 mol/L 
(23.06 %). This range was based on normative data (Monroe et al., 2014) which state 
that 96 % of people reach a suppressed cough threshold by 1.2 mol/L using a tidal 
breathing/face mask method. This range also includes the doses reported by 
Pounsford and Saunders (1985) as sensitive enough to detect diurnal variation in 
airway sensitivity and reflect current clinical methods (Kallesen, Psirides, & 
Huckabee, 2015; Miles, McLauchlan, & Huckabee, 2014)  
CRT was performed using a tidal breathing/face mask method. Citric acid was 
delivered via a facemask (Hudson Micro Mist Nebuliser Model 41893, Standard 
Connector & Adult Mask, Hudson RCI, Durham, North Carolina, USA) placed over 
the nose and mouth. The facemask was connected to a Turboneb 2 Nebuliser 
(Clement Clarke International Limited, Harlow, UK) with an obstructed flow rate of 
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6.6 L/minute. As different aerosols were presented for up to fifteen seconds, 
participants were instructed to “breathe normally through your mouth. Try not to 
cough”. The suppressed cough threshold (SCT) (as opposed to natural cough 
threshold) was chosen as the primary outcome measure, as this is considered to more 
closely approximate a true reflexive cough (Hegland et al., 2012; Monroe et al., 
2014). Participants were blinded to the concentration of doses. 
Initially, a placebo dose of 0.9 % sodium chloride was presented to 
accommodate the participants to the presentation of nebulised air. Up to twelve citric 
acid doses were presented in progressively higher concentrations, with placebo doses 
randomly interspersed throughout testing to increase challenge blindness and prevent 
tachyphylaxis (Morice, 1996). Each citric acid dose was presented up to three times, 
with at least 30 seconds between trials to prevent tachyphylaxsis (Morice et al., 2007). 
Cough response was considered positive if two or more consecutive coughs were 
triggered (C2 response threshold) on two out of three trials. The lowest concentration 
of citric acid that elicited a cough response was considered to be the SCT. All testing 
was video-recorded for reliability purposes. 
8.2.4. Data analysis. 
Statistical analyses were completed using SPSS (IBM Corp. Released 2015. IBM 
SPSS Statistics for Mac, Version 23.0. Armonk, New York, USA). An a priori 
sample size of 28 participants was calculated for an estimated effect size of 0.4 and 90 
% statistical power (p < .05) based on the Wilcoxon signed-rank test. However, post 
hoc data analysis revealed low statistical power (1 – β = 0.16). Using the effect size 
calculated from the first analysis, a second Wilcoxon signed-rank test indicated that 
by increasing the sample size to N = 53, statistical power would increase and the 
chances of a Type II error would be reduced. Statistical significance was set at a level 
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of p < .05 (two-tailed). Related-samples Wilcoxon signed-rank tests were conducted 
to compare SCTs measured in the morning versus the afternoon and to compare 
participants’ first SCT compared to their second SCT. Participants who did not cough 
at the highest citric acid dose were coded as having a SCT of 1.3 mol/L. A simple 
linear regression was used to predict SCT based on time of day (coded as hours since 
midnight). Intra-rater reliability was estimated by the primary researcher re-analysing 
20 % (n = 11) of participants’ recordings. The same 20 % samples were also used to 
estimate inter-rater reliability by two independent raters. Single measure intraclass 
correlation coefficients (ICC) were used for analysis.  
8.3. Results 
Morning SCTs (mean  = 0.6 mol/L, SD = 0.49) were not different from afternoon 
SCTs [(mean = 0.6 mol/L, SD = 0.46), p = .16, T = 101, r  = -0.14, 1 – β = 0.29] 
(Figure 1). There were no gender differences, with male participants’ morning SCTs 
(mean  = 0.8 mol/L, SD = 0.49) not different from afternoon SCTs [(mean = 0.7 
mol/L, SD = 0.47), p = .19, T = 27, r  = -0.18]. Similarly, female participants’ 
morning SCTs (mean  = 0.5 mol/L, SD = 0.47) did not differ from afternoon SCTs 
[(mean = 0.4 mol/L, SD = 0.44), p = .79, T = 30, r  = -0.04]. 
Regardless of time of day, SCTs from the first exposure (mean = 0.5 mol/L, 
SD = 0.47) were lower than the second exposure [(mean = 0.6 mol/L, SD = 0.48), p = 
.01, T = 247, r = 0.27, 1 – β = 0.77] (Figure 2). This order effect was present for 
females [p = .04, T = 56, r = 0.28] but not males [p = .06, T = 73, r = 0.26].   
Eleven participants (21 %) failed to trigger a SCT during either assessment. 
When these individuals were removed from the dataset, there continued to be no 
difference in morning SCTs (mean = 0.4 mol/L, SD = 0.39) compared to afternoon 




Figure 1. Cough reflex thresholds measured in the morning and the afternoon. Means 


































Figure 2. Cough reflex thresholds from the first and second tests. Means and 95 % 































(mean = 0.4 mol/L, SD = 0.31) continued to be lower than second SCTs [(mean = 0.4 
mol/L, SD = 0.38), p = .01, T = 247, r  = 0.27].  
When time of day was analysed as a continuous variable (i.e. hours since 
midnight), no relationship to SCT was found [F(1, 104) = .01, p = .93]. The overall 
model fit was poor [R2 < .01]. Time of day was not a significant predictor of SCT [β = 
-0.01, p = .93].  
Intra-rater reliability of cough reflex sensitivity was excellent (Cicchetti, 
1994), with a single measure ICC of 0.99. Inter-rater reliability was also excellent 
with an ICC of 0.99.
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Chapter 9. Evaluation of the Dysphagia in Stroke Protocol 
in Patients with Acute Stroke 
9.1. Research Aim 
The use of standardised patient management protocols is strongly advocated in the 
literature. Despite this, there is a lack of high-quality evidence into the use of 
dysphagia management protocols in the acute stroke population. The aim of this study 
was to evaluate the effect of the DiSP: a protocol that incorporated cough reflex 
testing, instrumental assessment and prescriptive clinical guidelines around the 
resumption of oral intake in acute stroke patients. Clinically-relevant outcomes from 
patients managed according to the DiSP were measured and compared to patients who 
had received CRT in the absence of a prescribed management protocol.  
9.2. Materials and Methods 
9.2.3. Study design.  
This study was registered with the Australian New Zealand Clinical Trials Registry 
(Trial Id: ACTRN12613000489796). Regional and locality ethical approval was 
received (Northern A Health and Disability Ethics Committee reference 13/NTA/111, 
University of Canterbury Human Ethics Committee reference HEC 2013/105) in 
conjunction with the Canterbury District Health Board Te Komiti Whakarite (Maori 
Ethics Committee).  
The study was a prospective-retrospective cohort study. Miles et al. (2013a) 
compared pneumonia-related outcomes in 311 patients admitted to four metropolitan 
hospitals (Hospitals A, B, C, D) with acute stroke and suspected dysphagia. Patients 
were randomly assigned to either a control group who received a standard clinical 
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evaluation (n = 163) or an experimental group who received CRT in addition to 
standard clinical evaluation (n = 148). For the present study, 284 patients were 
prospectively recruited from a single metropolitan hospital (Hospital A). Patients had 
a diagnosis of stroke and suspected dysphagia and were managed using the DiSP: a 
standardised dysphagia assessment and management protocol. These patients were 
compared to the experimental group from Miles et al. (2013a) who had received CRT 
but no standardised management protocol.  
9.2.4. Patient selection. 
Patients who had been referred to SLT for swallowing evaluation were recruited for 
both studies. For details of recruitment see Figure 3. Patients who were referred for 
palliative swallowing advice were excluded, as these patients do not typically undergo 
complete swallowing assessments and prevention of pneumonia is not a priority in 
management. Twenty patients were excluded in the DiSP group; the reasons for 
exclusion are listed in Figure 3. For each patient who was excluded, a replacement 
patient was recruited.  
9.2.5. Protocol. 
The Dysphagia in Stroke Protocol (DiSP) was considered to be ‘usual care’ at 
Hospital A during the prospective arm of the study. The DiSP is conceptualised in 
Figure 4. Briefly, all patients referred for swallowing evaluation underwent a clinical 
swallowing assessment, including informal communication screening, cranial nerve 
examination and functional assessment of oral, pharyngeal and laryngeal substrates. 
CRT was completed prior to the assessment of oral intake. If the patient failed the 
CRT, they were recommended NBM and referred for a VFSS. If the patient passed 
the CRT, they proceeded to an evaluation of oral intake. The DiSP also guided 




Figure 3. Details of Study Recruitment 
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Figure 4. The Dysphagia in Stroke Protocol 
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patient was recommended an appropriate oral diet. If aspiration was observed, 
recommendations regarding oral intake were made according to the patient’s ability to 
clear the aspirate. 
9.2.5.1. Cough reflex testing. 
CRT was performed based on the method described by Miles et al. (Miles et al., 
2013a).  Citric acid diluted in 0.9 % sodium chloride was prepared at two doses: 0.8 
mol/L at which 90 % of healthy people produce evoked coughing (Monroe et al., 
2014) and a higher dose of 1.2 mol/L at which 96 % of people can no longer suppress 
coughing (Monroe et al., 2014), considered to more closely represent a true reflex 
cough (Hegland et al., 2012). CRT was performed using a tidal breathing/face mask 
method. Citric acid was delivered via a facemask (Hudson Micro Mist Nebuliser 
Model 41893, Standard Connector & Adult Mask) placed over the nose and mouth. 
The facemask was connected to a Turboneb 2 Nebuliser (Clement Clarke 
International Limited) with an obstructed flow rate of 6.6 L/minute. Initially, a 
placebo dose of 0.9 % sodium chloride was presented to acclimate the patient to the 
presentation of nebulised air. Citric acid at a dose of 0.8 mol/L was then presented 
with the instruction to “breathe normally through your mouth. Cough if you need to”. 
Citric acid was presented for up to 15 seconds, during which time coughing 
presence/absence and a subjective judgement of coughing strength (strong/weak) was 
noted. The test was repeated up to three times at the lower dose, with at least 30 
seconds between presentations to prevent tachyphylaxis (Morice et al., 2007). 
Coughing response was considered positive if two or more consecutive “strong” 
coughs were triggered (C2 response threshold) on two out of three trials (Morice et 
al., 2007). The clinician then instructed the patient to “try not to cough” while 
administering the same low dose. If the patient was able to suppress coughing at 0.8 
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mol/L on two out of three trials, the test was repeated again using the higher dose at 
1.2 mol/L.A patient was considered to pass the CRT if they produced strong coughing 
to 0.8 mol/L citric acid and could not suppress coughing at either 0.8 mol/L or 1.2 
mol/L. A patient was considered to fail the CRT if they produced weak coughing to 
0.8 mol/L or could suppress coughing at 1.2 mol/L.  
 Patients who passed the CRT proceeded to bedside evaluation of oral intake, 
with decisions regarding diet modification, supplemental nutrition/hydration and 
referral for instrumental assessment determined by the SLT based on clinical 
presentation on further examination and in conjunction with the multi-disciplinary 
team. Patients who failed the CRT remained non-oral and were immediately referred 
for a VFSS.  
9.2.5.2. Diet management. 
The DiSP also dictated diet management following VFSS. Diet 
recommendations were made on the basis of aspiration and the patient’s response.  
Patients who presented with silent aspiration remained non-oral with alternative 
nutrition/hydration until recovery of the cough reflex (as determined by repeat CRT) 
or aspiration resolved (as determined by repeat VFSS). Patients who responded to 
aspiration with a weak cough response remained non-oral for the texture aspirated, 
with other textures recommended at the clinician’s discretion. Patients who presented 
a strong cough response to aspirate were recommended the safest oral diet per the 
clinician’s judgement. Similarly, patients with no aspiration were recommended the 
safest oral diet per the clinician’s judgement. 
9.2.6. Control group. 
Patients in the historical control group underwent a bedside swallowing assessment, 
including informal communication screening, cranial nerve examination and 
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functional assessment of oral, pharyngeal and laryngeal substrates. CRT was 
completed prior to the assessment of oral intake, using the method described by Miles 
et al. (2013a). Subsequent management decisions were not prescribed and were left to 
the discretion of the clinician.  
9.2.7. Outcome measurement. 
The primary outcome of interest was the proportion of patients with AP within 3 
months of recruitment. A diagnosis of AP was made on the basis of previously-
described criteria, namely, the presence of three or more of the following: fever (>38 
°C), abnormal chest examination (tachypnea [>22 breaths/minute], tachycardia, 
inspiratory crackles, bronchial breathing), productive coughing with purulent sputum, 
abnormal chest x-ray, arterial hypoxemia (PO2 <70 mm Hg) and detection of a 
relevant pathogen (positive Gram stain and culture) (Mann et al., 1999). Secondary 
outcome measures included: mortality, length of hospital stay, proportion of patients 
readmitted to hospital with pneumonia within three months and place of residence at 
three months. Demographic information and medical histories were collected from 
medical records. Clinical decision parameters were also examined, including use of 
instrumental swallowing assessment, recommended route of intake at three months 
(oral versus non-oral) and recommended diet restriction at three months (altered 
food/fluid texture). The primary outcome measure and several of the secondary 
outcome measures were determined by a physician and documented in the medical 
records. Outcome measurement was conducted by the primary researcher (S.D.) via 
telephone or facsimile to participants, family members, residential care staff and/or 
general practitioners as well as a retrospective chart review at three months.   
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9.2.8. Data analysis. 
Statistical analyses were completed using SPSS (IBM Corp.). After an evaluation by 
the clinical advisory board for this study, a relative risk reduction for pneumonia of 40 
% was considered clinically significant and achievable. Using a binomial proportion 
test, an a priori sample size of 284 participants in the experimental group was 
calculated for an estimated effect size of 0.4 and 90 % statistical power (p < .05).  
Binomial logistic regressions were performed to ascertain the effects of the 
DiSP protocol on the likelihood of 1) patients developing AP, 2) mortality, 3) 
pneumonia-related mortality, adjusted for confounding variables (age, gender, 
ethnicity, study site, cardiac and respiratory co-morbidities, previous stroke, lesion 
site and laterality, initial CRT result). Negative binomial regressions were completed 
to compare the mean length of stay (LOS) between groups. Patients who died during 
hospitalisation were excluded from LOS analysis. Multinomial logistic regressions 
were conducted to determine the effects of the DiSP on patients’ place of residence at 
three months post-stroke, adjusted for confounding variables (gender, age, cardiac and 
respiratory co-morbidities, previous stroke and pre-stroke residence). Patients’ pre-
stroke place of residence was categorised as either ‘independent’ (i.e. patient lived in 
their own home) or ‘dependent’ (i.e. patient lived in a rest home or public hospital at 
the time of their stroke). Chi-square tests were conduced to compare the proportion of 
patients in each group who were living at home vs. residential care facility vs. 
hospital at three months. For comparisons involving the patient returning home, only 
patients who were living at home prior to the stroke were considered. Chi-square tests 
were also conducted to assess the associations between diet tolerance at three months 
and group. Diet tolerance was categorised as tube-fed with no/minimal oral intake, 
modified oral diet +/- supplemental tube feeding or normal diet. Patients who had 
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died (n = 38) or who were lost to follow-up (n = 33) were excluded from this analysis. 
An independent samples t-test was used in a subsample of patients who underwent a 
VFSS to measure differences in the number of days between the initial clinical 
assessment of swallowing and receiving the VFSS between the two groups.  
9.3. Results 
Four hundred and thirty-two patients were included in the analysis: 284 patients 
managed per the DiSP and 148 historical control patients. Control patients were 
recruited from four different hospitals; however, patients did not significantly differ in 
terms of age, gender, lesion site or laterality, history of stroke or respiratory 
comorbidities, pre-stroke independence, response to CRT or initial diet 
recommendations [p > .05].  
The DiSP group and control group did not differ significantly on major 
demographic varables (Table 6). There were significant differences in ethnicity [p < 
.001], respiratory comorbidities [p = .02] and cardiac comorbidities [p = .004]. The 
groups also differed in terms of patients’ initial responses to CRT: more patients 
passed their initial CRT in the DiSP group compared to the control group and more 
patients in the control group had a weak or absent cough response compared to the 
DiSP group [p = .001]. See Table 7 for a summary of outcomes between the DiSP and 
control groups.  
Within the DiSP group, clinician compliance with the protocol was 90 %.  
Noncompliance with the DiSP was mainly due to the incorrect administration of the 
CRT (5 %), lack of referral for VFSS despite noting overt signs of aspiration on 
clinical examination (4 %) and inappropriate diet recommendations following VFSS 




Demographic Comparisons Between Experimental Group and Control Group 
Demographics DiSP  
(n = 284) 
Control  
(n = 148) 
p value 
Age Mean 76 years  
(SD = 12) 
Mean 76 years  
(SD = 15) 
.81 
Male 143 (50 %) 78 (53 %) .72 
Ethnicity:   < .001 
Caucasian 260 (92 %) 111 (75 %) 
New Zealand Maori 8 (3 %) 16 (11 %) 
Pacific Islander 7 (2 %) 13 (9 %) 
Other 11 (4 %) 8 (5 %) 
Hospital Site:   < .001 
Hospital A 284 (100 %) 43 (29 %) 
Hospital B 0 (0 %) 37 (25 %) 
Hospital C 0 (0 %) 52 (35 %) 
Hospital D 0 (0 %) 16 (11 %) 
Comorbidities:    
Previous stroke 82 (29 %) 44 (30 %) .89 
Respiratory  
comorbidities 
52 (18 %) 15 (10 %) .02 
Cardiac comorbidities 155 (55 %) 103 (70 %) .004 
Site of lesion:   .10 
Supratentorial 241 (85 %) 127 (86 %) 
Infratentorial 30 (11 %) 11 (7 %) 
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Mixed 4 (1 %) 1 (1 %)  
Not detected 9 (3 %) 8 (5 %) 
Laterality of lesion:   .41 
Left 116 (41 %) 69 (47 %) 
Right 138 (49 %) 64 (43 %) 
Bilateral 16 (6 %) 15 (10 %) 
Not reported 14 (5 %) 0 (0 %) 
Independence upon admission:   .39 
 Residential care facility or public 
hospital 
31 (11 %) 20 (14 %) 
 Home 253 (89 %) 128 (86 %) 
Response to initial cough reflex test:   .001 
Strong coughing (pass) 206 (73 %) 91 (61 %) 
Weak coughing (fail) 40 (14 %) 33 (22 %) 
Absent coughing (fail) 38 (13 %) 26 (18 %) 
Diet following initial assessment:    .55 
 Non-oral  103 (36 %) 43 (29 %) 
 Modified oral  90 (32 %) 40 (27 %) 
 Normal oral 91 (32 %) 22 (17 %) 




Comparison of Outcomes Between DiSP Group and Control Group 
 DiSP  Control  p value 
Pneumonia 29 (10 %) 41 (28 %) .03 
Mortality 39 (16 %) 20 (14 %) .37 
Pneumonia-related mortality 17 (6 %) 7 (5 %) .50 
Number of days in acute ward† !"= 6 days !"= 9 days <.001 
Number of days in hospital (acute + 
rehabilitation)† 
!"= 24 days !"= 32 days <.001 
Received an instrumental swallowing 
assessment 
88 (31 %) 27 (18 %) .005 
Readmission to hospital for pneumonia 0 (0 %) 7 (5 %) .99 
Independence at 3 months post-
assessment† 
   
Public hospital 9 (4 %) 41 (32 %) <.001 
Residential care facility 63 (29 %) 16 (13 %) <.001 
Home* 142 (71 %) 71 (63 %) .17 
Diet at 3 months post-assessment†    
 Tube-fed 1 (0.5 %) 3 (2 %) .15 
 Modified oral diet 54 (43 %) 40, 19 %) <.001 
 Normal diet 172 (81 %) 70 (55 %) <.001 
†Excluding participants who had died or were lost to follow-up. *Excluding 




accurately represent the real-world clinical application of the DiSP. 
9.3.1. Reducing complications of acute stroke. 
9.3.1.1. Aspiration pneumonia. 
There was a significant difference in the rate of AP between the DiSP group and the 
control group [adjusted odds ratio: 2.72, 95 % CI 1.08 – 6.85, b = 1.00, p = .03] 
(Figure 5). This result was not associated with whether a patient passed or failed their 
initial CRT [p = .19]. The logistic regression model significantly predicted the 
development of AP  [#$(19) = 44.42, p = .001]. Nagelkerke R2 for the model with 
group as the only predictor was .08, indicating a small effect size (Cohen, 1988). 
However, the model did correctly classify pneumonia development in 84 % of cases. 
Nagelkerke R2 increased to .17 with the addition of age, gender, ethnicity, study site, 
CRT result, lesion site and laterality and patient comorbidities to the model, 
suggesting that these variables accounted for an additional 9 % of the variance in the 
development of AP. Regression coefficients and standard errors can be found in Table 
8.  
9.3.1.2. Mortality. 
There was no significant difference in overall mortality between the two groups [p = 
.37] (Figure 6). Within the control group, the presence of cardiac comorbidities was a 
significant predictor of mortality [adjusted odds ratio: 6.72, 95 % CI 1.16 – 38.98, b = 
1.91, p = .03]. Within the DiSP group, there was a significant main effect of age, with 
increased age associated with an increased risk of mortality [odds ratio: 1.07, 95 % CI 
1.02 – 1.12, b = .06, p = .005]. There was no significant effect of group on mortality 
due to pneumonia [odds ratio: 1.37, 95 % CI 0.45 – 4.17, b = 0.32, p = .50] (Figure 7). 




Figure 5. Percentage of patients in the DiSP and control groups who developed 























Results from Logistic Regression Model Predicting Aspiration Pneumonia 
 
B (SE) 
95 % CI for Odds Ratio 
Lower Odds Ratio Upper 
Constant -3.43 (1.37)  0.03  
Control group vs. DiSP 1.00* (0.47) 1.08 2.72 6.85 
Age 0.02 (0.01) 0.99 1.02 1.04 
Male vs. Female 0.10 (0.30) 0.61 1.10 1.99 
Ethnicity     
Maori vs. Other 0.63 (0.69) 0.48 1.88 7.28 
Pacific Island vs. Other -0.21 (0.82) 0.16 0.81 4.02 
NZE vs. Other  0.56 (0.47) 0.69 1.74 4.40 
Lesion site:     
Supratentorial vs.  
Mixed 
-0.19 (1.19) 0.08 0.83 8.57 
Infratentorial vs.  
Mixed 
-1.28 (1.30) 0.02 0.28 3.57 
Not reported vs. Mixed 0.21 (1.48) 0.07 1.23 22.45 
Lesion laterality:     
Right vs. Not reported 0.54 (0.90) 0.30 1.71 9.93 
Left vs. Not reported 0.47 (0.90) 0.28 1.61 9.29 
Bilateral vs. Not reported 1.81 (1.07) 0.75 6.10 49.65 
Previous stroke 5.26 (0.30) 0.67 1.21 2.18 
Respiratory comorbidities 1.85 (.38) 0.81 1.72 3.62 
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Cardiac comorbidities 2.76 (0.33) 0.76 1.44 2.72 












Figure 6. Percentage of patients in the DiSP and control groups who died within three 
months of stroke. The difference between the two groups is not statistically significant 




Figure 7. Percentage of patients in the DiSP and control groups who died as a result 
of pneumonia within three months of stroke. The difference between the two groups 

















































to .32 with the addition of age, gender, ethnicity, study site, lesion site and laterality 
and patient comorbidities to the model, suggesting that these variables accounted for 
an additional 31 % of the variance in pneumonia-related mortality. Other causes of 
death are listed in Table 9.  
Within the DiSP group, further analysis was undertaken of patients who died 
as a result of AP (n = 16). Ten patients (63 %) in this group passed their initial CRT 
and six patients (38 %) failed. Three of sixteen patients (19 %) were not immediately 
diagnosed with stroke and were provided oral nutrition and hydration prior to an 
assessment of swallowing. Two of these patients passed their CRT and one patient 
failed. Two patients (13 %) were not managed strictly per the DiSP. One of these 
patients could not complete the full CRT due to difficulties following instructions but 
was considered to have passed the CRT. One patient was not referred for VFSS until 
the sixth SLT review, despite failing the CRT and presenting overt signs of aspiration 
as documented in five prior SLT reviews. Four patients (25 %) were identified as 
potential silent aspirators yet, despite clinical efforts, developed AP. The remaining 
seven patients (44 %) were not identified as at risk of silent aspiration. 
9.2.1.3. Length of hospitalisation. 
Patients in the control group spent significantly more days on an acute stroke ward 
compared to patients in the DiSP group [adjusted odds ratio 1.49, 95 % CI 1.31 – 
1.71, b = .40, p < .001] (Figure 8). Across both groups, male patients also spent 
significantly longer on the acute ward [!"= 7 days] compared to female patients [! = 6 
days, adjusted odds ratio 1.15, 95 % CI 1.32 – 1.01, b = .14, p = .04]. Control patients 
spent significantly more days in hospital (acute + rehabilitation [!"= 32 days]) 
compared to DiSP patients [!"= 24 days, adjusted odds ratio 1.42, 95 % CI 1.17 – 




Reported Causes of Death other than Pneumonia 
Reported Cause of Death n 
Stroke 15 
Cardiac arrest/heart attack 5 
Unknown/not reported 4 
Septicaemia 2 
Stroke, exhaustion coma, cerebral hypoxia 1 
Stroke, primary lung neoplasm 1 
Stroke, atrial fibrillation 1 
Intracerebral haematoma 1 
Pulmonary oedema, post-stroke seizures 1 
End stage congestive heart failure, septicaemia, limb ischaemia 1 
Urosepsis 1 
Cancer 1 






Figure 8. Length of acute hospitalisation and total hospitalisation for patients in the 
































patients for whom lesion laterality was not reported spent the least amount of days in 
hospital [!"= 9 days], followed by patients with bilateral lesions [!"= 19 days] and 
patients with left- or right-sided lesions [!"= 27 days, !"= 28 days]. 
9.2.1.4. Post-stroke independence. 
By three months, the majority of patients in both the DiSP and control groups had 
returned to their own home (Figure 9). Although greater numbers of patients in the 
DiSP group had returned home compared to the control group, this difference was not 
statistically significant [χ2(1) = 2.22, p = .17]. In the DiSP group, significantly more 
patients were in a residential care facility compared to patients in the control group 
[χ2(1) = 12.46, p < .001] (Figure 9). Of patients who were still in hospital, or had 
returned to hospital, at three months, significantly more were from the control group 
compared to the DiSP group [χ2(1) = 50.51, p < .001] (Figure 9). The best predictors 
of post-stroke place of residence were group, age and pre-stroke place of residence. 
Compared to patients in the DiSP group, patients in the control group were 
11.66 times more likely to be in hospital rather than home [adjusted odds ratio,  
95 % CI 5.38 – 25.00, p < .001] and 23.81 times more likely to be in hospital rather 
than a rest home at three months [adjusted odds ratio, 95 % CI 9.62 - 58.82, p < .001]. 
Older patients were more likely to be in hospital or in a rest home compared to 
younger people [p < .01]. Patients who were independent (i.e. in their own home) pre-
stroke were 12.35 – 26.32 times more likely to return home rather than reside in 
hospital or rest home compared to patients who were dependent (i.e. resided in a rest 
home or hospital) pre-stroke [p < .001].  
9.2.1.5. Pneumonia-related hospital readmissions. 
No patients in the DiSP group were readmitted to hospital with pneumonia during the  
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Figure 9. Percentage of patients in the DiSP and control groups who were living at 































study period, compared to seven patients (5 %) in the control group. The regression 
model significantly predicted readmission to hospital with pneumonia [#$(18) 
=36.93, p =.005]. Nagelkerke R2 for the model with group as the only predictor was 
.23, indicating a small effect (Cohen, 1988). This increased to .49 with the addition of 
age, gender, ethnicity, study site, lesion site and laterality and patient comorbidities to 
the model, suggesting that these variables accounted for an additional 26 % of the 
variance in readmission to hospital with AP. However, no significant main effects 
emerged for any of the predictor variables. 
9.2.1.6. Post-stroke oral feeding status. 
At three months post-stroke, there was no association between group and tube-feeding 
[p = .15]. One patient in the DiSP group (3 %) was tube-fed at three months compared 
to three patients (2 %) in the control group. There were significantly more patients on 
a modified oral diet in the control group (43 %) compared to the DiSP group (19 %) 
[χ2(1) = 22.42, p <.001]. Significantly more patients were on a normal diet (81 %) in 
the DiSP group compared to the control group (55 %) [χ2(1) = 25.48, p <.001] (Figure 
10).  
9.2.1.7. Changes in clinical practice. 
There was a significant increase in the rate of referral for instrumental swallowing 
assessment, with DiSP patients 2.02 times more likely to be referred for instrumental 
assessment compared to control patients [adjusted odds ratio, 95 % CI 1.24 – 3.30, b  
= .70, p = .005]. Among those patients who underwent a VFSS, the average time 
between undergoing an initial clinical swallowing evaluation and receiving a VFSS 
was 2.3 days (SE = 0.46) for patients in the DiSP group, compared to 8.5 days (SE 





Figure 10. Percentage of patients in the DiSP and control groups who were tube-fed, 






























and represented a medium-sized effect (Cohen, 1988) [t(30) = 3.57, p = .001, r = .55]. 
In the control group, three out of eight patients (38 %) who developed pneumonia 
were referred for instrumental assessment after the diagnosis of pneumonia was made. 
By comparison, five out of 15 patients (33 %) in the DiSP group who developed 
pneumonia received an instrumental swallowing assessment after the development of 
pneumonia. However, it should be noted that in four out of five patients pneumonia 
was suspected/confirmed at the time of admission to hospital. In the control group, the 




Chapter 10. The Relationship Between Oral Bacteria, Cough 
Reflex Sensitivity and Aspiration Pneumonia in Patients 
with Acute Stroke 
10.1. Research Aim 
Despite known relationships between oral bacteria and pneumonia, there are few 
documented reports of oral bacteria in patients with acute dysphagia. This population 
are particularly at risk for developing pneumonia in the early stages of stroke. A link 
between oral bacteria levels and cough reflex sensitivity has been suggested, but to 
date it remains unknown whether this relationship exists. The aim of this research was 
to document the relationships between oral bacteria, cough reflex sensitivity and 
aspiration pneumonia in patients with acute stroke and dysphagia. Oral bacteria 
samples were measured at three points in time and compared to measures of patients’ 
cough reflex sensitivity and the occurrence of aspiration pneumonia. 
10.2. Materials and Methods 
10.2.1. Study design.  
Regional and locality ethical approval for this study was received (Southern Health 
and Disability Ethics Committee reference 13/STH/121, University of Canterbury 
Human Ethics Committee reference HEC 2013/132) in conjunction with the 
Canterbury District Health Board Te Komiti Whakarite (Maori Ethics Committee). 
Consecutive patients (N = 102) were recruited from a metropolitan hospital between 
February 2014 and July 2015. Repeated measures were taken at baseline (within two 
days of stroke), at discharge from the acute stroke ward and at 30 days post-stroke.  
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10.2.2. Participant selection. 
Patients admitted to an acute hospital unit with a diagnosis of stroke and referred to 
SLT for an assessment of swallowing were approached for participation in this study. 
Patients who were referred for palliative swallowing advice – defined as advice that 
does not actively prevent pneumonia – were excluded, as these patients do not 
typically undergo complete swallowing assessments. Patients who had undergone 
CRT within the past twelve hours were also excluded due to sterilising effects of citric 
acid on bacteria (Falconer et al., 2014). Participants all provided written consent to 
take part in this study (Appendix I). For patients with aphasia, an “aphasia-friendly” 
consent form and supportive language techniques were used (Appendix I). If patients 
were unable to provide written consent, consent by proxy was sought. For details of 
recruitment see Figure 11. Where there was attrition, participants were replaced with 
patients who met the inclusion criteria for the study (i.e. diagnosis of acute stroke, 
referred for SLT assessment of swallowing). 
10.2.3. Data acquisition. 
10.2.3.1. Measurement of specific oral bacteria. 
Two saliva samples were collected at each measurement point and were used to 
measure oral bacteria. Samples were obtained using tubed, sterile rayon swabs 
(DrySwab™, Innovatek Medical Incorporated, Delta, British Columbia, Canada) 
inserted into the mouth and held in the sublingual cavity for 30 seconds. Samples 
were immediately placed in a sterile tube, sealed and placed inside a cooler bag until 
they could be transferred to a freezer for storage at -70 °C. Samples were identified by 
a code consisting of 1 – 3 digits and one letter.     




Figure 11. Details of Study Recruitment   
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samples were obtained at least twelve hours after the patient’s last CRT. Constraints 
of participant availability and hospital protocols around CRT meant that time of 
bacterial sampling could not be controlled for, however the time of sampling was 
recorded with the participants’ dental status (own teeth versus dentures), smoking 
status and dependence on others for oral care. 
10.2.3.2. Cough reflex threshold measurement. 
To measure cough reflex sensitivity, participants underwent CRTT (Monroe et al., 
2014) using a Turboneb 2 nebuliser (Clement Clarke International Limited). Citric 
acid diluted in 0.9 % sodium chloride was prepared in concentrations ranging from 
0.1 mol/L up to 1.2 mol/L, increasing in 0.1 mol/L increments. Solutions of citric acid 
were prepared weekly. CRTT was performed using a tidal breathing/face mask 
method whereby citric acid was delivered via a facemask (Hudson Micro Mist 
Nebuliser Model 41893, Standard Connector & Adult Mask) placed over the nose and 
mouth. The facemask was connected to a nebuliser with an obstructed flow rate of 6.6 
L/minute. Initially, a placebo dose of 0.9 % sodium chloride was presented to 
accustom the participant to the presentation of nebulised air. Prior to presentation of 
citric acid participants were instructed to “breathe normally through your mouth. Try 
not to cough”. Following this, citric acid was delivered at increasing concentrations, 
starting at 0.1 mol/L. Citric acid was presented for up to 15 seconds, during which 
time coughing presence/absence was noted. Suppressed, as opposed to natural, cough 
thresholds were selected for outcome measurement as this more closely represents a 
true reflex cough (Hegland et al., 2012).  
  The test was repeated up to three times at each dose, with at least 30 seconds 
between presentations to prevent tachyphylaxis (Morice et al., 2007). Coughing 
response was considered positive if two or more consecutive coughs were triggered 
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(C2 response threshold) on two out of three trials (Morice et al., 2007). The lowest 
dose of citric acid that elicited a positive response was recorded as the participant’s 
cough reflex threshold.  
 CRTT were determined three times for each participant: i) upon admission to 
hospital, ii) at discharge from hospital and iii) at one month post-stroke. If a 
participant discharged on the same day as the admission test, outcome measurement 
data from their admission test were carried over to discharge outcome measurement 
data.  
10.2.3.3. Aspiration pneumonia. 
The third outcome of interest was the number of patients who developed AP over a 
one-month post-stroke period. To measure this, participants’ medical charts and 
general practitioner records were reviewed. A diagnosis of AP was made according to 
previously-described criteria (Mann et al., 1999), specifically, the presence of ≥3 of 
the following: fever (>38°C), abnormal chest examination (tachypnea [>22 
breaths/minute], tachycardia, inspiratory crackles, bronchial breathing), productive 
coughing with purulent sputum, abnormal chest x-ray, arterial hypoxemia (PO2 < 70 
mm Hg) and detection of a relevant pathogen (positive Gram stain and culture), as 
determined by a physician and/or nurse. Secondary outcome measures were also 
collected, including: demographic information (age, gender, ethnicity), comorbidities, 
length of hospital stay, oral feeding status (oral vs. non-oral), diet and place of 
residence at one month. Outcome measurement was conducted by the primary 
researcher (S.D.) via telephone or facsimile to participants, family members, 
residential care staff and/or general practitioners as well as a retrospective chart 




10.2.4. Data extraction. 
10.2.4.1. Quantitative polymerase chain reaction assay design. 
10.2.4.1.1. Quantitative polymerase chain reaction standards. 
In qPCR, standards of known gDNA quantity are included as internal positive 
controls. By including at least one sample in each assay that is known to contain 
bacterial gDNA, it is possible to distinguish between true negative amplification, as 
opposed to unintentional qPCR inhibition, in samples of unknown gDNA quantity. 
Type strains S. mitis (ATCC 903), S. pneumoniae (NZ TCC 3517), K. pneumoniae 
(NZRM 482), S. aureus (ST 92429), E. coli (DH5α) and P. aeruginosa (OT15) were  
used as positive controls. Details of each specific strain are listed in Table 10. 
10.2.4.1.2. Preparation of genomic DNA. 
Purified genomic DNA (gDNA) were extracted from pure cultures of each type strain 
initially using the NucleoSpin® microbial DNA kit (Macherey-Nagal, Düren, 
Germany) as per the manufacturer’s instructions. This method uses the mechanical 
force of tiny glass beads (‘bead-beating’) to break down the bacterial cell wall and 
release the gDNA. The results of this process were evaluated using spectrophotometry 
to measure DNA yields (NanoVue™ UV, GE Healthcare, Little Chalfont, 
Buckinghamshire, UK). The resulting DNA yields were unacceptably low (< 2 ng/ 
µL). The process was repeated for S. mitis, K. pneumoniae, S. pneumoniae, E. coli and 
P. aeruginosa using the PureLink Genomic DNA kit (Invitrogen™, Carlsbad, 
California, USA) according to the manufacturer’s instructions. This method relies 
upon the addition of enzymes to achieve cell lysis and the release of gDNA. S. aureus 
gDNA was provided by Dr Trudy Milne (Otago University). The purified gDNA was 
stored at -20°C until qPCR analysis. Amplification of gDNA from bacterial isolates 
was by endpoint PCR followed by agarose gel electrophoresis.  
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Table 10  
Bacterial Strains and Culture Conditions. 
Bacterium Gram-type Strain 
designation 
Culture conditions 
S. mitis Positive ATCC 903 Cultured on blood agar under 
anaerobic then aerobic conditions. 
Transferred to brain-heart infusion 
and incubated overnight at 37°C.  
P. aeruginosa Negative OT 15 
K. pneumoniae Negative NZRM 482 
S. pneumoniae Positive NZRM 3517 Cultured on blood agar under aerobic 
conditions. Transferred to brain-heart 
infusion and incubated overnight at 
37°C. 
S. aureus Positive NZ isolate 
ST 92/492 
E. coli Negative DH5α 
Note. ATCC = American Type Culture Collection, NZRM = New Zealand Reference 
Culture Collection, NZ = New Zealand, OT = Otago University Department of 
Microbiology and Immunology collection  
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10.2.4.1.3. Endpoint PCR reaction conditions. 
PCR reactions were prepared in volumes ranging from 20 – 25 µL. Each reaction tube 
contained 10 – 12.5 µL qPCR mastermix (2x Fast SYBR® Green Master Mix, 
Thermo Fisher Scientific Incorporated, Waltham, Massachusetts, USA), 4.2 – 6 µL 
PCR-grade water (UltraPure™ DNase/RNase-free Distilled Water, Thermo Fisher), 5 
µL gDNA template and 0.4 – 0.75 µL appropriate forward and reverse primers (20 
µM). PCR was performed in a PTC-100 Programmable thermal controller (MJ 
Research, Waltham, Massachusetts, USA) using the following protocol:  
1.! Initial DNA denaturation and polymerase activation at 95°C for ten 
minutes 
2.! Thirty-five cycles of denaturation at 95°C for fifteen seconds, annealing 
(binding of primers to DNA) at 58°C for fifteen seconds and extension at 
72°C for one minute 
3.! Final extension at 72°C for ten minutes 
10.2.4.1.4. Agarose gel electrophoresis conditions. 
PCR products were visualised by agarose gel electrophoresis. To make a 1.6 % gel, 
1.28 g agarose (Bio-Gel A Agarose Gel, Bio-Rad Laboratories Incorporated, 
Hercules, California, USA) was added to 80 mL Tris buffer solution and heated in a 
microwave until the agarose dissolved. Once fully dissolved, 1 µL of ethidium 
bromide (0.5 µg/mL; Bio-Rad Laboratories) was added to the agarose which was then 
cooled until reaching ~55 °C. The preparation was poured into a casting tray with 
combs in situ and allowed to set for at least 20 minutes before the combs were 
removed. The gel was placed into a tank with approximately 300 mL Tris-acetate-
EDTA (TAE) buffer (40mM Tris, 20 mM acetic acid, 1 mM EDTA, pH 8.3) and 0.5 
µL ethidium bromide was added to the positive terminal end. DNA calibration ladder 
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(10 µL, 1 Kb Plus DNA Ladder, Invitrogen™, Carlsbad, California, USA) was loaded 
into the lateral wells of the gel. Gel loading dye (3 µL, 6X DNA Loading Dye, 
Thermo Fisher Scientific Incorporated, Waltham, Massachusetts, USA) was added to 
10 µL of each PCR product, mixed via pipetting and 13 µL of the preparation was 
loaded into each well of the gel. A current was applied to the gel at a fixed voltage for 
35 – 50 minutes.  
The gel was removed from the tank and visualised under ultraviolet light using 
a Gel Doc™ EZ System (Bio-Rad Laboratories). Image Lab™ software (Bio-Rad 
Laboratories) was used to photograph the gel.  
10.2.4.1.5. qPCR primer design. 
The primer sequences were adopted from published reports and are listed in Table 11. 
Primers were synthesised by Sigma-Aldrich (Castle Hill, New South Wales, 
Australia). The Sequence Manipulation Suite: PCR products online tool 
(www.bioinformatics.org/sms2/pcr_products.html) was used to align the primers to 
their corresponding DNA sequences to determine the size of expected PCR products 
(listed in Table 11).  
10.2.4.2. Measuring oral bacteria in saliva samples.  
10.2.4.2.1. DNA extraction. 
To prepare the saliva samples for analysis, the cotton tip of each swab was placed into 
a 15 mL Falcon™ tube (Corning Incorporated, Acton, Massachusetts, USA) 
containing 2 mL of phosphate-buffered saline (Gibco®, Life Technologies 
Corporation, Carlsbad, California, USA). Each tube was then vortexed for two 30-
second bursts. The cotton tips were then discarded. Tubes were centrifuged at room 
temperature for three minutes at 14,000 x g to pellet the bacteria. The supernatant was 




Locations, Optimised Reaction Concentrations and Annealing Temperatures of Primers for qPCR  
Target bacteria Gene 
target 






Streptococcus 16s   130 Rudney, Pan & Chen (2003) 
F AGA TGG ACC TGC GTT GT 59.2 
R CT GCC TCC CGT AGG AGT CT 63.4 
S. pneumoniae cps   72 Ewan, Sails, Walls, Rushton 
& Newton (2015) F GTG TCG CTG TTT TAG CAG ATA GTG A 65.3 
R TCC CAG TCG GTG CTG TCA 67.2 
S. aureus femB   122 Ewan et al. (2015) 
F GACATTTGATAGTCAACGTAAACGTA 61.8 
R GCTCTTCAGTTTCACGATATAAATCTAAGA 64.4 
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K. pneumoniae phoE   69 Shannon, Lee, Trevors & 
Beaudette (2007) F CCTGGATCTGACCCTGCAGTA 66.4 
R CCGTCGCCGTTCTGTTTC 66.9 
P. aeruginosa ecfX   65 Ewan et al. (2015) 
F GCC TGT CCC AGG TCG AAG T 66.7 
R GAT GTG CTT TTC CAC CAT GCT 66.1 
E. coli uidA   67 Ewan et al. (2015) 
F CGC GCT TTC CCA CCA A 67.4 
R CGG CCT GTG GGC ATT C 66.8 
Note. Tm = melting temperature, bp = base pairs, F = forward, R = reverse
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was added to each tube and mixed. The tubes were incubated in a 56 °C water bath 
for 30 minutes to inactivate PCR inhibitors and degradative enzymes. Following this, 
the tubes were vortexed for ten seconds to resuspend the InstaGene™ beads and tubes 
were then incubated in a 100 °C water bath for eight minutes in order to lyse the 
bacteria and release genomic DNA. Tubes were cooled on ice, vortexed for ten 
seconds and centrifuged for three minutes (14,000 x g) at room temperature to  
pellet the InstaGene™ beads. An aliquot (150 µL) of the supernatant containing 
genomic DNA was collected in 1.5 mL microcentrifuge tubes and stored at -20 °C 
until qPCR analysis. qPCR with a universal bacterial primer set and qPCR standards 
(0.2 ng/PCR well) was used to confirm the presence of target bacteria and quantify 
levels of gDNA extracted from twenty participant swabs prior to the final analysis. 
The qPCR cycling parameters are described below. 
10.2.4.2.2. Quantitative polymerase chain reaction (qPCR).  
To perform the qPCR assays, a preparation consisting of 0.2 µL (20 µM) of each 
forward and reverse primers (0.4 µL total), 4.2 µL of PCR-grade water and 10 µL of  
2x Fast SYBR® Green Master Mix was dispensed into each well of a barcoded qPCR 
array plate (MicroAmp® EnduraPlate Optical 96-Well Fast Green Reaction Plate, 
Applied Biosystems, Foster City, California, USA). To duplicate wells, 5 µL of 
gDNA purified from each saliva sample was added. Purified gDNA from pure 
cultures of target bacteria (0.4 ng/µL) served as positive controls and ultra-pure water 
served as the negative control for each plate. Thermal cycling fluorescent 
measurement of double-stranded DNA was performed using the QuantStudio™ 6 
Flex System.  
The qPCR cycling parameters for measuring S. aureus and K. pneumoniae 
were: 20 seconds at 95 °C followed by 40 cycles of three seconds at 95 °C and 30 
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seconds at 60 °C. The PCR cycling parameters for measuring Streptococcus, S. 
pneumoniae, E. coli and P. aeruginosa were: 20 seconds at 95°C followed by 40 
cycles of three seconds at 95 °C and 30 seconds at 63 °C. Fluorescence was measured 
during each cycle and the Cq calculated. The assays were calibrated with a dilution 
series of purified gDNA from each of the target bacteria. Linear amplification was 
assessed over a range of 0.002 – 2 ng/well (S. aureus), 0.002 – 0.11 ng/well (S. mitis), 
0.0002 – 2 ng/well (K. pneumoniae), 0.04 – 0.4 ng/well (S. pneumoniae), 0.0004 – 0.4 
ng/well (P. aeruginosa, E. coli).  




-./01 − 1 ×41004% 
10.2.5. Data analysis. 
Statistical analyses were undertaken with SPSS (IBM Corp.). Using a 2x2 Chi-square 
test based on the proportion of patients with AP colonised with S. mitis and S. 
pneumoniae (Bousbia et al., 2012), an a priori sample size of 102 participants was 
calculated for an estimated effect size of 0.4 and 90 % statistical power (p < .05).  
 For statistical analysis, the raw data from the qPCR was transformed from 
quantitation cycles to relative numbers of bacteria using the formula: 
Relative number of bacteria = 2-Cq 
The relative number of bacteria is a unitless measure and in this context refers to the 
number of bacteria in one sample relative to the next.  
Certain bacteria (i.e. Streptococcus) are commonly found in the oral cavities 
of normal, healthy people and were expected to be present in most of the samples. For 
this reason, it was decided to categorise the relative levels of bacteria as ‘high’, 
‘medium’ or ‘low’ for regression analysis.  
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Linear mixed modelling was used to measure changes in the levels of each 
bacterial species over time. A one-way repeated-measures analysis of variance 
(ANOVA) was performed to determine changes in total bacteria levels over time, 
controlling for age, gender, days spent in hospital, dependence for oral cares, smoking 
status, time of testing and oral feeding status. Participants who died during 
hospitalisation were excluded from this analysis (n = 10). Because fourteen 
participants discharged within 24 hours of baseline testing, the same data were used 
for their discharge measures. Repeat linear mixed modelling as well as a second one-
way repeated-measures ANOVA were run to determine if excluding these participants 
from the dataset made a difference to the ability to measure changes in bacterial levels 
over time. Logistic regressions were used to predict bacterial levels (high, medium, 
low) at i) admission to hospital, ii) discharge from hospital, iii) one month post-
stroke, adjusting for gender, age, smoking status, diabetes mellitus, dentition, ability 
to complete oral care independently, time of testing and number of days in hospital 
(for discharge and one-month measures only). Logistic regressions were also used to 
predict levels of specific target bacteria (high, medium, low), adjusted for age, gender 
and dependence for oral care. 
A one-way repeated-measures ANOVA was performed to determine changes 
in cough reflex thresholds over time, controlling for time of testing, age, gender and 
smoking status. Again, fourteen participants discharged within 24 hours of baseline  
testing, therefore the same data were used for their discharge measures. Multiple 
linear regressions were used to predict cough reflex thresholds at 1) admission, 2) 
discharge, 3) one month post-stroke, adjusted for gender, age and smoking (block 
one) and levels of Streptococcus, S. pneumoniae, S. aureus, E. coli, K. pneumoniae 
and P. aeruginosa and time of testing (block two). 
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Multinomial logistic regression was used to predict the occurrence of 
aspiration pneumonia at admission to hospital, discharge from hospital and at one 
month post-stroke, adjusted for the following variables: age, gender, cough reflex 
sensitivity, total bacteria levels at admission, discharge and one month and being in 
hospital for more than 30 days. A second model that included levels of Streptococcus, 
S. pneumoniae, S. aureus, K. pneumoniae, E. coli and P. aeruginosa at admission, 
discharge and one month was also run. 
Diet tolerance was categorised as i) tube-fed with no/minimal oral intake, ii) 
modified oral diet +/- supplemental tube feeding, or iii) normal diet. Participants’ 
ability to perform oral care independently was treated as a binary variable. 
Participants were considered to be smokers if they reported smoking within six weeks 
prior to admission to hospital. Dentition was categorised as: own teeth, own teeth plus 
dentures, full dentures or edentate. Time of testing was categorised as morning (8am – 
11.59am), noon (12pm – 2pm) or afternoon (2.01pm – 5pm).  
 
10.3. Results i) Preparatory Analyses 
This section contains the results of preliminary analyses that were required to 
determine the sensitivity and specificity of the qPCR assay. This series of experiments 
was completed prior to the analysis of patient samples.  
10.3.1. Analysis of genomic DNA. 
The purity and concentration of gDNA extracted from each of the pure cultures is 
listed in Table 12. A260:A280 ratios of 1.8 – 2.0 indicate appropriate DNA purity 




Comparison of Bacterial gDNA Purity and Yield by Two Lysis Methods 





S. mitis 2.00 1.76 1.90 7.72 
S. pneumoniae 2.25 0.18 2.04 4.56 
K. pneumoniae 2.00 0.40 1.72 1.10 
S. aureus 1.90 0.76 1.90 20.00 
E. coli 1.80 0.72 1.31 8.42 
P. aeruginosa 1.86 1.60 1.43 8.66 
 
1 bead-beating essentials (NucleoSpin® microbial DNA kit), 2 enzymatic essentials 
(PureLink Genomic DNA kit)  
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confirmed detection of identified bacterial species (Figures 12, 13, 14, 15) prior to 
primer optimisation for qPCR.  
Assessment of the purity and concentration of the DNA extracted from the 
saliva samples was attempted originally spectrophotometrically. However, this was 
abandoned due to wide variability in repeated readings. The most likely explanation 
for this variability was that the concentration and/or purity of the extracted DNA was 
too low to be measured accurately by this method. Therefore, qPCR using a universal 
bacterial primer set and qPCR standards (0.2 ng/PCR well) was used to confirm the 
presence of target bacteria and to quantify relative levels of gDNA extracted from 
twenty participant samples prior to the final analysis. Cq values in the participant 
subset were between 24 – 37 (Figure 16). Visual inspection of melting curves 
confirmed the detection of target bacteria. Analysing a subset of qPCR products by 
gel electrophoresis also verified this (Figure 17).  
A comparison of gDNA extraction method efficiency was undertaken by PCR 
analysis of gDNA templates that were extracted by the mechanical lysis method and 
by the enzymatic lysis method. The PCR products were resolved by gel 
electrophoresis. 
10.3.2. Sensitivity of qPCR primers. 
Sensitivity of the primers was assessed by preparing serial dilutions of gDNA 
templates. Endpoint PCR and agarose gel electrophoresis were used to compare the 
expected product size of each bacterial product against a 1 Kb Plus DNA calibration 
ladder (Figures 18, 19).  
10.3.3. Specificity of qPCR primers. 




Figure 12. Validation of gDNA extraction methods, primers and PCR parameters for 
amplifying K. pneumoniae and E. coli by end-point PCR and agarose gel 
electrophoresis. Lanes 1, 20: 1 Kb plus markers; Lane 2, 11: blank; Lanes 3 – 6: K. 
pneumoniae gDNA extracted using the mechanical lysis method: 5 ng/PCR tube 
(Lanes 3, 4) and 0.5 ng/PCR tube (Lanes 5, 6); Lanes 7 – 10: K. pneumoniae gDNA 
extracted using the enzymatic lysis method: 5 ng/PCR tube (Lanes 7, 8) and 0.5 
ng/PCR tube (Lanes 9, 10); Lanes 12-15: E. coli gDNA extracted using the 
mechanical lysis method: 5 ng/PCR tube (Lanes 12, 13) and 0.5 ng/PCR tube (Lanes 
14, 15); Lanes 16 – 19: E. coli gDNA extracted using the enzymatic lysis method: 5 
ng/PCR tube (Lanes 16, 17) and 0.5 ng/PCR tube (Lanes 18, 19). Amplified products 
(amplicons) were not evident in two PCR wells (lanes 16, 17). A ~100-base pair 










Figure 13. Validation of gDNA extraction methods, primers and PCR parameters for 
amplifying S. aureus and P. aeruginosa by end-point PCR and agarose gel 
electrophoresis. Lanes 1, 20: 1 Kb plus markers; Lane 2, 11: blank; Lanes 3 – 6: S. 
aureus gDNA extracted using the mechanical lysis method: 5 ng/PCR tube (Lanes 3, 
4) and 0.5 ng/PCR tube (Lanes 5, 6); Lanes 7 – 10: S. aureus gDNA extracted using 
the enzymatic lysis method: 5 ng/PCR tube (Lanes 7, 8) and 0.5 ng/PCR tube (Lanes 
9, 10); Lanes 12-15: P. aeruginosa gDNA extracted using the mechanical lysis 
method: 5 ng/PCR tube (Lanes 12, 13) and 0.5 ng/PCR tube (Lanes 14, 15); Lanes 16 
– 19: P. aeruginosa gDNA extracted using the enzymatic lysis method: 5 ng/PCR 
tube (Lanes 16, 17) and 0.5 ng/PCR tube (Lanes 18, 19). A ~100-base pair product 


















Figure 14. Validation of gDNA extraction methods, primers and PCR parameters for 
amplifying Streptococcus by end-point PCR and agarose gel electrophoresis. 
Visualisation of amplification products was only undertaken for S. mitis gDNA 
extracted using the mechanical lysis method. Lane 1: 1 Kb plus markers; Lane 2: 
blank; Lanes 3 – 6: S. mitis gDNA: 5 ng/PCR tube (Lanes 3, 4) and 0.5 ng/PCR tube 
(Lanes 5, 6). A ~100-base pair product indicates amplification of the bacterial gene 


















Figure 15. Validation of gDNA extraction methods, primers and PCR parameters for 
amplifying S. pneumoniae by end-point PCR and agarose gel electrophoresis. Lanes 
1, 11: 1 Kb plus markers; Lane 2: blank; Lanes 3 – 6: S. pneumoniae gDNA extracted 
using the mechanical lysis method: 5 ng/PCR tube (Lanes 3, 4) and 0.5 ng/PCR tube 
(Lanes 5, 6); Lanes 7 – 10: S. pneumoniae gDNA extracted using the enzymatic lysis 
method: 5 ng/PCR tube (Lanes 7, 8) and 0.5 ng/PCR tube (Lanes 9, 10). A ~100-base 

































Figure 16. Relative bacterial levels in qPCR standards and gDNA samples from participants 1 – 20 using universal bacterial primers. E. coli was 





























































































































































Figure 17. Example of melting curve analysis of qPCR products by agarose gel 
electrophoresis. Lane 1: 1 Kb Plus markers; Lanes 2, 3: qPCR products generated 
from S. pneumoniae gDNA (0.2 ng/PCR well); Lanes 4, 5: participant sample with a 
melting curve identical to the S. pneumoniae standard; Lanes 6, 7: participant sample 
with a melting curve that did not match the S. pneumoniae standard; Lanes 8, 9: water 
with a melting curve that did not match the S. pneumoniae standard. Samples were 

















Figure 18. Validation of Streptococcus, S. pneumoniae and S. aureus primers using 
end-point PCR products and agarose gel electrophoresis. Expected product sizes were 
130 bp (S. mitis), 72 bp (S. pneumoniae), 122 bp (S. aureus). Lanes 1, 8, 13: water; 
Lanes 2-4: serial dilutions of S. mitis gDNA; Lane 6: 1 Kb Plus markers 
(Invitrogen™); Lanes 9-11: serial dilutions of S. pneumoniae gDNA; Lanes 14-16: 





















 Figure 19. Validation of K. pneumoniae, E. coli and P. aeruginosa primers using 
end-point PCR products and agarose gel electrophoresis. Expected product sizes were 
69 bp (K. pneumoniae), 67 bp (E. coli), 65 bp (P. aeruginosa). Lanes 1, 8, 13: water; 
Lanes 2-4: serial dilutions of K. pneumoniae gDNA; Lane 6: 1 Kb Plus markers 
(Invitrogen™); Lanes 9-11: serial dilutions of E. coli gDNA; Lanes 14-16: serial 




















against the GenBank nucleotide database. None of the primer sets produced 
unexpected matches. Specificity was further confirmed by qPCR and agarose gel 
electrophoresis by comparing amplicons from mis-matched primer-gDNA 
combinations. For each gDNA target, six PCR tubes were prepared, containing qPCR 
mastermix, PCR-grade water and gDNA template. One set (forward and reverse) of 
each primer was added to the reaction tubes such that one of six tubes received the 
correct primer set and five received a primer mis-match.  
The resulting amplification plots are displayed in Figures 20, 23, 26, 29, 32 
and 35. Ideally, the correct primer-target combination should result in a Cq value in 
the range of fifteen to twenty cycles, with the primer mismatches resulting in a Cq 
value of 40 cycles (i.e. no amplification occurred after 40 cycles). Visual inspection of 
melting curves also confirmed primer specificity. Figures 21, 24, 27, 30, 33 and 36 
are examples of melting curves where the amplified products matched the target 
product (melting curves overlap) and Figures 22, 25, 28, 31, 34 and 37 are examples 
of melting curves where the amplified products did not match the target product 
(melting curves do not overlap).  
As a final check of primer specificity, agarose gel electrophoresis was used to 
compare the product size against the 1 Kb Plus DNA ladder. Ideally, the correct 
primer-target combination should result in an intense band of the expected size and 
the primer mismatches should result in no bands. The PCR products were resolved by 
agarose gel electrophoresis (Figures 38 - 43).  
Inspection of the amplification plots, melting curves and agarose gels 
indicated acceptable specificity of the S. aureus (Figures 26, 28, 40) and K. 








Figure 20. Mismatch assessment of Streptococcus primers against six bacterial standards 
by qPCR with an annealing temperature of 60°C. gDNA templates expected to be 
















































Figure 21. Melting curve of Streptococcus gDNA qPCR products using an annealing 
temperature of 60°C. 
Figure 22. Comparison of melting curves of amplified qPCR products from six bacterial 
gDNA templates when a Streptococcus primer set was tested under an annealing 




Figure 23. Mismatch assessment of S. pneumoniae primers against six bacterial 
standards by qPCR with an annealing temperature of 60°C. gDNA templates 
matching the primer set are highlighted in red. The dashed line represents the 















































































Figure 24. Melting curve of S. pneumoniae gDNA qPCR products using an annealing 




Figure 25. Comparison of melting curves of amplified qPCR products from six 
bacterial gDNA templates when S. pneumoniae primers were tested under an 




Figure 26. Mismatch assessment of S. aureus primers against six bacterial standards 
by qPCR with an annealing temperature of 60°C. gDNA templates matching the 
















































Figure 27. Melting curve of S. aureus gDNA qPCR products using an annealing 
temperature of 60°C. 
 
 
Figure 28. Comparison of melting curves of amplified qPCR products from six 
bacterial gDNA templates when S. aureus primers were tested under an annealing 















Figure 29. Mismatch assessment of E. coli primers against six bacterial standards by 
qPCR with an annealing temperature of 60°C. Efficiently amplified gDNA templates 















































Figure 30. Melting curve of E. coli gDNA qPCR products using an annealing 




Figure 31. Comparison of melting curves of amplified qPCR products from six 
bacterial gDNA templates when E. coli primers were tested under an annealing 




Figure 32. Mismatch assessment of K. pneumoniae primers against six bacterial 
standards by qPCR with an annealing temperature of 60°C. gDNA templates 
matching the primer set are highlighted in red. The dashed line represents the 
















































Figure 33. Melting curve of K. pneumoniae gDNA qPCR products using an annealing 




Figure 34. Comparison of melting curves of amplified qPCR products from six 
bacterial gDNA templates when K. pneumoniae primers were tested under an 




 Figure 35. Mismatch assessment of P. aeruginosa primers against six bacterial 
standards by qPCR with an annealing temperature of 60°C. gDNA templates 
matching the primer set are highlighted in red. The dashed line represents the 
















































Figure 36. Melting curve of P. aeruginosa gDNA qPCR products using an annealing 




Figure 37. Comparison of melting curves of amplified qPCR products from six 
bacterial gDNA templates when P. aeruginosa primers were tested under an 




Figure 38. Validation of a Streptococcus primer set by agarose gel electrophoresis 
following qPCR with an annealing temperature of 60°C. Lane 1: 1 Kb Plus markers; 
Lanes 2, 3: S. mitis gDNA; Lanes 4, 5: S. aureus gDNA; Lanes 6, 7: K. pneumoniae 
gDNA; Lanes 8,9: P. aeruginosa gDNA; Lanes 10, 11: E. coli gDNA; Lanes 12, 12: 
S. pneumoniae gDNA. 
 
 
Figure 39. Validation of S. pneumoniae primers by agarose gel electrophoresis 
following qPCR with an annealing temperature of 60°C. Lanes 1, 2: S. pneumoniae 
gDNA; Lanes 3, 4: S. mitis gDNA; Lanes 5, 6: S. aureus gDNA; Lanes 7, 9: K. 
pneumoniae gDNA; Lane 8: 1 Kb Plus markers; Lanes 10, 11: E. coli gDNA; Lanes 




























































Figure 40. Validation of S. aureus primers by agarose gel electrophoresis following 
qPCR with an annealing temperature of 60°C. Lane 1: 1 Kb Plus markers; Lanes 2, 3: 
S. aureus gDNA; Lanes 4, 5: S. mitis gDNA; Lanes 6, 7: S. pneumoniae gDNA; Lanes 





Figure 41. Validation of E. coli primers by agarose gel electrophoresis following 
qPCR with an annealing temperature of 60°C. Lanes 1, 10: 1 Kb Plus markers; Lanes 
2, 3: E. coli gDNA; Lanes 4, 5: S. mitis gDNA; Lanes 6, 7: S. pneumoniae gDNA; 

























































Figure 42. Validation of K. pneumoniae primers by agarose gel electrophoresis 
following qPCR with an annealing temperature of 60°C. Lanes 1, 3: 1 Kb Plus 
markers; Lanes 2, 4: K. pneumoniae gDNA; Lanes 5, 6: S. mitis gDNA; Lanes 7, 8: S. 
pneumoniae gDNA; Lanes 9, 10: S. aureus gDNA; Lanes 11, 12: E. coli gDNA; 










Figure 43. Validation of P. aeruginosa primers by agarose gel electrophoresis 
following qPCR with an annealing temperature of 60°C. Lane 1: 1 Kb Plus markers; 
Lanes 2, 3: P. aeruginosa gDNA; Lanes 4, 5: S. mitis gDNA; Lanes 6, 7: S. 
pneumoniae gDNA; Lanes 8, 9: S. aureus gDNA; Lanes 10, 11: E. coli gDNA; Lanes 
























































remaining primers, further end-point PCR using a temperature gradient protocol of 59 
°C to 69 °C was undertaken. Visual inspection of the PCR products indicated that 63 
°C was the optimal annealing temperature as this tended to be the final point before 
amplification was inhibited (Figures 44 - 47). The primer specificity experiment was 
repeated for Streptococcus, S. pneumoniae, E. coli and P. aeruginosa primers by 
qPCR. The qPCR cycling parameters were adjusted to 10 minutes at 95 °C and 40 
cycles of 15 seconds at 95 °C and one minute at 63 °C. Inspection of the resulting 
amplification plots and melting curves indicated acceptable specificity of 
Streptococcus, S. pneumoniae, E. coli and P. aeruginosa primers at the new annealing 
temperature of 63 °C (Figures 48 - 55). 
10.3.4. qPCR assay sensitivity. 
Assay efficiencies are reported in Table 13. Schematic representations are also 
provided in Figures 57 and 57.   
 
10.4. Results ii) Hypothesis Testing 
Of the 102 participants included in the analysis: 102 completed the first outcome 
measurement, 95 completed the second outcome measurement and 94 completed the 
third outcome measurement. Clinical and demographic information is detailed in 
Table 14. 
10.4.1. Changes in prevalence of target bacteria. 
The relative levels of bacteria were not normally distributed so to categorise them, the 
median, upper and lower quartiles were calculated. For ease of interpretation, these 
are expressed in Table 15 as Cq values. Participants with relative levels of bacteria in 
the upper quartile were categorised as having ‘high’ amounts of bacteria, participants 











Figure 44. Investigation of optimal annealing temperature of a Streptococcus primer 
set using a temperature gradient protocol and amplicons visualised by agarose gel 
electrophoresis. Lane 1: 1 Kb Plus markers; Lanes 2 – 12: Streptococcus gDNA 










Figure 45. Investigation of optimal annealing temperature of S. pneumoniae primers 
using a temperature gradient protocol and amplicons visualised by agarose gel 
electrophoresis. Lane 7: 1 Kb Plus markers; Lanes 1 – 6, 8 – 12: S. pneumoniae 































































































































































































Figure 46. Investigation of optimal annealing temperature of E. coli primers using a 
temperature gradient protocol and amplicons visualised by agarose gel 
electrophoresis. Lane 7: 1 Kb Plus markers; Lanes 1 – 5, 9 – 13: E. coli gDNA 









Figure 47. Investigation of optimal annealing temperature of P. aeruginosa primers 
using a temperature gradient protocol and amplicons visualised by agarose gel 
electrophoresis. Lane 12: 1kb Plus markers; Lanes 1 – 11: P. aeruginosa gDNA 





























































































































































































Figure 48. Amplification plot of a Streptococcus primer set against six bacterial 
standards at an annealing temperature of 63 °C. gDNA templates matching the primer 





Figure 49. Melting curve plot depicting amplified gDNA products from six bacterial 



















































Figure 50. Amplification plot of S. pneumoniae primers against six bacterial 
standards at an annealing temperature of 63 °C. gDNA templates matching the primer 
set are highlighted in red. The dashed line represents the detectable limit of the assay. 
 
 
Figure 51. Melting curve plot depicting amplified gDNA products from six bacterial 
























































Figure 52. Amplification plot of E. coli primers against six bacterial standards at an 
annealing temperature of 63 °C. gDNA templates matching the primer set are 




Figure 53. Melting curve plot depicting amplified gDNA products from six bacterial 



















































Figure 54. Amplification plot of P. aeruginosa primers against six bacterial standards 
at an annealing temperature of 63 °C. gDNA templates matching the primer set are 
highlighted in red. The dashed line represents the detectable limit of the assay. 
 
 
Figure 55. Melting curve plot depicting amplified gDNA products from six bacterial 
templates when P. aeruginosa primers were tested under annealing conditions of 63 


















































Assay Efficiencies for Detecting Streptococcus, S. pneumoniae, S. aureus, E. coli, K. 
pneumoniae and P. aeruginosa 
Assay/target bacteria qPCR efficiency (%) Slope R2 
Streptococcus 90.60 -3.57 1.00 
S. pneumoniae 95.64 -3.43 0.72 
S. aureus 91.32 -3.55 1.00 
E. coli 92.60 -3.51 0.80 
K. pneumoniae 93.62 -3.49 1.00 





Figure 56. qPCR assay sensitivity for Streptococcus (A), S. pneumoniae (B) and S. aureus (C). Assay (A) used Streptococcus primers and 
achieved a 90.60 % amplification efficiency (slope = -3.57, R2 = 1.00) with a five-fold dilution series of 0.002 – 0.11 ng/well of gDNA template. 
Assay (B) used S. pneumoniae primers and achieved a 95.64 % amplification efficiency (slope = -3.43, R2 = 0.72) with a five-fold dilution series 
of 0.4 – 0.04 ng/well of gDNA template. Assay (C) used S. aureus primers and achieved a 91.32 % amplification efficiency (slope = -3.55, R2 = 
1.00) with a ten-fold dilution series of 0.002 – 2 ng/well of gDNA. The mean Cq and standard error of the mean are displayed. No error bars are 
visible due to the small differences between duplicate wells.  
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Figure 57. qPCR assay sensitivity for K. pneumoniae (D), E. coli (E) and P. aeruginosa (F). Assay (D) used K. pneumoniae primers and 
achieved a 93.62 % amplification efficiency (slope = -3.49, R2 = 1.00) with a ten-fold dilution series of 0.002 – 2 ng/well of gDNA template. 
Assay (E) used E. coli primers and achieved a 92.60 % amplification efficiency (slope = -3.51, R2 = 0.80), with a ten-fold dilution series of 
0.0004 – 0.4 ng/well of gDNA template. Assay (F) used P. aeruginosa primers and achieved a 92.35 % amplification efficiency (slope = -3.52, 
R2 = 1.00) with a ten-fold dilution series of 0.0004 – 0.4 ng/well of gDNA template. The mean Cq and standard error of the mean are expressed. 
No error bars are visible due to the small difference between duplicate wells.  
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Clinical and Demographic Information of Participants  
Clinical/Demographic Variable n 
Age (years) Mean = 76, SD = 12.5 
Gender  
 Male 61 (60 %) 
 Female 41 (40 %) 
Ethnicity  
 New Zealand European 85 (83 %) 
 European 11 (11 %) 
 Chinese 2 (2 %) 
 New Zealand Maori 2 (2 %) 
 Indian 1 (1 %) 
 Niuean 1 (1 %) 
Comorbidities  
 Previous stroke 27 (26 %) 
 Respiratory illness 21 (21 %) 
 Cardiac illness 58 (57 %) 
 Dementia 4 (4 %) 
 Diabetes Mellitus 19 (19 %) 
Type of stroke  
 Ischaemic 89 (87 %) 
 Haemorrhagic 11 (11 %) 
 Ischaemic with haemorrhagic transformation 1 (1 %) 
 Not reported 1 (1 %) 
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Site of lesion  
 Supratentorial 88 (86 %) 
 Infratentorial 11 (11 %) 
 Mixed 2 (2 %) 
 Not reported 1 (1 %) 
Lesion laterality  
 Left 42 (41 %) 
 Right 56 (55 %) 
 Bilateral 3 (3 %) 
 Not reported 1 (1 %) 
Independent for oral hygiene at admission*  55 (54 %) 
Independent for oral hygiene at discharge* 74 (78 %) 
Independent for oral hygiene at one month* 78 (83 %) 
Days between admission to hospital and first data 
collection (median and range) 
2, 33 
Days between discharge from hospital and second data 
collection (median and range) 
0, 11** 
Days between stroke and third data collection (median 
and range) 
0, 11 
Days on acute hospital ward† (median and range) 5, 12 
More than 30 days in hospital*† 30 
Suspected/diagnosed AP on admission* 6 (6 %) 
Developed AP during hospital admission* 11 (11 %) 
Incidence of AP over one month period 11 (11 %) 
Mortality within one month of stroke 9 (9 %) 
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 Cause of death:  
 Pneumonia 5 (5 %) 
 Other (stroke, cardiac disease) 4 (4 %) 
Note. †Excluding participants who died while in hospital, SD = standard 
deviation, * refers to the number of participants, ** refers to the number of days prior 










Measurement Point Lower 
quartile 
Median Cq Upper 
quartile 
Streptococcus Admission 17.74 18.63 21.39 
Discharge 17.92 20.85 26.13 
One Month 18.18 19.99 21.93 
S. pneumoniae Admission 24.79 25.74 26.30 
Discharge 23.43 25.63 26.95 
One Month 24.92 26.23 26.62 
S. aureus Admission 40 40 40 
Discharge 26.85 28.09 29.34 
One Month 27.85 27.85 27.85 
E. coli Admission 17.17 17.27 17.37 
Discharge 40 40 40 
One Month 40 40 40 
K. pneumoniae Admission 40 40 40 
Discharge 29.36 29.53 29.71 
One Month 40 40 40 
P. aeruginosa Admission 29.42 29.85 30.18 
Discharge 27.23 29.68 30.33 
One Month 29.71 30.01 30.39 
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amounts of bacteria and participants with relative bacteria levels within this range 
were characterised as having ‘medium’ amounts of bacteria.  
Eighteen participants (18 %) had no detectable pathogens at any sampling 
point, 25 participants (25 %) had at least one pathogen at all three sample times and 
one participant (P46; 1 %) had two pathogens present at all three time points. The 
proportion of participants with detectable levels of pathogenic bacteria at each 
sampling location is depicted in Figure 58. There was a significant association 
between the proportion of patients with detectable levels of pathogenic  
bacteria and the patients’ location at the time of sampling [χ2 (2) = 6.38, p = .04]. 
Specifically, the greatest proportion of detectable oral pathogens was from patients 
sampled on an acute hospital ward. 
Streptococcus were the most commonly detected bacteria, whereas S. aureus, 
K. pneumoniae and E. coli were extremely rare (Figure 59). Levels of bacteria were 
not significantly different at the different time points [F(1.11, 7.74) = 0.45, p = .54, 1 
– β = .09] (Figure 60). Epsilon (ε) was 0.55, as calculated according to Greenhouse & 
Geisser (1959) and was used to correct the one-way repeated measures ANOVA. 
Because fourteen participants discharged within 24 hours of baseline testing, the same 
data were used for their discharge measures. A second one-way repeated-measures 
ANOVA was run to determine if excluding these participants from the dataset made a 
difference to the ability to measure changes in bacteria levels over time. The second 
model was not statistically significant [F(1.03, 5.17) = 0.26, p = .64, 1 – β = .11].  
None of the six target bacteria displayed a significant change in prevalence at 
the three measurement points (Table 16). Repeated testing excluding those 





Figure 58. The proportion of participants with detectable levels of pathogenic bacteria 




















































































Figure 60. Cq values of all target bacteria at three measurement points (median and 




































Prevalence of Six Target Bacteria at Three Measurement Points 
 
Bacteria Mean Cq at 
baseline 
Mean Cq at 
discharge 
Mean Cq at one 
month 
b SE b p 95 % CI 
Streptococcus 20.63 22.32 20.32 20.52 0.91 .06 19.71 – 22.34 
S. pneumoniae 25.43 25.16 25.56 -0.27 0.37 .46 -1.00 – 0.45 
S. aureus 40 28.09 27.85 -0.06 0.07 0.44 -0.23 – 0.11 
E. coli 17.27 N.D N.D 0.11 0.09 0.22 -0.07 – 0.29 
K. pneumoniae N.D 29.53 N.D N/A N/A N/A N/A 
P. aeruginosa 29.4 28.92 29.98 0.08 0.21 0.71 -0.34 – 0.49 
Note. CI = confidence interval, N.D = not detected. The occurrence of K. pneumoniae was too low for linear mixed modelling.
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The logistic regression model did not significantly predict levels of total bacteria at 
admission to hospital [p = .09] or discharge from hospital [p = .27]. At one  
month, the model did not significantly predict total bacteria levels [p = .08]. 
Further logistic regression modelling did not significantly predict levels of 
Streptococcus at admission [p = .75], discharge [p = .44] or one month [p = .37]. 
There was a significant main effect of gender on levels of S. pneumoniae at admission 
[χ2(2) = 8.47, p = .01], with being female associated with higher levels of this 
bacterium. The model did not predict levels of S. pneumoniae at discharge [p = .17] or 
one month [p = .94]. The model did not predict levels of S. aureus at discharge [p = 
.32] or one month [p = .17] and levels of this bacterium at admission were too low for 
analysis. Levels of K. pneumoniae were also too low for analysis. The model did not 
predict levels of P. aeruginosa at admission [p = .32] or one month [p = .20]. Gender 
had a significant main effect on levels of P. aeruginosa at discharge [χ2(2) = 9.26, p = 
.01], with females more likely to have medium or high levels of bacteria compared to 
males. There was also a main effect of age, with younger patients more likely to have 
medium or high levels of this bacterium at discharge [χ2(2) = 9.39, p = .01]. The 
model did not predict levels of E. coli at admission [p = .43], with levels of this 
bacterium at discharge and one month too low for analysis.  
10.4.2. Changes in cough reflex sensitivity over time. 
Changes in cough reflex thresholds are displayed in Figure 61. Data were not 
normally distributed. Cough reflex thresholds remained identical across admission, 
discharge and at one month [Median = 0.40 mol/L]. Cough reflex thresholds did not 
significantly differ by time point [F(2, 166) = 0.12, p = .88, 1 – β = .08]. When 
participants who discharged within 24 hours of baseline testing were excluded, there 


























0.05, p = .95].   
The multiple regression model significantly predicted baseline cough reflex 
thresholds [F(12, 100) = 2.52, p = .007, 1 – β = .78]. R2 for the first model was 11 %, 
indicating a small effect size (Cohen, 1988). The addition of bacteria levels and time 
of testing as predictors of cough reflex thresholds increased the R2 to 26 %, 
suggesting that these variables accounted for an additional 15 % of the variance in 
cough reflex thresholds. Gender was revealed as a significant predictor of baseline 
cough reflex thresholds, with being female associated with higher cough reflex 
thresholds [p = .02]. Regression coefficients and standard errors can be found in Table 
17.  
At discharge, the basic linear regression model significantly predicted cough 
reflex thresholds [F(3, 92) = 3.32, p = .02, 1 – β = .11], however no individual 
predictor emerged as significantly associated with cough reflex thresholds. The 
addition of time of testing and bacteria levels as predictors did not significantly 
improve the model [F(13, 92) = 1.39, p = .18, 1 – β = .72]. The overall model had an 
R2 of 19 %, indicating a small effect (Cohen, 1988). Regression coefficients and 
standard errors can be found in Table 18. 
At one month, the basic linear regression model significantly predicted cough 
reflex thresholds [F(3, 89) = 3.49, p = .02, 1 – β = .08], however no individual 
predictor emerged as significantly associated with cough reflex thresholds. The 
addition of time of testing and bacteria levels as predictors did not significantly 
improve the model [F(12, 89) = 1.45, p = .16, 1 – β = .14].  The overall model had an  
R2 of 11 %, indicating a small effect (Cohen, 1988). Regression coefficients and 
standard errors can be found in Table 19. The relationship between cough reflex 
sensitivity and levels of each bacteria is depicted in Figure 62.  
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Table 17  
Multiple Regression Models Predicting Cough Reflex Thresholds on Admission to 
Hospital 
 B SE B β p 
Step 1  
 Constant .84 .22  .00 
 Age -.01 .00 -.18 .09 
 Gender .14 .06 .22 .03* 
 Smoking .07 .10 .07 .51 
Step 2  
 Constant .61 .23  .01 
 Age -.00 .00 -.12 .25 
 Gender .16 .06 .24 .02* 
 Smoking .05 .11 .05 .66 
 High levels of Streptococcus .03 .07 .04 .66 
 Moderate levels of Streptococcus .16 .09 .18 .07 
 High levels of S. pneumoniae .15 .12 .14 .20 
 Moderate levels of S. 
pneumoniae 
.05 .14 .03 .74 
 High levels of E. coli .51 .32 .16 .12 
 High levels of P. aeruginosa .24 .14 .18 .09 
 Moderate levels of P. aeruginosa -.07 .22 -.03 .74 
 Testing was at noon .13 .07 .18 .08 
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Results from Multiple Regression Models Predicting Cough Reflex Thresholds at 
Discharge from Hospital 
 B SE B β p 
Step 1  
 Constant .81 .25  .00 
 Age -.00 .00 -.14 .21 
 Gender .13 .07 .18 .08 
 Smoking .17 .12 .15 .16 
Step 2  
 Constant .59 .29  .04 
 Age -.00 .00 -.05 .67 
 Gender .15 .08 .21 .07 
 Smoking .21 .13 .19 .11 
 High levels of Streptococcus .01 1.00 .01 .92 
 Moderate levels of Streptococcus -.22 .15 -.16 .14 
 High levels of S. pneumoniae .14 .27 .06 .61 
 Moderate levels of S. pneumoniae .09 .12 .09 .43 
 High levels of P. aeruginosa .16 .22 .08 .48 
 Moderate levels of P. aeruginosa .28 .38 .08 .47 
 High levels of S. aureus -.22 .35 -.06 .54 
 Moderate levels of S. aureus -.22 .35 -.06 .53 
 Testing was at noon -.09 .10 -.11 .35 
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Note. R2 = .10 for Step 1 (p < .05), ΔR2 = .09 for Step 2 (p > .05).  
 Testing was in the afternoon .18 .10 .19 .10 
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 Table 19.  
Results from Multiple Regression Models Predicting Cough Reflex Thresholds at One 
Month Post-stroke 
 B SE B β p 
Step 1  
 Constant .90 .26  .00 
 Age -.01 .00 -.16 .14 
 Gender .10 .08 .12 .21 
 Smoking .21 .12 .19 .09 
Step 2  
 Constant .82 .27  .00 
 Age -.00 .00 -.11 .35 
 Gender .12 .08 .15 .15 
 Smoking .22 .13 .20 .09 
 High levels of Streptococcus -.15 .11 -.15 .20 
 Moderate levels of Streptococcus .05 .15 .04 .75 
 High levels of S. pneumoniae -.02 .13 -.02 .90 
 Moderate levels of S. pneumoniae .18 .17 .11 .30 
 High levels of P. aeruginosa .29 .20 .17 .14 
 Moderate levels of P. aeruginosa .21 .22 .11 .34 
 High levels of S. aureus -.15 .37 -.04 .69 
 Testing at noon vs. in the morning -.11 .10 -.13 .28 
 Testing was in the afternoon vs. -.09 .09 -.12 .31 
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Figure 62. The relationship between mean bacteria levels (expressed as Cq) and 
cough reflex sensitivity levels. The dashed line represents the assay limit of detection 















































10.4.3. Prevalence of aspiration pneumonia. 
Six participants (6 %) presented to hospital with suspected pneumonia, eleven 
participants (11 %) developed AP during hospitilisation with one of these participants 
also testing positive for influenza. There were no new diagnoses of AP following 
discharge.  
The multinomial logistic regression models did not predict the occurrence of 
AP at admission to hospital regardless of whether target bacteria were combined 
[χ2(5) = 2.63, p = .76] or categorised individually [χ2(10) = 7.42, p = .69]. Similarly, 
the regression models did not predict the occurrence of AP at discharge from hospital 
regardless of whether target bacteria were combined [χ2(5) = 4.74, p = .45] or 
categorised individually [χ2(11) = 13.66, p = .25]. The relationship between overall 
levels of bacteria over time and the incidence of aspiration pneumonia in all 
participants is displayed in Figure 63. The relationship between specific bacteria 





Figure 63. The relationship between bacteria numbers (expressed as Cq) across all 
target bacteria and time in participants with acute stroke and dysphagia. Participants 
who developed aspiration pneumonia are indicated in colour. The dashed line 
represents the detection limit of the assay. Points on the dashed line indicate that no 




















































































































































































Figure 64. The relationship between levels of target bacteria (expressed as Cq) at 
different sampling points among patients who developed AP. 

















Chapter 11. Discussion 
The aim of this thesis was to investigate contributing factors to the development of 
AP among patients with acute post-stroke dysphagia and evaluate methods in which 
AP may be prevented in this population. For the first time, diurnal variation in 
reflexive cough sensitivity was investigated using the facemask/tidal breathing 
method. No evidence of a diurnal effect was found, challenging current views in CRT 
methodology. Adaptation to the test, as described in similar studies, was confirmed. 
This has implications for clinicians and researchers who use repeated outcome 
measurements.  
This is the first record of the effects of the Dysphagia in Stroke Protocol 
(DiSP) on functional patient outcomes. The DiSP is unique in that it incorporates 
standardised management guidelines, screening for silent aspiration, instrumental 
assessment and CRT methods that are appropriate for a neurologically-impaired 
population. A significant reduction in AP was observed, as well as improvements in 
LOS, post-stroke independence and diet level tolerance. Despite significantly 
improved patient outcomes, other variables not accounted for in this study appear to 
influence these positive outcomes. The extent to which these results can be attributed 
to the DiSP is unclear and warrants further investigation.  
A relationship between oral bacteria, cough reflex sensitivity and AP in this 
population could not be confirmed. A low observed rate of AP and difficulties 
recruiting patients with severe stroke-related impairment contributed to low statistical 
power. The hypothesis that oral bacteria levels are related to cough reflex sensitivity 
and AP is theoretically sound and studies with larger sample sizes may reveal this. 
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Data from the present study represent a valuable contribution to future study designs 
and power calculations.  
11.1. Cough Reflex Testing Methodology 
Although CRT has been used in the field of respiratory medicine for over 60 years 
(Bickerman et al., 1954; Bickerman, German, Cohen, & Itkin, 1957), its application to 
the field of speech-language therapy is relatively recent. Given the wide variability in 
CRT methods, including tussive agents, nebulisers, method of administration and 
outcome measurement, it is vital that users of the CRT understand its limitations, 
including test reproducibility and confounding variables. 
Since Pounsford and Saunders (1985) first reported diurnal variation in cough 
reflex sensitivity, time of testing has been considered a major confounding variable 
(Morice et al., 2001; Nakajoh et al., 2000) in clinical research. However, diurnal 
variation has only been described in CRT using a vital-capacity method. Study III 
aimed to measure variation in cough reflex sensitivity at different times of the day in 
healthy young adults using the tidal-breathing method that is commonly used in 
clinical assessment and attempting to control for oral bacteria. It was hypothesized 
that there would be no significant differences in cough reflex sensitivity when 
measured at different times of the day. 
11.2. Diurnal Variation in Cough Reflex Sensitivity. 
No evidence of diurnal variability in cough reflex sensitivity was observed and the 
null hypothesis was rejected. This is in direct contrast to the findings reported by 
Pounsford and Saunders (1985). One possible explanation for this difference could be 
related to oral bacteria levels. While the present study controlled for oral bacteria at a 
basic level by having participants brush their teeth prior to each testing session, the 
historical study by Pounsford and Saunders did not. Watando et al. (2004) 
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demonstrated significantly improved reflexive cough thresholds among elderly rest 
home residents who underwent an intensive oral hygiene regime, although the 
mechanism for this improvement remains unknown. In Study III, an attempt was 
made to characterise the relationship between pathogenic oral bacteria and cough 
reflex sensitivity, however findings were limited by low statistical power and no firm 
conclusions were drawn. To date, there remains a lack of empirical research that 
adequately describes the relationship between oral bacteria and cough reflex 
sensitivity. However, given that Pounsford and Saunders found significantly higher 
cough thresholds over the course of the day as oral bacteria levels presumably 
increased, it is possible that the true variable of influence in their study was oral 
bacteria and not time of day.  
 The average SCT in the present study was 0.6 mol/L (morning and afternoon 
tests) compared to ~ 0.2 mol/L (morning) and ~ 0.4 mol/L (afternoon) reported by 
Pounsford and Saunders (1985). Normative data established using the tidal 
breathing/face mask method suggest that the majority of young, healthy adults have a 
suppressed cough reflex threshold of 0.8 mol/L (Monroe et al., 2014). The reason for 
these discrepancies is most likely due to methodological differences. It is well-
established that differences in CRT administration can affect the deposition of drug 
particles throughout the respiratory tract. This can be a function of nebuliser flow rate 
(Barros et al., 1990), administration of the aerosol (Wolfsdorf et al., 1969), individual 
respiratory rate, irritation and coughing (Barros et al., 1990; Pounsford & Saunders). 
For example, presenting the aerosol via a mouthpiece (e.g. Pounsford & Saunders) is 
likely to deposit the majority of particles in the lower respiratory tract (Wolfsdorf et 
al.), compared to presentation via a facemask (e.g. the present study and Monroe et 
al.), which deposits the majority of particles in the upper respiratory tract (Wolfsdorf 
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et al.). Such differences in methodology between Pounsford and Saunders and the 
present study are the obvious source of the differing cough reflex thresholds, but do 
not explain why Pounsford and Saunders observed diurnal variation using their CRT 
method. Further investigation is required to satisfactorily answer this question. 
Eleven participants (21 %) failed to trigger a SCT during either assessment. 
This number is consistent with normative data (Monroe et al., 2014). It is unlikely that 
the present study suffered from a ‘ceiling effect’, as citric acid concentrations of up to 
1.2 mol/L were presented to participants. According to norms, 96 % of healthy 
individuals produce a SCT by this concentration (Monroe et al.).  
11.3. Reproducibility of the Cough Reflex Test. 
A significant order effect was identified in SCTs that was not related to time of 
testing, supporting the theory that a degree of supramedullary influence over the 
cough reflex is possible in healthy participants (Hegland et al., 2012). This is in line 
with previous reports of a learning effect in CRT (Bickerman et al., 1954; Bickerman, 
Cohen, German, & Itkin, 1956; Pounsford & Saunders, 1985), with second 
presentations resulting in higher cough reflex thresholds (Hoffmeyer et al., 2013; 
Morice et al., 1992) as subjects learn to exert greater control over their response.  
 It has long since been recognised that in order for CRT to be clinically useful, 
subjects must respond in a uniform and consistent manner and there must be within-
subject reproducibility (Bickerman et al., 1954). Cough response to citric acid is 
reproducible within one to three dose levels when measured on the same day (Barber 
et al., 2005; Bickerman et al., 1957; Wright, Jackson, Thompson, & Morice, 2010) 
and within one dose level when measured within the same week (Pounsford & 
Saunders, 1985) and the same month (Di Franco et al., 2001; Rees & Clark, 1983; 
Schmidt, Jörres, & Magnussen, 1997; Wright et al., 2010), with the exception of one 
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study using a Mefar dosimeter protocol (Wright et al.). However, the definition of 
“dose level” differs widely between studies. This can be problematic for clinical 
application, where a difference of one dose level may constitute the difference 
between a pass/fail on clinical examination (Addington, Stephens, & Gilliland, 1999; 
Miles et al., 2013a). Standardisation of CRT methods would greatly improve the 
ability to synthesize results across studies and apply the findings to clinical 
populations. Despite the limitations of current CRT methods, the test has high 
reported sensitivity and specificity for detecting silent aspiration in clinical 
populations (Miles et al., 2013b; Wakasugi et al., 2008, 2014) and, as discussed in 
Study I, when CRT is incorporated into a standardised management protocol there is 
an associated reduction in AP. Issues with test-retest reliability may be less relevant 
for clinical populations who typically only require a single test.  
The only identified data regarding the reproducibility of citric acid CRT using 
a facemask method is from 1957 (Bickerman et al.) where reproducibility was 
measured over only four hours. In 2007, the European Respiratory Society (Morice et 
al., 2007) called for standardisation of all CRT methods and increased information 
regarding the reproducibility of CRT. This request remains to be satisfied. In the 
meantime, clinicians wanting to incorporate CRT into their clinical practice must pay 
close attention to CRT methodology and be cautious in their interpretation of results 
from repeated CRTs. Based on the findings of the present study and others 
(Hoffmeyer et al., 2013; Morice et al., 1992), a higher CRT threshold on subsequent 
testing may not necessarily indicate worsening reflexive cough function, but rather 
adaptation to the test.        
The question of which cough reflex threshold more accurately represents an 
individual’s true cough reflex threshold is debateable. It can be argued that, for the 
 
 260 
first assessment, the role of expectation and cortical modulation may exert less 
influence on the individual’s response. On the other hand, perhaps the second result 
more accurately represents the true reflex, as the individual reaches the point where 
they can (presumably) no longer over-ride the cortical modulation that includes the 
learning effect. Future work is needed to clarify this issue.   
11.4. Limitations. 
There are inherent limitations in applying results from a healthy, young population to 
a clinical population. In Study I, participants were frequently observed to be 
competitive about achieving a more successful suppression of cough during their 
second assessment, despite the fact that they were not told what their first SCT was. 
In our young, healthy participants the effect of expectation and adaptation to the test 
was greater than one dose above initial thresholds. It is unlikely that a clinical 
population would have the same motivation and cognitive ability. Perhaps then, the 
issue of test repeatability becomes less relevant.  
Results from the present study offer no evidence of diurnal variation in cough 
reflex sensitivity in young, healthy individuals using citric acid CRT and the tidal 
breathing/facemask method. There is, however, an order effect irrespective of time of 
day, confirming that healthy participants are able to volitionally modulate their cough 
response. In the present study, this order effect was greater than one dose above initial 
thresholds. Translating these findings to clinical practice, clinicians should interpret 
the results of repeated cough reflex tests with caution. 
11.5. Reducing Aspiration Pneumonia. 
Based on prior research (Addington, Stephens, & Gilliland, 1999; Miles et al., 2013a; 
Wakasugi et al., 2008), it was hypothesized that the DiSP would guide clinicians 
towards making appropriate management decisions that would ultimately result in a 
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reduced rate of AP. This research confirms this hypothesis. Incorporating the DiSP 
into routine practice significantly improved patient outcomes. This study supports 
previous research documenting reduced AP rates when clear clinical decision-making 
pathways are in place for dysphagia screening (Hinchey et al., 2005; Lakshminarayan 
et al., 2010; Odderson et al., 1995; Yeh et al., 2011) and management (Addington, 
Stephens, & Gilliland, 1999; Burek et al., 2008; Odderson & McKenna, 1993). The 
effectiveness of such pathways may result from the elimination of bias imposed by 
clinical judgement as a contributing factor in patient outcomes. Similar research that 
used CRT but did not dictate subsequent management found no difference in AP rates 
or mortality (Miles et al., 2013a). When taken in the context of the study by Miles et 
al. (2013a), it can be inferred that the use of a protocol may be as important, or indeed 
more important, than the CRT itself in reducing the risk of AP in patients with acute 
stroke. The advantage of the DiSP protocol over most other published protocols is 
that it provides the clinician with information about patients’ risk of silent aspiration 
and includes clear guidelines on the appropriate management of patients at high risk 
of, or identified as presenting, silent aspiration.  
The DiSP accounted for only 8 % of the reduction in AP with individual 
patient factors accounting for an additional 9 %. The remaining 83 % of the variance 
was unexplained in the regression model. However, the model did correctly predict 84 
% of pneumonia cases based on the DiSP. The DiSP was the only major change in 
medical practice that occurred since the Miles et al. (2013a) study, supporting the 
hypothesis that the results are attributable, in part, to this protocol. 
Of note, more patients passed their initial CRT in the DiSP group (73 %) 
compared to the control group (61 %), suggesting that there may have been more 
‘silent aspirators’ in the control group. It is concerning that clinicians in the control 
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group, despite being able to identify potential silent aspirators, had a low referral rate 
for VFSS at 46 %. This highlights the importance of a standardised approach to 
dysphagia assessment. The rates of CRT ‘fails’ in both the DiSP group (27 %) and 
control group (38 %) are higher than the 10 % fail rate reported by Addington et al. 
(1999) however, the difference in tussive agent and CRT administration used by 
Addington et al. may explain this difference in findings. Furthermore, Addington et 
al. do not describe how data from patients who could not achieve a complete lip seal 
or follow test instructions were handled. Other published reports where citric acid 
CRT was used report fail rates of 27 % among patients with acute stroke (Guillén-
Solà et al., 2015) and 23 – 45 % among patients with mixed aetiologies (Miles et al., 
2013b; Wakasugi et al., 2008, 2014), which are similar to the fail rates observed in the 
present study. 
11.6. Reducing Mortality 
Use of the DiSP did not result in decreased mortality or pneumonia-related 
mortality. Although not statistically significant, mortality rates were slightly higher in 
the DiSP group, which may be clinically significant. This was a concerning finding 
and reinforces the vulnerability of this patient population. It is unlikely that the higher 
mortality rates in the DiSP group were due to site-specific differences in medical 
practice, as study site did not emerge as a main effect in the regression model.  
Examination of specific cases of pneumonia-related mortality in the DiSP 
patients revealed that the majority (63 %) had passed their initial CRT, with 
subsequent feeding management decisions made at the discretion of the SLT. It could 
be hypothesized that this group may represent patients with false negative results on 
the CRT who were inappropriately recommended an oral diet. This may also reflect 
weaknesses in clinical practice patterns. There was one case where a SLT did not 
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refer a patient for VFSS until the sixth review, despite noting overt signs of aspiration 
on five prior reviews. While the DiSP may be effective at identifying and managing 
patients with silent aspiration, future iterations of the DiSP should carefully consider 
ways to improve the management of patients who pass the CRT. Cases such as this 
highlight the need for SLTs to provide standardised management rather than relying 
on clinical judgement. 
It is possible that other differences between the groups existed, such as a 
higher tendency for patients/families to request ‘comfort cares’ rather than aggressive 
medical intervention in the DiSP group, or the presence of other comorbidities that 
were not measured. Naughton et al. (2000) provide a model for predicting mortality in 
elderly patients with community-acquired pneumonia. Increased respiratory and pulse 
rate, altered mental status and co-existing dementia were all significant predictors of 
pneumonia-related mortality, with the probability of death greater than 30 % if two or 
more of these features are present (Naughton et al., 2000). Future studies should 
consider incorporating these diagnostic outcomes into regression analysis models for 
mortality. 
11.7. Secondary Benefits of the DiSP 
 The findings from the present study suggest that the DiSP not only had a 
direct effect on AP but had secondary benefits for patients as well. It was 
hypothesized that patients in the DiSP group would have a significantly reduced 
length of hospital admission compared to patients in the control group. This 
hypothesis was accepted, with a reduction in acute length of stay from nine to six 
days and reduction in total hospitalisation from 32 to 24 days. This may be 
attributable to the lower incidence of AP in the DiSP group, resulting in a less 
complicated course of admission. Another possibility is that infections such as AP can 
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suppress neural recovery from stroke (Aslanyan et al., 2004). Pneumonia, in 
particular, can cause hypoxia and result in extension of the stroke (Aslanyan et al., 
2004). Lower infection rates in the DiSP patients may have contributed towards their 
overall stroke recovery and resulted in a reduced length of hospitalisation.  
 Another secondary benefit from the DiSP that was not hypothesized was 
improved post-stroke independence, as evidenced by a greater proportion of DiSP 
patients living in their own home or a rest home at three months post-stroke compared 
to control patients, who were more likely to be in hospital. This is the first report of 
improved long-term benefits in a stroke population following the implementation of a 
dysphagia protocol. As mentioned above, this effect may have been due in part to 
lower rates of AP among DiSP patients resulting in improved stroke recovery and 
independence. Of course, domicile is but one facet of an individual’s independence. 
Future research in this area may benefit from including a more standardised approach 
to measures of independence, such as the Functional Independence Measure™ (Guide 
for the Uniform Data Set for Medical Rehabilitation, 1996). Such an approach was 
not possible in the present study due to inconsistent documentation in patients’ 
medical files but would have admittedly increased the validity of the findings.  
 It was also hypothesized that the DiSP would result in improvements in diet-
level tolerance and route of intake. The specific hypothesis that significantly fewer 
DiSP patients would require an alternative route of intake compared to control 
patients could not be accepted; however, the low overall rates of alternative (i.e. tube) 
feeding across both the DiSP group (n = 1) and the control group (n = 3) were likely 
too low to reveal meaningful differences. The hypothesis that diet restriction at three 
months would differentiate DiSP patients from control patients was accepted. While 
43 % of patients in the control group were on some form of modified diet, only 19 % 
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of DiSP patients continued to require diet modification. It is possible that the 
increased rate of VFS in the DiSP group meant that clinicians felt more confident 
about recommending higher (i.e. closer to normal) diet levels for these patients 
compared to clinicians in the control group, who relied more on clinical observation. 
The direct relationship between use of instrumental versus clinical assessment, 
clinician confidence and oral feeding outcomes has not been reported in the literature. 
Although quality of life was not included as an outcome measure in this study, there 
is evidence that patients generally do not enjoy texture-modified diets (Garcia, 
Chambers IV, & Molander, 2005; Ickenstein et al., 2010). It is reasonable to suggest 
that the DiSP, by means of improved diet level tolerance, may lead to improved 
quality of life among post-stroke patients. Further investigation is required to confirm 
this. 
  Not only do the results of the present study reflect positive functional 
outcomes for patients with acute stroke and dysphagia, in addition, the DiSP may 
benefit healthcare providers by reducing the costs associated with AP. Wilson (2012) 
reported that an additional $27,633 per patient was spent when pneumonia 
accompanied stroke. In the present study, no patients in the DiSP group were re-
admitted to hospital with AP during the three-month follow-up period, although there 
may have been other contributing factors to this besides the DiSP.  
The DiSP costs very little to implement, at less than $12 per test (cost of 
disposable face mask, tubing and sterile citric acid) plus a one-off cost of $400 per 
nebuliser. While there were increased costs associated with the increased rate of VFS, 
evidence from a recent cost-analysis model (Wilson & Howe, 2012) suggests that it is 
more cost-effective to refer every patient with acute stroke for a VFSS, compared to 
clinical examination alone or clinical examination followed by a VFSS. Clearly there 
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are ethical and resource limitations that prevent the implementation of VFS for every 
patient with acute stroke. The DiSP offers an alternative by identifying the patients 
who may benefit the most from VFS. A detailed cost-analysis study is needed to 
confirm the cost-benefit ratio of implementing the DiSP and is a suggested direction 
for future research. 
11.8. Changes in Clinical Practice 
Clinician adherence to the DiSP was encouragingly high at 90 %. Duncan et 
al. (2002) have reported wide variability of clinician compliance with stroke 
rehabilitation guidelines, from 18-92 % in acute rehabilitation settings. In the present 
study, clinicians were able to administer CRT and incorporate the protocol into 
clinical routine accurately and without the need for on-going support or training. 
Analysis of cases where the DiSP was not adhered to revealed a need for clarification 
around the use of compensatory strategies following VFSS. The DiSP does not 
currently include compensatory strategies which may contribute to confusion about 
appropriate management of some patients.  
The high rate of clinician adherence to the DiSP suggests that, overall, 
clinicians accepted the protocol. However, there were some exceptions. Qualitative 
analysis of informal comments suggested that some clinicians did not agree with the 
‘one-size-fits-all’ approach to dysphagia assessment. There were a few cases where 
patients with very mild stroke symptoms failed the CRT and were subsequently 
recommended nil-by-mouth and referred for a VFSS. Comments made by clinicians 
suggested that they found it difficult to justify this decision to patients and medical 
teams and did not necessarily agree with the decision themselves, preferring to 
proceed with a clinical evaluation of oral trials. Unfortunately, like any assessment of 
aspiration risk, the CRT does not have 100 % sensitivity and there is a trade-off 
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between identifying true positives and accepting the chance of also identifying false 
positives. Despite this, over-managing a small number of patients may be justified if 
the alternative is under-management of many patients, which can occur when 
clinicians rely solely on their own judgement. Without undertaking a formal, 
qualitative analysis of clinicians’ views on the DiSP, it is difficult to comment on 
overall acceptability. Future work in this area should consider analysing clinicians’ 
views on barriers and facilitators to incorporating the DiSP into clinical practice. This 
may provide insight into ways to increase adherence to the DiSP, which in turn may 
lead to further improvements in patient outcomes. 
 The results of the present study suggest a positive shift in clinical behaviour. 
Patients in the DiSP group were referred for instrumental swallowing assessment at a 
rate of 31 %, with 95 % of patients who failed the CRT referred for VFSS. This 
compares to reports of 25 % or less in the United Kingdom (Cocks & Ferreira, 2013), 
36 % in Canada (Martino, Pron, & Diamant, 2004) and 60 % in the United States of 
America (Carnaby & Harenberg, 2013), although these reports come from a variety of 
clinical settings and patient populations. A recent study from New Zealand (Miles et 
al., 2013a) identified a referral rate of just 12 % among patients with acute stroke and 
dysphagia. In the study by Miles et al. (2013a), clinicians who did not use CRT 
frequently used pneumonia as a clinical indicator of dysphagia, referring for 
instrumental assessment only once pneumonia had developed. In the present study, a 
change in clinical decision-making was evident. Only five patients developed AP 
prior to being referred for an instrumental swallowing assessment, four of whom had 
presented with suspected or diagnosed pneumonia on admission to hospital.   
There was a risk that the use of CRT may have led to clinician over-
confidence in managing dysphagia at the bedside, if the results of a passed CRT were 
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over-interpreted as meaning the patient was not dysphagic. In fact, the opposite was 
observed, with referral rates for VFSS significantly increased compared to historical 
data (Miles et al., 2013a). Furthermore, 36 % of referrals for VFSS in the DiSP group 
were for patients who had passed their initial CRT. The significant decrease in AP 
rates observed in the present study is likely to be a reflection of the structured 
approach to dysphagia management rather than the use of CRT alone.  
11.9. Managing Dysphagia by Withholding Oral Intake. 
The issue of managing dysphagia by withholding oral intake requires further 
comment. International guidelines for the management of acute stroke (Jauch et al., 
2013; Lindsay, Furie, Davis, Donnan, & Norrving, 2014; Stroke Foundation of New 
Zealand & New Zealand Guidelines Group, 2010) state that all patients with acute 
stroke should be nil per orem until their swallowing has been assessed and that this 
should occur within 24 hours of the stroke. The Royal College of Physicians (Gomes, 
Hookway, & Weekes, 2014) recommend that patients who are deemed unsafe for oral 
intake should be considered for enteral feeding within 24 hours. In the present study, 
patients’ swallowing was assessed within 1 day (on average) of admission to hospital 
with many patients (64 %) resuming oral intake following this assessment. The use of 
the DiSP delayed the resumption of normal oral intake for only ten patients (3.5 %) 
for an average of two days (range = 1 – 3 days). The remaining patients were found to 
require diet modifications following VFSS. These figures may be considered 
acceptable when taken in the context of the overall reduction in AP that was observed 
following initiation of the DiSP. For the ten patients, this short-term period of 
discomfort was managed with enteral hydration and administration of medication via 
alternative routes where possible.  
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11.10. Future Directions. 
Consistent with the discussion above, there are four issues that future research in this 
area should address. First, the use of a retrospective control group is admittedly 
problematic. This study design was unavoidable because the DiSP was already in 
place at the study location at the time this research was conducted, therefore no 
control group was available with the imposition of significant bias. However, a 
randomised controlled trial is needed to confirm this and is suggested for future 
research in this area.  
Second, SLPs and nursing staff were relied upon to identify potential research 
participants. It is possible that some patients were not identified by accident or 
because staff felt that patients or their families would not want to participate in 
research due to the seriousness of their condition. Several patients were also excluded 
from the study as their medical team made decisions about oral intake that over-rode 
the DiSP. In most cases, this involved patients with very mild stroke symptoms. By 
not including these patients in the study, the sample is biased against patients with 
mild strokes. Future work should make efforts to recruit patients with a variety of 
stroke-related impairments. 
Third, a criticism of the DiSP is that emphasis is placed on the function of a 
single cranial nerve (vagus), tested with the CRT. This test intends to identify patients 
with the potential for silent aspiration and subsequent AP. However, AP is, by nature, 
multifactorial and eliminating it will require a multi-faceted approach. Future work 
may consider expanding the DiSP to include the assessment and management of other 
known risk factors for AP, such as oral hygiene and mobility (Langmore et al., 1998; 
Langmore, Skarupski, Park, & Fries, 2002; Quagliarello et al., 2005; Terpenning et 
al., 2001).  
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Finally, including a survival curve analysis could also have been useful in 
revealing a critical window of time when patients with acute stroke were the most at 
risk for AP or identify a point during stroke recovery where the DiSP was the most 
effective in reducing AP rates. However, such an analysis requires detailed outcome 
measurement data that allows the researcher to pinpoint the day on which the 
infection presented. This was not possible in the present study due to the large 
variability in the documentation of patient symptoms and an absence of daily 
monitoring post-discharge from hospital, but is suggested for future work. 
11.11. Risk Factors for Aspiration Pneumonia: Pathogenic Oral Bacteria. 
The aspiration of pathogenic oral bacteria is another risk-factor for AP. Study III 
aimed to address this by investigating the relationship between pathogenic oral 
bacteria, cough reflex sensitivity and AP. Previous research (Watando et al., 2004) 
has suggested a potential relationship between oral bacteria levels and cough reflex 
sensitivity whereby reducing levels of oral bacteria through intensive oral hygiene 
was associated with improvements in reflexive cough sensitivity. However, the 
mechanism for such a relationship remains poorly understood. Patients with acute 
stroke and dysphagia are at risk of increased levels of pathogenic bacteria, poor cough 
reflex sensitivity and developing AP, yet the relationship between these variables 
remains undocumented.  
 In this study, it was hypothesized that relative levels of each of the target 
bacteria would increase from the point of admission to the point of discharge as 
participants may have been unable to perform their usual oral hygiene routines and 
relied on others to do this for them. Oral care is often overlooked in the context of 
acute medical or elderly care settings (Salamone, Yacoub, Mahoney, & Edward, 
2013) due to time constraints (Wårdh, Hallberg, Berggren, Andersson, & Sörensen, 
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2000), oral hygiene being perceived as an undesirable task (Wårdh et al., 2000), lack 
of awareness/education/training around the importance of oral hygiene (Kuramoto et 
al., 2011; Salamone et al., 2013; Talbot, Brady, Furlanetto, Frenkel, & Williams, 
2005; Wårdh et al., 2000), lack of formal oral hygiene protocols (Talbot et al., 2005) 
and patient non-compliance (Wårdh et al., 2000).  
11.12. Prevalence of Pathogenic Oral Bacteria. 
Relative levels of target bacteria did not significantly change over time and the null 
hypothesis was retained. This finding could be interpreted in several ways. Results 
support Zhu et al. (2008), who found that the oral carriage of coliforms did not 
significantly change over a six month period in patients with acute stroke. On the 
other hand, it is also possible that bacteria levels in the present study did increase over 
time, but that the study was insufficiently powered to detect this change [1 – β = .09], 
resulting in a Type II error. Previous research (Millns et al., 2003) has identified an 
increase in Gram-negative, anaerobic bacteria in the acute phase of stroke, with a 
decrease in bacteria levels associated with stroke recovery. In the present study, the 
proportion of patients with detectable oral pathogens also significantly decreased over 
time.  
It is also possible that the participants in the present study do not truly 
represent all patients with acute stroke and dysphagia. This is evidenced by low 
recruitment rates – out of 154 patients who met the inclusion criteria for the study, 52 
(34 %) declined to participate. The most frequently cited reason for declining was the 
patient was too unwell, therefore it is likely that the results of this study are biased 
towards “well” patients. An analysis of stroke-severity ratings to confirm this was not 
possible due to inconsistent reporting in participants’ medical records, however, the 
observation that 54 % of participants were able to independently complete oral 
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hygiene routines at admission to hospital suggests that the majority of the study 
population had only a mild physical impairment.  
Difficulties in obtaining saliva samples at the point of admission to hospital 
may also explain the lack of significant changes in relative bacteria levels. When a 
patient is admitted to hospital with an acute stroke, stabilization and medical 
treatment are prioritized, making it difficult to access patients for research and obtain 
true baseline measures. For this reason, it was decided that any bacterial measures 
obtained within the first 48 hours following admission would be considered 
‘admission’ measurements. The inherent flaw with this approach is that bacteria 
numbers increase exponentially over time in the absence of routine oral hygiene 
(Wilson, 2005). It is unlikely that the ‘admission’ measurements reported in the 
present study are a true reflection of patients’ actual bacteria levels at admission to 
hospital. Future research of this nature could investigate other options for expedited 
recruitment and outcome measurement, such as having a researcher present in the 
emergency/acute assessment unit or collaborating with medical staff to obtain saliva 
samples at the point of admission and seeking patient consent to use the samples for 
research post hoc.   
When attempting to compare bacteria levels at admission to bacteria levels at 
discharge from hospital, an unexpected difficulty was the wide variability in the 
length of hospitalization between participants. Some participants were admitted to and 
discharged from hospital on the same day, while others spent up to sixteen days on an 
acute stroke ward before being transferred to a rehabilitation ward. Collecting the 
second outcome measure after a certain number of days is one way to control for this 
variability, however this introduces a confounding variable of the participants’ 
location. In the present study, every attempt was made to collect the second saliva 
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sample whilst participants’ were still in hospital. It is possible that the variation in 
length of hospitilisation made it difficult to detect any differences in bacteria levels 
over time that may have been present. 
Another potential confounding variable when attempting to measure relative 
bacteria levels is the time the sample is taken. Due to the busy nature of an acute 
hospital ward and difficulties accessing participants, time of sampling was not able to 
be controlled for in the present study. However, time of testing was included in the 
regression analyses and did not emerge as a significant predictor of relative bacteria 
levels. As bacteria levels tend to fluctuate throughout the day, it is also possible that 
taking only three samples over a one-month period was an insufficient number to 
draw accurate conclusions about the changes in bacteria levels over time. Ewan et al. 
(Ewan et al., 2015) obtained five bacterial samples from elderly hospitalized patients 
and identified significant trends in bacterial prevalence. Bacteria can be transient 
colonizers and, in Study III, may not have been present on the days that sampling took 
place. Future research may benefit from increasing the number of samples, however 
this would also increase analysis costs.  
Alternatively, the results of the present study may be interpreted as evidence 
that patients on specialist acute stroke units are receiving adequate oral hygiene. 
Supporting this argument, the prevalence of S. pneumoniae in the present study was 
17-25 %, compared with a 29 % prevalence in a similar study of elderly, hospitalized 
patients with lower limb fractures (Ewan et al., 2015), the prevalence of S. aureus was 
1-2 % compared to 4-5 % reported elsewhere  (Bousbia et al., 2012; Ewan et al., 
2015) the prevalence of E. coli was 1 % compared to 8 % reported by Bousbia et al. 
(2012), the prevalence of Streptococcus was 38-57 % - lower than the 93 % 
prevalence previously reported in healthy participants (Rozkiewicz et al., 2006) and 
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the prevalence of P. aeruginosa was 5-10 %, lower than the 36 % prevalence in 
patients with post-stroke dysphagia reported by Hirota et al. (2010). On the other 
hand, P. aeruginosa, K. pneumoniae and E. coli are not typically found in healthy 
mouths, yet were detected in the present study within 48 hours of admission to 
hospital (P. aeruginosa and E. coli) and at discharge from hospital (K. pneumoniae). 
This finding suggests a 48-hour critical window may be present for preventing the 
colonization of potential respiratory pathogens in this patient population. Further 
comment on the adequacy of oral hygiene in the acute care setting is not possible, as 
the study was not designed to investigate this. Future research would benefit from the 
inclusion of control participants in order to draw clear conclusions on this topic. 
Of course, antibiotic use is a major confounding variable when attempting to 
draw comparisons between data from hospitalized patients and normative data as well 
as investigate relationships between bacteria levels and variables such as cough reflex 
sensitivity and AP. Unfortunately, in the present study, detailed information about 
patients’ antibiotic use was not available from medical records. Antibiotic use is the 
most likely explanation for the low observed rate of Streptococcus in the present 
study, as this species is highly prevalent amongst healthy individuals (Rozkiewicz et 
al., 2006). Watando et al. (2004) do not comment about whether antibiotic use was 
controlled for in their study of rest home residents and it is possible that some of their 
participants were also taking antibiotics. Future work in this area should consider 
excluding participants who are taking antibiotics. This would allow more accurate 
comparisons to normative data to be drawn.  
The outcome measurement tools used in the present study require further 
comment. Previous research (Ewan et al., 2009) has indicated that for bacteria such as 
S. aureus and P. aeruginosa, sampling via oral rinse is the preferred method. This was 
 
 275 
not possible in the present study due to the risk of aspiration in this cohort. Protected 
specimen brush sampling has also been suggested as a valid and reliable means of 
measuring respiratory pathogens (Mertens et al., 1998) however, this technique is not 
routinely conducted in New Zealand and was considered too invasive for the nature of 
this study. Oral swabs, while appealing due to their low level of invasiveness, patient 
acceptability and ease of use, are limited in their ability to collect saliva in patients 
with xerostomia, a condition not uncommon in the acute stroke population (Sellars et 
al., 2007). Although the use of nasopharyngeal swabs may have increased the yield of 
S. pneumoniae (Lieberman et al., 2006), sampling of oral bacteria was chosen because 
of the causative links between oral bacteria and AP (Bousbia et al., 2012; Simmons-
Trau et al., 2004; Watando et al., 2004; Yoneyama et al., 2002; Yoshino et al., 2001). 
It is possible that the use of oral swabs resulted in lower bacteria yields compared to 
other methods. The data presented here represent the best measurements that could be 
taken without invasive sampling. 
The present study measured bacterial outcomes in terms of relative levels 
rather than number of bacteria as it is not possible to convert directly from the amount 
of gDNA on a standard curve to a bacterial count (Siddiqi, Milne, Cullinan, & 
Seymour, 2014). Furthermore, measuring bacterial cells has little relevance in the 
present study due to a lack of published reports describing clinically relevant levels of 
bacteria. What constitutes a ‘healthy’ quantity of bacteria is yet to be documented and 
is necessary in order to draw comparisons between the oral bacteria in a person who 
has AP. Attempting to define clinically relevant bacteria levels was not possible in the 
present study due to the relatively low incidence of AP (10 %) and the limited number 
of repeated measures collected. However, among the participants who developed AP, 
36 % had relative levels of target bacteria at admission that were higher than the 
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average admission levels of participants who did not develop AP. This trend warrants 
further investigation as findings may have direct implications for AP-risk screening at 
admission to hospital.  
As the nature of this work was exploratory, it was decided to include a 
Streptococcus primer set rather than a S. mitis-specific primer set. Oral Streptococcus 
are found in abundance in the mouths of healthy adults (Malhotra-Kumar et al., 2004; 
Morita et al., 2004; Rozkiewicz et al., 2006) so were considered as a positive control 
in the present study and confirmation that the qPCR assays were functioning 
correctly. Due to S. mitis being the most dominant species of the oral Streptococcus 
(Malhotra-Kumar et al., 2004; Morita et al., 2004), evidence of amplification on 
qPCR can be considered as evidence of S. mitis. Of course, amplification of other 
Streptococcus spp cannot be ruled out and future work in this area should consider 
including a S. mitis-specific primer set to increase confidence in the interpretation of 
qPCR results.  
11.13. The Relationship Between Oral Bacteria and Aspiration Pneumonia. 
In contrast with a recent study which found a relationship between oral colonisation 
of E. coli/P. aeruginosa/S. aureus/Methicillin-resistant S. aureus (MRSA) and 
hospital-acquired pneumonia in elderly patients with lower limb fractures (Ewan et 
al., 2015), in the present study, AP was not associated with any bacterial variables. 
The main differences between these two studies are that Ewan et al. undertook 
bacterial sampling at five points during hospitalisation and measured hospital-
acquired pneumonia rates over a 90-day period, compared to the present study which 
undertook bacterial sampling at three points in time and measured aspiration-
pneumonia rates over a 30-day period. Ewan et al. report that 50 % of cases of 
pneumonia occurred after 25 days. Due to fluctuations in bacteria levels, increasing 
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the number of repeated measures of bacteria is likely to increase the chances of 
detecting transient colonisers. This in turn may reveal the relationship of these 
organisms to AP. For example, in the present study, the incidence of AP in those with 
S. aureus (n = 2) was 50 %; for those with P. aeruginosa (n = 20) the incidence was 
15 % and a single participant with K. pneumoniae developed AP (100 %). However, 
these figures are drawn from such low base numbers that it is difficult to draw firm 
associations. 
The prevalence of E. coli and S. aureus was slightly higher in the Ewan et al. 
study than the present study (2 % and 5 % versus 1 % and 2 %, respectively). 
However, the present study had a higher prevalence of P. aeruginosa at 5-10 % 
compared to 4 % reported by Ewan et al. Ewan et al.’s findings indicate that the 
presence of pathogenic oral bacteria is a significant factor in the development of 
hospital-acquired pneumonia in elderly patients with fractures. For patients with acute 
stroke, however, the pathogenesis of AP is more complex, involving other variables 
such as dysphagia severity and reflexive cough strength, which were not measured in 
the present study.      
The one-month mortality rate in the present study was 9 %, however, as noted 
above, the study was biased towards ‘well’ patients. Of those patients who died, 
pneumonia was the leading cause of mortality, accounting for 56 % of deaths. It is 
clear that interventions to prevent pneumonia in this population are warranted. 
Any relationship between bacteria and cough sensitivity was not apparent 
using clinically-relevant doses of citric acid. However, this relationship has 
previously been reported using lower doses of citric acid (Watando et al., 2004) and is 
worth investigating further. The present pilot study was insufficiently powered to 
detect this relationship, which may be due in part to power calculations that were 
 
 278 
based on a higher reported rate of AP (Miles et al., 2013a) than was observed. 
However, given the difficulties recruiting participants, the prolonged follow-up period 
and the time needed to develop qPCR assays, it was not possible to recruit more 
participants. This pilot study adds to the limited amount of literature describing 
clinical, microbiological, and pneumonia-related outcomes and will form the basis for 
future, large-scale studies investigating possible relationships between these variables. 
Measuring AP is difficult because there is no gold standard diagnostic test. 
The present study relied on previously published diagnostic criteria (Mann et al., 
1999), applied to documentation from physicians and nursing staff in participants’ 
medical files. This method of outcome measurement is limited by the accuracy of the 
documentation as well as the subjective observations of medical staff, for example, in 
observing for chest crepitations and crackles.  
11.14. Cough Reflex Sensitivity in Patients with Acute Stroke. 
Overall cough reflex sensitivity levels in patients with acute stroke did not change 
over time. This was an unexpected finding, given that patients were all in the acute 
stages of stroke recovery. Addington et al. (2005) described a temporary or permanent 
suppression of the reflexive cough response in the acute stages of stroke which they 
termed “brainstem shock”. This phenomenon was only observed in 12 % of the 
participants in the present study, who did not trigger a reflexive cough at the highest 
level of citric acid (1.2 mol/L) upon admission to hospital. Indeed, the vast majority 
of participants (70 %) had cough reflex sensitivity levels of 0.4 mol/L or less, which 
is within the normal range for elderly people (Monroe et al., 2014). This finding 
supports that the present study was biased towards ‘well’ patients.  
 As mentioned above, due to difficulties accessing patients immediately 
following their admission to hospital, the window of opportunity to measure patients’ 
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cough reflex sensitivity levels at their most impaired may have been lost. Future 
research in this area should consider ways to improve access to acute patients.  
 It is also possible that a Type II error was introduced, as suggested by the low 
observed power [1 – β = .08]. Another explanation for the lack of observed change in 
cough reflex sensitivity levels is the possibility of a flooring effect. The lowest dose 
of citric acid that was administered to participants was 0.4 mol/L. This dose was 
selected based on the average suppressed cough threshold level of healthy elderly 
people (Monroe et al., 2014). However, significant changes in cough reflex sensitivity 
levels over time have been documented in healthy elderly subjects using lower doses 
of citric acid. Watando et al. (2004) reported that participants’ cough reflex thresholds 
changed from approximately 0.15 mol/L to 0.08 mol/L over a 30-day period when 
provided with intensive, daily oral hygiene. It is possible that similar changes may 
have been observed in the present study if lower doses of citric acid were used.  
 Gender emerged as a significant predictor of cough reflex thresholds upon 
admission to hospital, with being female associated with higher cough reflex 
thresholds. This is in contrast to previous reports that females have lower cough reflex 
thresholds compared to males (Monroe et al., 2014; Rostami-Hodjegan et al., 2001). 
Given that this finding was not observed at discharge from hospital or at one month 
post-stroke, it is likely to be an incidental finding rather than a true gender effect.  
Cough reflex sensitivity was measured by a single researcher (S.D.) on the 
basis of a subjective rating of cough presence/absence. The CRT method used in the 
present study was selected due to its portability and ease of use in an acute hospital 
setting, however, future work in this area may benefit from the use of objective 
measures of reflexive cough, such as cough expiratory volume and peak expiratory 
flow rate, as well as the inclusion reliability measures. 
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Chapter 12. Concluding Remarks 
Aspiration pneumonia is a serious, yet largely preventable, complication of acute 
stroke. There is a growing body of evidence supporting the use of CRT in clinical 
dysphagia assessment. As CRT becomes more widely used, there is a need for 
standardisation of CRT methodology. This research does not support the need to 
control for time of testing, however, has identified that adaptation to the test may 
represent a potential confounding variable. Until a standard CRT method is accepted, 
clinicians and researchers should refer to the existing literature with close attention to 
methodology.  
This research contributes to the literature by providing evidence that an 
assessment and management protocol may be as important as the CRT itself in 
preventing AP. When CRT is used in the context of a protocol, the rate of AP in acute 
post-stroke patients significantly decreases. The DiSP protocol is appropriate for use 
in acute medical settings and requires little training or cost to implement. The addition 
of this protocol into clinical routine is endorsed. 
This research was not able to convincingly confirm or deny that a relationship 
exists between cough reflex sensitivity and oral bacterial levels, but has identified 
methodological limitations and established directions for future work in this area. If 
future research identifies a strong relationship between oral bacteria and cough reflex 
sensitivity, there would be an ideal opportunity for establishing oral hygiene 
interventions, which may further reduce rates of AP.  
AP remains an issue for stroke patients in New Zealand and internationally. 
Further research is needed to refine dysphagia protocols and understand the effects of 
oral bacteria on reflexive airway protection mechanisms. This will ultimately inform 
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